id	sid	tid	token	lemma	pos
ecj-9795	1	1	hrev_master	hrev_master	NOUN
ecj-9795	2	1	[	[	X
ecj-9795	2	2	page	page	NOUN
ecj-9795	2	3	26	26	NUM
ecj-9795	2	4	]	]	PUNCT
ecj-9795	3	1	[	[	X
ecj-9795	3	2	emergency	emergency	NOUN
ecj-9795	3	3	care	care	NOUN
ecj-9795	3	4	journal	journal	PROPN
ecj-9795	3	5	2021	2021	NUM
ecj-9795	3	6	;	;	PUNCT
ecj-9795	3	7	17:9795	17:9795	NUM
ecj-9795	3	8	]	]	X
ecj-9795	3	9	emergency	emergency	NOUN
ecj-9795	3	10	care	care	NOUN
ecj-9795	3	11	journal	journal	PROPN
ecj-9795	3	12	2021	2021	NUM
ecj-9795	3	13	;	;	PUNCT
ecj-9795	3	14	volume	volume	NOUN
ecj-9795	3	15	17:9795	17:9795	NUM
ecj-9795	3	16	abstract	abstract	ADJ
ecj-9795	3	17	hypercoagulability	hypercoagulability	NOUN
ecj-9795	3	18	is	be	AUX
ecj-9795	3	19	a	a	DET
ecj-9795	3	20	common	common	ADJ
ecj-9795	3	21	complication	complication	NOUN
ecj-9795	3	22	of	of	ADP
ecj-9795	3	23	the	the	DET
ecj-9795	3	24	systemic	systemic	ADJ
ecj-9795	3	25	inflammation	inflammation	NOUN
ecj-9795	3	26	related	relate	VERB
ecj-9795	3	27	to	to	ADP
ecj-9795	3	28	coronavirus	coronavirus	NOUN
ecj-9795	3	29	disease	disease	NOUN
ecj-9795	3	30	2019	2019	NUM
ecj-9795	3	31	creating	create	VERB
ecj-9795	3	32	debate	debate	NOUN
ecj-9795	3	33	within	within	ADP
ecj-9795	3	34	the	the	DET
ecj-9795	3	35	critical	critical	ADJ
ecj-9795	3	36	care	care	NOUN
ecj-9795	3	37	community	community	NOUN
ecj-9795	3	38	on	on	ADP
ecj-9795	3	39	the	the	DET
ecj-9795	3	40	therapeutic	therapeutic	ADJ
ecj-9795	3	41	utility	utility	NOUN
ecj-9795	3	42	of	of	ADP
ecj-9795	3	43	low	low	ADJ
ecj-9795	3	44	molecular	molecular	ADJ
ecj-9795	3	45	weight	weight	NOUN
ecj-9795	3	46	heparin	heparin	NOUN
ecj-9795	3	47	(	(	PUNCT
ecj-9795	3	48	lmwh	lmwh	NOUN
ecj-9795	3	49	)	)	PUNCT
ecj-9795	3	50	.	.	PUNCT
ecj-9795	4	1	we	we	PRON
ecj-9795	4	2	collected	collect	VERB
ecj-9795	4	3	data	datum	NOUN
ecj-9795	4	4	on	on	ADP
ecj-9795	4	5	consecutive	consecutive	ADJ
ecj-9795	4	6	patients	patient	NOUN
ecj-9795	4	7	with	with	ADP
ecj-9795	4	8	covid-19	covid-19	PROPN
ecj-9795	4	9	admitted	admit	VERB
ecj-9795	4	10	to	to	ADP
ecj-9795	4	11	the	the	DET
ecj-9795	4	12	emergency	emergency	NOUN
ecj-9795	4	13	department	department	PROPN
ecj-9795	4	14	of	of	ADP
ecj-9795	4	15	castel	castel	PROPN
ecj-9795	4	16	san	san	PROPN
ecj-9795	4	17	giovanni	giovanni	PROPN
ecj-9795	4	18	hospital	hospital	NOUN
ecj-9795	4	19	,	,	PUNCT
ecj-9795	4	20	between	between	ADP
ecj-9795	4	21	february	february	PROPN
ecj-9795	4	22	29th	29th	NOUN
ecj-9795	4	23	and	and	CCONJ
ecj-9795	4	24	april	april	PROPN
ecj-9795	4	25	7th	7th	NOUN
ecj-9795	4	26	,	,	PUNCT
ecj-9795	4	27	2020	2020	NUM
ecj-9795	4	28	.	.	PUNCT
ecj-9795	5	1	exclusion	exclusion	NOUN
ecj-9795	5	2	criteria	criterion	NOUN
ecj-9795	5	3	were	be	AUX
ecj-9795	5	4	age	age	NOUN
ecj-9795	5	5	<	<	X
ecj-9795	5	6	18	18	NUM
ecj-9795	5	7	years	year	NOUN
ecj-9795	5	8	,	,	PUNCT
ecj-9795	5	9	hospital	hospital	NOUN
ecj-9795	5	10	stay	stay	VERB
ecj-9795	5	11	<	<	X
ecj-9795	5	12	7	7	NUM
ecj-9795	5	13	days	day	NOUN
ecj-9795	5	14	,	,	PUNCT
ecj-9795	5	15	patients	patient	NOUN
ecj-9795	5	16	on	on	ADP
ecj-9795	5	17	dialysis	dialysis	NOUN
ecj-9795	5	18	and	and	CCONJ
ecj-9795	5	19	patients	patient	NOUN
ecj-9795	5	20	who	who	PRON
ecj-9795	5	21	had	have	AUX
ecj-9795	5	22	been	be	AUX
ecj-9795	5	23	transferred	transfer	VERB
ecj-9795	5	24	to	to	ADP
ecj-9795	5	25	other	other	ADJ
ecj-9795	5	26	centers	center	NOUN
ecj-9795	5	27	for	for	ADP
ecj-9795	5	28	which	which	PRON
ecj-9795	5	29	we	we	PRON
ecj-9795	5	30	could	could	AUX
ecj-9795	5	31	not	not	PART
ecj-9795	5	32	collect	collect	VERB
ecj-9795	5	33	data	datum	NOUN
ecj-9795	5	34	.	.	PUNCT
ecj-9795	6	1	of	of	ADP
ecj-9795	6	2	the	the	DET
ecj-9795	6	3	257	257	NUM
ecj-9795	6	4	patients	patient	NOUN
ecj-9795	6	5	included	include	VERB
ecj-9795	6	6	in	in	ADP
ecj-9795	6	7	the	the	DET
ecj-9795	6	8	study	study	NOUN
ecj-9795	6	9	,	,	PUNCT
ecj-9795	6	10	49	49	NUM
ecj-9795	6	11	(	(	PUNCT
ecj-9795	6	12	19.1	19.1	NUM
ecj-9795	6	13	%	%	NOUN
ecj-9795	6	14	)	)	PUNCT
ecj-9795	6	15	died	die	VERB
ecj-9795	6	16	during	during	ADP
ecj-9795	6	17	hospitalization	hospitalization	NOUN
ecj-9795	6	18	.	.	PUNCT
ecj-9795	7	1	we	we	PRON
ecj-9795	7	2	considered	consider	VERB
ecj-9795	7	3	a	a	DET
ecj-9795	7	4	wide	wide	ADJ
ecj-9795	7	5	set	set	NOUN
ecj-9795	7	6	of	of	ADP
ecj-9795	7	7	variables	variable	NOUN
ecj-9795	7	8	as	as	ADP
ecj-9795	7	9	independent	independent	ADJ
ecj-9795	7	10	variables	variable	NOUN
ecj-9795	7	11	(	(	PUNCT
ecj-9795	7	12	age	age	NOUN
ecj-9795	7	13	,	,	PUNCT
ecj-9795	7	14	sex	sex	NOUN
ecj-9795	7	15	,	,	PUNCT
ecj-9795	7	16	comorbidities	comorbiditie	NOUN
ecj-9795	7	17	and	and	CCONJ
ecj-9795	7	18	in	in	ADP
ecj-9795	7	19	-	-	PUNCT
ecj-9795	7	20	hospital	hospital	NOUN
ecj-9795	7	21	treatments	treatment	NOUN
ecj-9795	7	22	)	)	PUNCT
ecj-9795	7	23	.	.	PUNCT
ecj-9795	8	1	we	we	PRON
ecj-9795	8	2	used	use	VERB
ecj-9795	8	3	a	a	DET
ecj-9795	8	4	multivariate	multivariate	NOUN
ecj-9795	8	5	logistic	logistic	ADJ
ecj-9795	8	6	regression	regression	NOUN
ecj-9795	8	7	model	model	NOUN
ecj-9795	8	8	and	and	CCONJ
ecj-9795	8	9	,	,	PUNCT
ecj-9795	8	10	being	be	AUX
ecj-9795	8	11	heparin	heparin	ADJ
ecj-9795	8	12	the	the	DET
ecj-9795	8	13	only	only	ADJ
ecj-9795	8	14	one	one	NUM
ecj-9795	8	15	therapy	therapy	NOUN
ecj-9795	8	16	affecting	affect	VERB
ecj-9795	8	17	survival	survival	NOUN
ecj-9795	8	18	rate	rate	NOUN
ecj-9795	8	19	,	,	PUNCT
ecj-9795	8	20	we	we	PRON
ecj-9795	8	21	compared	compare	VERB
ecj-9795	8	22	prophylactic	prophylactic	ADJ
ecj-9795	8	23	lmwh	lmwh	NOUN
ecj-9795	8	24	(	(	PUNCT
ecj-9795	8	25	p	p	NOUN
ecj-9795	8	26	-	-	PUNCT
ecj-9795	8	27	lmwh	lmwh	NOUN
ecj-9795	8	28	)	)	PUNCT
ecj-9795	8	29	and	and	CCONJ
ecj-9795	8	30	therapeutic	therapeutic	ADJ
ecj-9795	8	31	lmwh	lmwh	NOUN
ecj-9795	8	32	(	(	PUNCT
ecj-9795	8	33	t	t	NOUN
ecj-9795	8	34	-	-	PUNCT
ecj-9795	8	35	lmwh	lmwh	NOUN
ecj-9795	8	36	)	)	PUNCT
ecj-9795	8	37	groups	group	NOUN
ecj-9795	8	38	.	.	PUNCT
ecj-9795	9	1	kaplan	kaplan	PROPN
ecj-9795	9	2	meier	meier	PROPN
ecj-9795	9	3	curve	curve	PROPN
ecj-9795	9	4	showed	show	VERB
ecj-9795	9	5	a	a	DET
ecj-9795	9	6	higher	high	ADJ
ecj-9795	9	7	survival	survival	NOUN
ecj-9795	9	8	probability	probability	NOUN
ecj-9795	9	9	in	in	ADP
ecj-9795	9	10	the	the	DET
ecj-9795	9	11	t	t	NOUN
ecj-9795	9	12	-	-	PUNCT
ecj-9795	9	13	lmwh	lmwh	NOUN
ecj-9795	9	14	and	and	CCONJ
ecj-9795	9	15	the	the	DET
ecj-9795	9	16	difference	difference	NOUN
ecj-9795	9	17	between	between	ADP
ecj-9795	9	18	the	the	DET
ecj-9795	9	19	two	two	NUM
ecj-9795	9	20	groups	group	NOUN
ecj-9795	9	21	was	be	AUX
ecj-9795	9	22	statistically	statistically	ADV
ecj-9795	9	23	significant	significant	ADJ
ecj-9795	9	24	according	accord	VERB
ecj-9795	9	25	to	to	ADP
ecj-9795	9	26	the	the	DET
ecj-9795	9	27	log	log	NOUN
ecj-9795	9	28	-	-	PUNCT
ecj-9795	9	29	rank	rank	NOUN
ecj-9795	9	30	or	or	CCONJ
ecj-9795	9	31	mantelhaenszel	mantelhaenszel	ADJ
ecj-9795	9	32	test	test	NOUN
ecj-9795	9	33	(	(	PUNCT
ecj-9795	9	34	p	p	X
ecj-9795	9	35	<	<	X
ecj-9795	9	36	0.0001	0.0001	NUM
ecj-9795	9	37	)	)	PUNCT
ecj-9795	9	38	.	.	PUNCT
ecj-9795	10	1	in	in	ADP
ecj-9795	10	2	a	a	DET
ecj-9795	10	3	stratified	stratified	ADJ
ecj-9795	10	4	analysis	analysis	NOUN
ecj-9795	10	5	by	by	ADP
ecj-9795	10	6	ventilation	ventilation	NOUN
ecj-9795	10	7	type	type	NOUN
ecj-9795	10	8	,	,	PUNCT
ecj-9795	10	9	the	the	DET
ecj-9795	10	10	subgroup	subgroup	NOUN
ecj-9795	10	11	of	of	ADP
ecj-9795	10	12	patients	patient	NOUN
ecj-9795	10	13	who	who	PRON
ecj-9795	10	14	benefited	benefit	VERB
ecj-9795	10	15	from	from	ADP
ecj-9795	10	16	therapeutic	therapeutic	ADJ
ecj-9795	10	17	lmwh	lmwh	NOUN
ecj-9795	10	18	was	be	AUX
ecj-9795	10	19	that	that	SCONJ
ecj-9795	10	20	in	in	ADP
ecj-9795	10	21	non	non	ADJ
ecj-9795	10	22	-	-	ADJ
ecj-9795	10	23	invasive	invasive	ADJ
ecj-9795	10	24	mechanical	mechanical	ADJ
ecj-9795	10	25	ventilation	ventilation	NOUN
ecj-9795	10	26	.	.	PUNCT
ecj-9795	11	1	using	use	VERB
ecj-9795	11	2	a	a	DET
ecj-9795	11	3	multivariate	multivariate	NOUN
ecj-9795	11	4	analysis	analysis	NOUN
ecj-9795	11	5	and	and	CCONJ
ecj-9795	11	6	adjusting	adjust	VERB
ecj-9795	11	7	for	for	ADP
ecj-9795	11	8	the	the	DET
ecj-9795	11	9	drugs	drug	NOUN
ecj-9795	11	10	intake	intake	NOUN
ecj-9795	11	11	,	,	PUNCT
ecj-9795	11	12	tlmwh	tlmwh	PROPN
ecj-9795	11	13	was	be	AUX
ecj-9795	11	14	the	the	DET
ecj-9795	11	15	only	only	ADJ
ecj-9795	11	16	therapy	therapy	NOUN
ecj-9795	11	17	impacting	impact	VERB
ecj-9795	11	18	on	on	ADP
ecj-9795	11	19	survival	survival	NOUN
ecj-9795	11	20	(	(	PUNCT
ecj-9795	11	21	hr	hr	NOUN
ecj-9795	11	22	0.293	0.293	NUM
ecj-9795	11	23	,	,	PUNCT
ecj-9795	11	24	p	p	X
ecj-9795	11	25	<	<	X
ecj-9795	11	26	0.001	0.001	NUM
ecj-9795	11	27	)	)	PUNCT
ecj-9795	11	28	.	.	PUNCT
ecj-9795	12	1	no	no	DET
ecj-9795	12	2	fatal	fatal	ADJ
ecj-9795	12	3	bleeding	bleeding	NOUN
ecj-9795	12	4	was	be	AUX
ecj-9795	12	5	observed	observe	VERB
ecj-9795	12	6	.	.	PUNCT
ecj-9795	13	1	therapeutic	therapeutic	ADJ
ecj-9795	13	2	dose	dose	NOUN
ecj-9795	13	3	of	of	ADP
ecj-9795	13	4	lmwh	lmwh	NOUN
ecj-9795	13	5	in	in	ADP
ecj-9795	13	6	patients	patient	NOUN
ecj-9795	13	7	admitted	admit	VERB
ecj-9795	13	8	to	to	ADP
ecj-9795	13	9	hospital	hospital	NOUN
ecj-9795	13	10	with	with	ADP
ecj-9795	13	11	covid-19	covid-19	PROPN
ecj-9795	13	12	pneumonia	pneumonia	NOUN
ecj-9795	13	13	was	be	AUX
ecj-9795	13	14	70	70	NUM
ecj-9795	13	15	associated	associate	VERB
ecj-9795	13	16	with	with	ADP
ecj-9795	13	17	a	a	DET
ecj-9795	13	18	decrease	decrease	NOUN
ecj-9795	13	19	risk	risk	NOUN
ecj-9795	13	20	of	of	ADP
ecj-9795	13	21	intra	intra	ADJ
ecj-9795	13	22	-	-	ADJ
ecj-9795	13	23	hospital	hospital	ADJ
ecj-9795	13	24	mortality	mortality	NOUN
ecj-9795	13	25	.	.	PUNCT
ecj-9795	14	1	introduction	introduction	NOUN
ecj-9795	14	2	coronavirus	coronavirus	NOUN
ecj-9795	14	3	disease	disease	NOUN
ecj-9795	14	4	2019	2019	NUM
ecj-9795	14	5	(	(	PUNCT
ecj-9795	14	6	covid-19	covid-19	PROPN
ecj-9795	14	7	)	)	PUNCT
ecj-9795	14	8	is	be	AUX
ecj-9795	14	9	a	a	DET
ecj-9795	14	10	systemic	systemic	ADJ
ecj-9795	14	11	infection	infection	NOUN
ecj-9795	14	12	characterized	characterize	VERB
ecj-9795	14	13	by	by	ADP
ecj-9795	14	14	high	high	ADJ
ecj-9795	14	15	risk	risk	NOUN
ecj-9795	14	16	of	of	ADP
ecj-9795	14	17	death	death	NOUN
ecj-9795	14	18	;	;	PUNCT
ecj-9795	14	19	it	it	PRON
ecj-9795	14	20	was	be	AUX
ecj-9795	14	21	first	first	ADV
ecj-9795	14	22	reported	report	VERB
ecj-9795	14	23	in	in	ADP
ecj-9795	14	24	wuhan	wuhan	PROPN
ecj-9795	14	25	,	,	PUNCT
ecj-9795	14	26	the	the	DET
ecj-9795	14	27	capital	capital	NOUN
ecj-9795	14	28	city	city	NOUN
ecj-9795	14	29	of	of	ADP
ecj-9795	14	30	hubei	hubei	PROPN
ecj-9795	14	31	,	,	PUNCT
ecj-9795	14	32	in	in	ADP
ecj-9795	14	33	december	december	PROPN
ecj-9795	14	34	2019	2019	NUM
ecj-9795	14	35	.	.	PUNCT
ecj-9795	15	1	the	the	DET
ecj-9795	15	2	first	first	ADJ
ecj-9795	15	3	case	case	NOUN
ecj-9795	15	4	in	in	ADP
ecj-9795	15	5	italy	italy	PROPN
ecj-9795	15	6	was	be	AUX
ecj-9795	15	7	reported	report	VERB
ecj-9795	15	8	on	on	ADP
ecj-9795	15	9	february	february	PROPN
ecj-9795	15	10	21	21	NUM
ecj-9795	15	11	,	,	PUNCT
ecj-9795	15	12	2020	2020	NUM
ecj-9795	15	13	and	and	CCONJ
ecj-9795	15	14	,	,	PUNCT
ecj-9795	15	15	a	a	DET
ecj-9795	15	16	few	few	ADJ
ecj-9795	15	17	days	day	NOUN
ecj-9795	15	18	later	later	ADV
ecj-9795	15	19	,	,	PUNCT
ecj-9795	15	20	castel	castel	PROPN
ecj-9795	15	21	san	san	PROPN
ecj-9795	15	22	giovanni	giovanni	PROPN
ecj-9795	15	23	hospital	hospital	NOUN
ecj-9795	15	24	was	be	AUX
ecj-9795	15	25	entirely	entirely	ADV
ecj-9795	15	26	dedicated	dedicated	ADJ
ecj-9795	15	27	to	to	ADP
ecj-9795	15	28	the	the	DET
ecj-9795	15	29	treatment	treatment	NOUN
ecj-9795	15	30	of	of	ADP
ecj-9795	15	31	covid-19	covid-19	PROPN
ecj-9795	15	32	patients	patient	NOUN
ecj-9795	15	33	.	.	PUNCT
ecj-9795	16	1	no	no	DET
ecj-9795	16	2	specific	specific	ADJ
ecj-9795	16	3	pharmacological	pharmacological	ADJ
ecj-9795	16	4	protocols	protocol	NOUN
ecj-9795	16	5	with	with	ADP
ecj-9795	16	6	proved	proved	ADJ
ecj-9795	16	7	efficacy	efficacy	NOUN
ecj-9795	16	8	were	be	AUX
ecj-9795	16	9	available	available	ADJ
ecj-9795	16	10	for	for	ADP
ecj-9795	16	11	the	the	DET
ecj-9795	16	12	treatment	treatment	NOUN
ecj-9795	16	13	of	of	ADP
ecj-9795	16	14	covid-19	covid-19	PROPN
ecj-9795	16	15	pneumonia	pneumonia	NOUN
ecj-9795	16	16	patients.1	patients.1	ADJ
ecj-9795	16	17	pneumonia	pneumonia	NOUN
ecj-9795	16	18	with	with	ADP
ecj-9795	16	19	respiratory	respiratory	ADJ
ecj-9795	16	20	failure	failure	NOUN
ecj-9795	16	21	is	be	AUX
ecj-9795	16	22	the	the	DET
ecj-9795	16	23	main	main	ADJ
ecj-9795	16	24	clinical	clinical	ADJ
ecj-9795	16	25	feature	feature	NOUN
ecj-9795	16	26	of	of	ADP
ecj-9795	16	27	covid-19	covid-19	PROPN
ecj-9795	16	28	and	and	CCONJ
ecj-9795	16	29	it	it	PRON
ecj-9795	16	30	is	be	AUX
ecj-9795	16	31	often	often	ADV
ecj-9795	16	32	associated	associate	VERB
ecj-9795	16	33	with	with	ADP
ecj-9795	16	34	correspondence	correspondence	NOUN
ecj-9795	16	35	:	:	PUNCT
ecj-9795	16	36	marco	marco	PROPN
ecj-9795	16	37	stabile	stabile	PROPN
ecj-9795	16	38	,	,	PUNCT
ecj-9795	16	39	plastic	plastic	ADJ
ecj-9795	16	40	surgery	surgery	NOUN
ecj-9795	16	41	unit	unit	NOUN
ecj-9795	16	42	,	,	PUNCT
ecj-9795	16	43	surgery	surgery	NOUN
ecj-9795	16	44	department	department	NOUN
ecj-9795	16	45	,	,	PUNCT
ecj-9795	16	46	castel	castel	PROPN
ecj-9795	16	47	san	san	PROPN
ecj-9795	16	48	giovanni	giovanni	PROPN
ecj-9795	16	49	hospital	hospital	PROPN
ecj-9795	16	50	,	,	PUNCT
ecj-9795	16	51	asl	asl	NOUN
ecj-9795	16	52	of	of	ADP
ecj-9795	16	53	piacenza	piacenza	PROPN
ecj-9795	16	54	,	,	PUNCT
ecj-9795	16	55	viale	viale	NOUN
ecj-9795	16	56	2	2	NUM
ecj-9795	16	57	giugno	giugno	NOUN
ecj-9795	16	58	1	1	NUM
ecj-9795	16	59	,	,	PUNCT
ecj-9795	16	60	29015	29015	NUM
ecj-9795	16	61	castel	castel	PROPN
ecj-9795	16	62	san	san	PROPN
ecj-9795	16	63	giovanni	giovanni	PROPN
ecj-9795	16	64	(	(	PUNCT
ecj-9795	16	65	piacenza	piacenza	PROPN
ecj-9795	16	66	)	)	PUNCT
ecj-9795	16	67	,	,	PUNCT
ecj-9795	16	68	italy	italy	PROPN
ecj-9795	16	69	.	.	PUNCT
ecj-9795	17	1	tel	tel	PROPN
ecj-9795	17	2	.	.	PUNCT
ecj-9795	17	3	:	:	PUNCT
ecj-9795	18	1	+39	+39	NOUN
ecj-9795	18	2	339	339	NUM
ecj-9795	18	3	7974402	7974402	NUM
ecj-9795	18	4	e	e	NOUN
ecj-9795	18	5	-	-	NOUN
ecj-9795	18	6	mail	mail	NOUN
ecj-9795	18	7	:	:	PUNCT
ecj-9795	18	8	marcostabile@gmail.com	marcostabile@gmail.com	X
ecj-9795	19	1	key	key	ADJ
ecj-9795	19	2	words	word	NOUN
ecj-9795	19	3	:	:	PUNCT
ecj-9795	19	4	pneumonia	pneumonia	NOUN
ecj-9795	19	5	;	;	PUNCT
ecj-9795	19	6	covid-19	covid-19	PROPN
ecj-9795	19	7	;	;	PUNCT
ecj-9795	19	8	thrombosis	thrombosis	NOUN
ecj-9795	19	9	;	;	PUNCT
ecj-9795	19	10	heparin	heparin	NOUN
ecj-9795	19	11	;	;	PUNCT
ecj-9795	19	12	mortality	mortality	NOUN
ecj-9795	19	13	.	.	PUNCT
ecj-9795	20	1	acknowledgements	acknowledgement	NOUN
ecj-9795	20	2	:	:	PUNCT
ecj-9795	20	3	special	special	ADJ
ecj-9795	20	4	thanks	thank	NOUN
ecj-9795	20	5	to	to	ADP
ecj-9795	20	6	the	the	DET
ecj-9795	20	7	members	member	NOUN
ecj-9795	20	8	of	of	ADP
ecj-9795	20	9	castel	castel	PROPN
ecj-9795	20	10	san	san	PROPN
ecj-9795	20	11	giovanni	giovanni	PROPN
ecj-9795	20	12	covid	covid	PROPN
ecj-9795	20	13	-	-	PUNCT
ecj-9795	20	14	speciality	speciality	NOUN
ecj-9795	20	15	hospital	hospital	NOUN
ecj-9795	20	16	:	:	PUNCT
ecj-9795	20	17	francesco	francesco	PROPN
ecj-9795	20	18	andrani	andrani	PROPN
ecj-9795	20	19	,	,	PUNCT
ecj-9795	20	20	angelo	angelo	PROPN
ecj-9795	20	21	benedetti	benedetti	PROPN
ecj-9795	20	22	,	,	PUNCT
ecj-9795	20	23	mara	mara	PROPN
ecj-9795	20	24	bozzarelli	bozzarelli	PROPN
ecj-9795	20	25	,	,	PUNCT
ecj-9795	20	26	carlo	carlo	PROPN
ecj-9795	20	27	cagnoni	cagnoni	PROPN
ecj-9795	20	28	,	,	PUNCT
ecj-9795	20	29	paolo	paolo	PROPN
ecj-9795	20	30	cambrini	cambrini	PROPN
ecj-9795	20	31	,	,	PUNCT
ecj-9795	20	32	esther	esther	PROPN
ecj-9795	20	33	centenara	centenara	PROPN
ecj-9795	20	34	,	,	PUNCT
ecj-9795	20	35	sara	sara	PROPN
ecj-9795	20	36	chiesa	chiesa	PROPN
ecj-9795	20	37	,	,	PUNCT
ecj-9795	20	38	mauro	mauro	PROPN
ecj-9795	20	39	codeluppi	codeluppi	PROPN
ecj-9795	20	40	,	,	PUNCT
ecj-9795	20	41	patrizia	patrizia	PROPN
ecj-9795	20	42	colazzo	colazzo	NOUN
ecj-9795	20	43	,	,	PUNCT
ecj-9795	20	44	donatella	donatella	NOUN
ecj-9795	20	45	covini	covini	NOUN
ecj-9795	20	46	,	,	PUNCT
ecj-9795	20	47	paolo	paolo	NOUN
ecj-9795	20	48	magri	magri	NOUN
ecj-9795	20	49	,	,	PUNCT
ecj-9795	20	50	angelo	angelo	PROPN
ecj-9795	20	51	mangia	mangia	PROPN
ecj-9795	20	52	,	,	PUNCT
ecj-9795	20	53	demostene	demostene	NOUN
ecj-9795	20	54	marifoglou	marifoglou	NOUN
ecj-9795	20	55	,	,	PUNCT
ecj-9795	20	56	massimiliano	massimiliano	PROPN
ecj-9795	20	57	mazzilli	mazzilli	PROPN
ecj-9795	20	58	,	,	PUNCT
ecj-9795	20	59	samantha	samantha	PROPN
ecj-9795	20	60	mazzocchi	mazzocchi	PROPN
ecj-9795	20	61	,	,	PUNCT
ecj-9795	20	62	monica	monica	PROPN
ecj-9795	20	63	pellegrini	pellegrini	PROPN
ecj-9795	20	64	,	,	PUNCT
ecj-9795	20	65	iacopo	iacopo	ADJ
ecj-9795	20	66	pellegrino	pellegrino	NOUN
ecj-9795	20	67	,	,	PUNCT
ecj-9795	20	68	annamaria	annamaria	PROPN
ecj-9795	20	69	pieri	pieri	PROPN
ecj-9795	20	70	,	,	PUNCT
ecj-9795	20	71	daria	daria	PROPN
ecj-9795	20	72	sacchini	sacchini	PROPN
ecj-9795	20	73	,	,	PUNCT
ecj-9795	20	74	anna	anna	PROPN
ecj-9795	20	75	chiara	chiara	PROPN
ecj-9795	20	76	vermi	vermi	PROPN
ecj-9795	20	77	,	,	PUNCT
ecj-9795	20	78	corrado	corrado	PROPN
ecj-9795	20	79	tosca	tosca	PROPN
ecj-9795	20	80	,	,	PUNCT
ecj-9795	20	81	lucia	lucia	PROPN
ecj-9795	20	82	torretta	torretta	PROPN
ecj-9795	20	83	,	,	PUNCT
ecj-9795	20	84	gioacchino	gioacchino	PROPN
ecj-9795	20	85	valenti	valenti	PROPN
ecj-9795	20	86	,	,	PUNCT
ecj-9795	20	87	ercole	ercole	PROPN
ecj-9795	20	88	zanotti	zanotti	PROPN
ecj-9795	20	89	.	.	PUNCT
ecj-9795	21	1	contributions	contribution	NOUN
ecj-9795	21	2	*	*	PUNCT
ecj-9795	21	3	:	:	PUNCT
ecj-9795	21	4	da	da	NOUN
ecj-9795	21	5	and	and	CCONJ
ecj-9795	21	6	ms	ms	PROPN
ecj-9795	21	7	contributed	contribute	VERB
ecj-9795	21	8	equally	equally	ADV
ecj-9795	21	9	.	.	PUNCT
ecj-9795	22	1	conflicts	conflict	NOUN
ecj-9795	22	2	of	of	ADP
ecj-9795	22	3	interest	interest	NOUN
ecj-9795	22	4	:	:	PUNCT
ecj-9795	22	5	the	the	DET
ecj-9795	22	6	authors	author	NOUN
ecj-9795	22	7	declare	declare	VERB
ecj-9795	22	8	no	no	DET
ecj-9795	22	9	conflict	conflict	NOUN
ecj-9795	22	10	of	of	ADP
ecj-9795	22	11	interest	interest	NOUN
ecj-9795	22	12	.	.	PUNCT
ecj-9795	23	1	availability	availability	NOUN
ecj-9795	23	2	of	of	ADP
ecj-9795	23	3	data	datum	NOUN
ecj-9795	23	4	and	and	CCONJ
ecj-9795	23	5	material	material	NOUN
ecj-9795	23	6	:	:	PUNCT
ecj-9795	23	7	data	datum	NOUN
ecj-9795	23	8	are	be	AUX
ecj-9795	23	9	available	available	ADJ
ecj-9795	23	10	upon	upon	SCONJ
ecj-9795	23	11	request	request	NOUN
ecj-9795	23	12	from	from	ADP
ecj-9795	23	13	the	the	DET
ecj-9795	23	14	first	first	ADJ
ecj-9795	23	15	author	author	NOUN
ecj-9795	23	16	.	.	PUNCT
ecj-9795	24	1	ethics	ethic	NOUN
ecj-9795	24	2	approval	approval	NOUN
ecj-9795	24	3	and	and	CCONJ
ecj-9795	24	4	consent	consent	NOUN
ecj-9795	24	5	to	to	PART
ecj-9795	24	6	participate	participate	VERB
ecj-9795	24	7	:	:	PUNCT
ecj-9795	24	8	the	the	DET
ecj-9795	24	9	healthcare	healthcare	NOUN
ecj-9795	24	10	directorate	directorate	NOUN
ecj-9795	24	11	of	of	ADP
ecj-9795	24	12	piacenza	piacenza	PROPN
ecj-9795	24	13	local	local	ADJ
ecj-9795	24	14	health	health	NOUN
ecj-9795	24	15	authority	authority	NOUN
ecj-9795	24	16	approved	approve	VERB
ecj-9795	24	17	the	the	DET
ecj-9795	24	18	therapeutic	therapeutic	ADJ
ecj-9795	24	19	protocol	protocol	NOUN
ecj-9795	24	20	.	.	PUNCT
ecj-9795	25	1	all	all	DET
ecj-9795	25	2	methods	method	NOUN
ecj-9795	25	3	involving	involve	VERB
ecj-9795	25	4	patients	patient	NOUN
ecj-9795	25	5	,	,	PUNCT
ecj-9795	25	6	data	datum	NOUN
ecj-9795	25	7	and	and	CCONJ
ecj-9795	25	8	information	information	NOUN
ecj-9795	25	9	were	be	AUX
ecj-9795	25	10	carried	carry	VERB
ecj-9795	25	11	out	out	ADP
ecj-9795	25	12	in	in	ADP
ecj-9795	25	13	accordance	accordance	NOUN
ecj-9795	25	14	with	with	ADP
ecj-9795	25	15	relevant	relevant	ADJ
ecj-9795	25	16	guidelines	guideline	NOUN
ecj-9795	25	17	and	and	CCONJ
ecj-9795	25	18	regulations	regulation	NOUN
ecj-9795	25	19	.	.	PUNCT
ecj-9795	26	1	the	the	DET
ecj-9795	26	2	healthcare	healthcare	NOUN
ecj-9795	26	3	directorate	directorate	NOUN
ecj-9795	26	4	of	of	ADP
ecj-9795	26	5	piacenza	piacenza	PROPN
ecj-9795	26	6	local	local	ADJ
ecj-9795	26	7	health	health	NOUN
ecj-9795	26	8	authority	authority	NOUN
ecj-9795	26	9	granted	grant	VERB
ecj-9795	26	10	a	a	DET
ecj-9795	26	11	waiver	waiver	NOUN
ecj-9795	26	12	of	of	ADP
ecj-9795	26	13	informed	informed	ADJ
ecj-9795	26	14	consent	consent	NOUN
ecj-9795	26	15	.	.	PUNCT
ecj-9795	27	1	informed	informed	ADJ
ecj-9795	27	2	consent	consent	NOUN
ecj-9795	27	3	:	:	PUNCT
ecj-9795	27	4	no	no	DET
ecj-9795	27	5	consent	consent	NOUN
ecj-9795	27	6	for	for	ADP
ecj-9795	27	7	publication	publication	NOUN
ecj-9795	27	8	was	be	AUX
ecj-9795	27	9	requested	request	VERB
ecj-9795	27	10	,	,	PUNCT
ecj-9795	27	11	because	because	SCONJ
ecj-9795	27	12	data	datum	NOUN
ecj-9795	27	13	are	be	AUX
ecj-9795	27	14	presented	present	VERB
ecj-9795	27	15	in	in	ADP
ecj-9795	27	16	aggregate	aggregate	ADJ
ecj-9795	27	17	form	form	NOUN
ecj-9795	27	18	and	and	CCONJ
ecj-9795	27	19	do	do	AUX
ecj-9795	27	20	not	not	PART
ecj-9795	27	21	include	include	VERB
ecj-9795	27	22	sensitive	sensitive	ADJ
ecj-9795	27	23	data	datum	NOUN
ecj-9795	27	24	.	.	PUNCT
ecj-9795	28	1	received	receive	VERB
ecj-9795	28	2	for	for	ADP
ecj-9795	28	3	publication	publication	NOUN
ecj-9795	28	4	:	:	PUNCT
ecj-9795	28	5	31	31	NUM
ecj-9795	28	6	march	march	NOUN
ecj-9795	28	7	2021	2021	NUM
ecj-9795	28	8	.	.	PUNCT
ecj-9795	29	1	revision	revision	NOUN
ecj-9795	29	2	received	receive	VERB
ecj-9795	29	3	:	:	PUNCT
ecj-9795	29	4	4	4	NUM
ecj-9795	29	5	august	august	PROPN
ecj-9795	29	6	2021	2021	NUM
ecj-9795	29	7	.	.	PUNCT
ecj-9795	30	1	accepted	accept	VERB
ecj-9795	30	2	for	for	ADP
ecj-9795	30	3	publication	publication	NOUN
ecj-9795	30	4	:	:	PUNCT
ecj-9795	30	5	6	6	NUM
ecj-9795	30	6	august	august	PROPN
ecj-9795	30	7	2021	2021	NUM
ecj-9795	30	8	.	.	PUNCT
ecj-9795	31	1	this	this	DET
ecj-9795	31	2	work	work	NOUN
ecj-9795	31	3	is	be	AUX
ecj-9795	31	4	licensed	license	VERB
ecj-9795	31	5	under	under	ADP
ecj-9795	31	6	a	a	DET
ecj-9795	31	7	creative	creative	ADJ
ecj-9795	31	8	commons	common	NOUN
ecj-9795	31	9	attribution	attribution	NOUN
ecj-9795	31	10	4.0	4.0	NUM
ecj-9795	31	11	license	license	NOUN
ecj-9795	31	12	(	(	PUNCT
ecj-9795	31	13	by	by	ADP
ecj-9795	31	14	-	-	PUNCT
ecj-9795	31	15	nc	nc	PROPN
ecj-9795	31	16	4.0	4.0	NUM
ecj-9795	31	17	)	)	PUNCT
ecj-9795	31	18	.	.	PUNCT
ecj-9795	32	1	©	©	PROPN
ecj-9795	32	2	copyright	copyright	NOUN
ecj-9795	32	3	:	:	PUNCT
ecj-9795	32	4	the	the	DET
ecj-9795	32	5	author(s	author(s	PROPN
ecj-9795	32	6	)	)	PUNCT
ecj-9795	32	7	,	,	PUNCT
ecj-9795	32	8	2021	2021	NUM
ecj-9795	32	9	licensee	licensee	NOUN
ecj-9795	32	10	pagepress	pagepress	NOUN
ecj-9795	32	11	,	,	PUNCT
ecj-9795	32	12	italy	italy	PROPN
ecj-9795	32	13	emergency	emergency	PROPN
ecj-9795	32	14	care	care	PROPN
ecj-9795	32	15	journal	journal	PROPN
ecj-9795	32	16	2021	2021	NUM
ecj-9795	32	17	;	;	PUNCT
ecj-9795	32	18	17:9795	17:9795	NUM
ecj-9795	32	19	doi:10.4081	doi:10.4081	NOUN
ecj-9795	32	20	/	/	SYM
ecj-9795	32	21	ecj.2021.9795	ecj.2021.9795	NUM
ecj-9795	32	22	potential	potential	ADJ
ecj-9795	32	23	benefits	benefit	NOUN
ecj-9795	32	24	of	of	ADP
ecj-9795	32	25	anticoagulant	anticoagulant	ADJ
ecj-9795	32	26	doses	dose	NOUN
ecj-9795	32	27	of	of	ADP
ecj-9795	32	28	low	low	ADJ
ecj-9795	32	29	molecular	molecular	ADJ
ecj-9795	32	30	weight	weight	NOUN
ecj-9795	32	31	heparin	heparin	NOUN
ecj-9795	32	32	in	in	ADP
ecj-9795	32	33	covid-19	covid-19	PROPN
ecj-9795	32	34	:	:	PUNCT
ecj-9795	32	35	an	an	DET
ecj-9795	32	36	observational	observational	ADJ
ecj-9795	32	37	retrospective	retrospective	ADJ
ecj-9795	32	38	study	study	NOUN
ecj-9795	32	39	daniela	daniela	PROPN
ecj-9795	32	40	aschieri,1	aschieri,1	PROPN
ecj-9795	32	41	*	*	PROPN
ecj-9795	32	42	marco	marco	PROPN
ecj-9795	32	43	stabile,2	stabile,2	PROPN
ecj-9795	32	44	*	*	PROPN
ecj-9795	32	45	cristina	cristina	PROPN
ecj-9795	32	46	maestri,3	maestri,3	VERB
ecj-9795	32	47	luca	luca	PROPN
ecj-9795	32	48	rosato,2	rosato,2	PROPN
ecj-9795	32	49	michela	michela	PROPN
ecj-9795	32	50	giovanna	giovanna	PROPN
ecj-9795	32	51	coccia,1	coccia,1	PROPN
ecj-9795	32	52	paola	paola	PROPN
ecj-9795	32	53	novara,1	novara,1	NOUN
ecj-9795	32	54	gianluca	gianluca	PROPN
ecj-9795	32	55	lanati,1	lanati,1	PROPN
ecj-9795	32	56	mariateresa	mariateresa	PROPN
ecj-9795	32	57	di	di	X
ecj-9795	32	58	dio,1	dio,1	PROPN
ecj-9795	32	59	cosimo	cosimo	PROPN
ecj-9795	32	60	franco,4	franco,4	PROPN
ecj-9795	32	61	giuseppina	giuseppina	PROPN
ecj-9795	32	62	bisceglie,6	bisceglie,6	PROPN
ecj-9795	32	63	giuseppe	giuseppe	PROPN
ecj-9795	32	64	leddi,5	leddi,5	PROPN
ecj-9795	32	65	enrico	enrico	PROPN
ecj-9795	32	66	fabrizi,7	fabrizi,7	PROPN
ecj-9795	32	67	paola	paola	PROPN
ecj-9795	32	68	rucci,8	rucci,8	PROPN
ecj-9795	32	69	gloria	gloria	PROPN
ecj-9795	32	70	taliani9	taliani9	PROPN
ecj-9795	32	71	1cardiology	1cardiology	NUM
ecj-9795	32	72	unit	unit	NOUN
ecj-9795	32	73	,	,	PUNCT
ecj-9795	32	74	emergency	emergency	NOUN
ecj-9795	32	75	department	department	PROPN
ecj-9795	32	76	,	,	PUNCT
ecj-9795	32	77	castel	castel	PROPN
ecj-9795	32	78	san	san	PROPN
ecj-9795	32	79	giovanni	giovanni	PROPN
ecj-9795	32	80	hospital	hospital	PROPN
ecj-9795	32	81	,	,	PUNCT
ecj-9795	32	82	asl	asl	NOUN
ecj-9795	32	83	of	of	ADP
ecj-9795	32	84	piacenza	piacenza	PROPN
ecj-9795	32	85	,	,	PUNCT
ecj-9795	32	86	castel	castel	PROPN
ecj-9795	32	87	san	san	PROPN
ecj-9795	32	88	giovanni	giovanni	PROPN
ecj-9795	32	89	;	;	PUNCT
ecj-9795	32	90	2plastic	2plastic	NUM
ecj-9795	32	91	surgery	surgery	NOUN
ecj-9795	32	92	unit	unit	NOUN
ecj-9795	32	93	,	,	PUNCT
ecj-9795	32	94	surgery	surgery	NOUN
ecj-9795	32	95	department	department	NOUN
ecj-9795	32	96	,	,	PUNCT
ecj-9795	32	97	castel	castel	PROPN
ecj-9795	32	98	san	san	PROPN
ecj-9795	32	99	giovanni	giovanni	PROPN
ecj-9795	32	100	hospital	hospital	PROPN
ecj-9795	32	101	,	,	PUNCT
ecj-9795	32	102	asl	asl	NOUN
ecj-9795	32	103	of	of	ADP
ecj-9795	32	104	piacenza	piacenza	PROPN
ecj-9795	32	105	,	,	PUNCT
ecj-9795	32	106	castel	castel	PROPN
ecj-9795	32	107	san	san	PROPN
ecj-9795	32	108	giovanni	giovanni	PROPN
ecj-9795	32	109	;	;	PUNCT
ecj-9795	32	110	3emergency	3emergency	NUM
ecj-9795	32	111	care	care	NOUN
ecj-9795	32	112	unit	unit	NOUN
ecj-9795	32	113	,	,	PUNCT
ecj-9795	32	114	castel	castel	PROPN
ecj-9795	32	115	san	san	PROPN
ecj-9795	32	116	giovanni	giovanni	PROPN
ecj-9795	32	117	hospital	hospital	PROPN
ecj-9795	32	118	,	,	PUNCT
ecj-9795	32	119	asl	asl	NOUN
ecj-9795	32	120	of	of	ADP
ecj-9795	32	121	piacenza	piacenza	PROPN
ecj-9795	32	122	,	,	PUNCT
ecj-9795	32	123	castel	castel	PROPN
ecj-9795	32	124	san	san	PROPN
ecj-9795	32	125	giovanni	giovanni	PROPN
ecj-9795	32	126	;	;	PUNCT
ecj-9795	32	127	4respiratory	4respiratory	NUM
ecj-9795	32	128	intensive	intensive	ADJ
ecj-9795	32	129	care	care	NOUN
ecj-9795	32	130	unit	unit	NOUN
ecj-9795	32	131	,	,	PUNCT
ecj-9795	32	132	castel	castel	PROPN
ecj-9795	32	133	san	san	PROPN
ecj-9795	32	134	giovanni	giovanni	PROPN
ecj-9795	32	135	hospital	hospital	PROPN
ecj-9795	32	136	,	,	PUNCT
ecj-9795	32	137	asl	asl	NOUN
ecj-9795	32	138	of	of	ADP
ecj-9795	32	139	piacenza	piacenza	PROPN
ecj-9795	32	140	,	,	PUNCT
ecj-9795	32	141	castel	castel	PROPN
ecj-9795	32	142	san	san	PROPN
ecj-9795	32	143	giovanni	giovanni	PROPN
ecj-9795	32	144	;	;	PUNCT
ecj-9795	32	145	5orthopedic	5orthopedic	NUM
ecj-9795	32	146	unit	unit	NOUN
ecj-9795	32	147	,	,	PUNCT
ecj-9795	32	148	castel	castel	PROPN
ecj-9795	32	149	san	san	PROPN
ecj-9795	32	150	giovanni	giovanni	PROPN
ecj-9795	32	151	hospital	hospital	PROPN
ecj-9795	32	152	,	,	PUNCT
ecj-9795	32	153	asl	asl	NOUN
ecj-9795	32	154	of	of	ADP
ecj-9795	32	155	piacenza	piacenza	PROPN
ecj-9795	32	156	,	,	PUNCT
ecj-9795	32	157	castel	castel	PROPN
ecj-9795	32	158	san	san	PROPN
ecj-9795	32	159	giovanni	giovanni	PROPN
ecj-9795	32	160	;	;	PUNCT
ecj-9795	32	161	6general	6general	NUM
ecj-9795	32	162	medicine	medicine	NOUN
ecj-9795	32	163	unit	unit	NOUN
ecj-9795	32	164	,	,	PUNCT
ecj-9795	32	165	castel	castel	PROPN
ecj-9795	32	166	san	san	PROPN
ecj-9795	32	167	giovanni	giovanni	PROPN
ecj-9795	32	168	hospital	hospital	PROPN
ecj-9795	32	169	,	,	PUNCT
ecj-9795	32	170	asl	asl	NOUN
ecj-9795	32	171	of	of	ADP
ecj-9795	32	172	piacenza	piacenza	PROPN
ecj-9795	32	173	,	,	PUNCT
ecj-9795	32	174	castel	castel	PROPN
ecj-9795	32	175	san	san	PROPN
ecj-9795	32	176	giovanni	giovanni	PROPN
ecj-9795	32	177	;	;	PUNCT
ecj-9795	32	178	7dises	7dises	NUM
ecj-9795	32	179	and	and	CCONJ
ecj-9795	32	180	dss	dss	NOUN
ecj-9795	32	181	,	,	PUNCT
ecj-9795	32	182	università	università	PROPN
ecj-9795	32	183	cattolica	cattolica	PROPN
ecj-9795	32	184	del	del	PROPN
ecj-9795	32	185	s.	s.	PROPN
ecj-9795	32	186	cuore	cuore	PROPN
ecj-9795	32	187	,	,	PUNCT
ecj-9795	32	188	piacenza	piacenza	NOUN
ecj-9795	32	189	;	;	PUNCT
ecj-9795	32	190	8department	8department	NUM
ecj-9795	32	191	of	of	ADP
ecj-9795	32	192	biomedical	biomedical	ADJ
ecj-9795	32	193	and	and	CCONJ
ecj-9795	32	194	neuromotor	neuromotor	NOUN
ecj-9795	32	195	sciences	sciences	PROPN
ecj-9795	32	196	,	,	PUNCT
ecj-9795	32	197	alma	alma	NOUN
ecj-9795	32	198	mater	mater	PROPN
ecj-9795	32	199	studiorum	studiorum	PROPN
ecj-9795	32	200	university	university	PROPN
ecj-9795	32	201	,	,	PUNCT
ecj-9795	32	202	bologna	bologna	NOUN
ecj-9795	32	203	;	;	PUNCT
ecj-9795	32	204	9department	9department	NUM
ecj-9795	32	205	of	of	ADP
ecj-9795	32	206	translational	translational	ADJ
ecj-9795	32	207	and	and	CCONJ
ecj-9795	32	208	precision	precision	NOUN
ecj-9795	32	209	medicine	medicine	NOUN
ecj-9795	32	210	,	,	PUNCT
ecj-9795	32	211	sapienza	sapienza	PROPN
ecj-9795	32	212	university	university	PROPN
ecj-9795	32	213	,	,	PUNCT
ecj-9795	32	214	rome	rome	PROPN
ecj-9795	32	215	,	,	PUNCT
ecj-9795	32	216	italy	italy	PROPN
ecj-9795	32	217	non	non	PROPN
ecj-9795	32	218	-co	-co	PROPN
ecj-9795	32	219	mmerc	mmerc	PROPN
ecj-9795	32	220	ial	ial	PROPN
ecj-9795	32	221	us	us	PROPN
ecj-9795	32	222	e	e	NOUN
ecj-9795	32	223	o	o	NOUN
ecj-9795	32	224	nly	nly	ADV
ecj-9795	32	225	systemic	systemic	ADJ
ecj-9795	32	226	inflammation	inflammation	NOUN
ecj-9795	32	227	that	that	PRON
ecj-9795	32	228	induces	induce	VERB
ecj-9795	32	229	diffuse	diffuse	ADJ
ecj-9795	32	230	endothelial	endothelial	ADJ
ecj-9795	32	231	injury	injury	NOUN
ecj-9795	32	232	and	and	CCONJ
ecj-9795	32	233	hypercoagulability	hypercoagulability	NOUN
ecj-9795	32	234	state.2	state.2	PROPN
ecj-9795	32	235	-	-	PUNCT
ecj-9795	32	236	5	5	NUM
ecj-9795	32	237	the	the	DET
ecj-9795	32	238	relationship	relationship	NOUN
ecj-9795	32	239	between	between	ADP
ecj-9795	32	240	viral	viral	ADJ
ecj-9795	32	241	infections	infection	NOUN
ecj-9795	32	242	and	and	CCONJ
ecj-9795	32	243	thrombosis	thrombosis	NOUN
ecj-9795	32	244	is	be	AUX
ecj-9795	32	245	recognized	recognize	VERB
ecj-9795	32	246	,	,	PUNCT
ecj-9795	32	247	but	but	CCONJ
ecj-9795	32	248	it	it	PRON
ecj-9795	32	249	seems	seem	VERB
ecj-9795	32	250	to	to	PART
ecj-9795	32	251	be	be	AUX
ecj-9795	32	252	predominant	predominant	ADJ
ecj-9795	32	253	in	in	ADP
ecj-9795	32	254	sars	sars	PROPN
ecj-9795	32	255	-	-	PUNCT
ecj-9795	32	256	cov2	cov2	PROPN
ecj-9795	32	257	infection	infection	NOUN
ecj-9795	32	258	,	,	PUNCT
ecj-9795	32	259	leading	lead	VERB
ecj-9795	32	260	to	to	ADP
ecj-9795	32	261	life	life	NOUN
ecj-9795	32	262	-	-	PUNCT
ecj-9795	32	263	threatening	threaten	VERB
ecj-9795	32	264	thrombotic	thrombotic	ADJ
ecj-9795	32	265	complications	complication	NOUN
ecj-9795	32	266	such	such	ADJ
ecj-9795	32	267	as	as	ADP
ecj-9795	32	268	venous	venous	ADJ
ecj-9795	32	269	and	and	CCONJ
ecj-9795	32	270	arterial	arterial	ADJ
ecj-9795	32	271	thrombosis	thrombosis	NOUN
ecj-9795	32	272	,	,	PUNCT
ecj-9795	32	273	pulmonary	pulmonary	ADJ
ecj-9795	32	274	embolism	embolism	NOUN
ecj-9795	32	275	and	and	CCONJ
ecj-9795	32	276	microvascular	microvascular	ADJ
ecj-9795	32	277	thrombi.6	thrombi.6	NOUN
ecj-9795	32	278	-	-	PUNCT
ecj-9795	32	279	8	8	NUM
ecj-9795	32	280	low	low	ADJ
ecj-9795	32	281	molecular	molecular	ADJ
ecj-9795	32	282	weight	weight	NOUN
ecj-9795	32	283	heparin	heparin	NOUN
ecj-9795	32	284	(	(	PUNCT
ecj-9795	32	285	lmwh	lmwh	NOUN
ecj-9795	32	286	)	)	PUNCT
ecj-9795	32	287	is	be	AUX
ecj-9795	32	288	recommended	recommend	VERB
ecj-9795	32	289	in	in	ADP
ecj-9795	32	290	covid-19	covid-19	PROPN
ecj-9795	32	291	patients	patient	NOUN
ecj-9795	32	292	by	by	ADP
ecj-9795	32	293	some	some	DET
ecj-9795	32	294	expert	expert	ADJ
ecj-9795	32	295	consensus	consensus	NOUN
ecj-9795	32	296	,	,	PUNCT
ecj-9795	32	297	but	but	CCONJ
ecj-9795	32	298	its	its	PRON
ecj-9795	32	299	efficacy	efficacy	NOUN
ecj-9795	32	300	and	and	CCONJ
ecj-9795	32	301	safety	safety	NOUN
ecj-9795	32	302	at	at	ADP
ecj-9795	32	303	therapeutic	therapeutic	ADJ
ecj-9795	32	304	doses	dose	NOUN
ecj-9795	32	305	has	have	AUX
ecj-9795	32	306	not	not	PART
ecj-9795	32	307	been	be	AUX
ecj-9795	32	308	described	describe	VERB
ecj-9795	32	309	yet.9	yet.9	NOUN
ecj-9795	32	310	-	-	SYM
ecj-9795	32	311	11	11	NUM
ecj-9795	32	312	we	we	PRON
ecj-9795	32	313	assumed	assume	VERB
ecj-9795	32	314	that	that	SCONJ
ecj-9795	32	315	lmwh	lmwh	NOUN
ecj-9795	32	316	at	at	ADP
ecj-9795	32	317	therapeutic	therapeutic	ADJ
ecj-9795	32	318	doses	dose	NOUN
ecj-9795	32	319	could	could	AUX
ecj-9795	32	320	exert	exert	VERB
ecj-9795	32	321	a	a	DET
ecj-9795	32	322	beneficial	beneficial	ADJ
ecj-9795	32	323	effect	effect	NOUN
ecj-9795	32	324	on	on	ADP
ecj-9795	32	325	the	the	DET
ecj-9795	32	326	clinical	clinical	ADJ
ecj-9795	32	327	course	course	NOUN
ecj-9795	32	328	of	of	ADP
ecj-9795	32	329	covid-19	covid-19	PROPN
ecj-9795	32	330	thanks	thank	NOUN
ecj-9795	32	331	to	to	ADP
ecj-9795	32	332	its	its	PRON
ecj-9795	32	333	anticoagulant	anticoagulant	NOUN
ecj-9795	32	334	,	,	PUNCT
ecj-9795	32	335	anti	anti	ADJ
ecj-9795	32	336	-	-	ADJ
ecj-9795	32	337	inflammatory	inflammatory	ADJ
ecj-9795	32	338	and	and	CCONJ
ecj-9795	32	339	in	in	ADP
ecj-9795	32	340	vitro	vitro	X
ecj-9795	32	341	antiviral	antiviral	ADJ
ecj-9795	32	342	properties.12	properties.12	NOUN
ecj-9795	32	343	-	-	PROPN
ecj-9795	32	344	16	16	NUM
ecj-9795	32	345	the	the	DET
ecj-9795	32	346	aim	aim	NOUN
ecj-9795	32	347	of	of	ADP
ecj-9795	32	348	this	this	DET
ecj-9795	32	349	observational	observational	ADJ
ecj-9795	32	350	study	study	NOUN
ecj-9795	32	351	was	be	AUX
ecj-9795	32	352	to	to	PART
ecj-9795	32	353	estimate	estimate	VERB
ecj-9795	32	354	the	the	DET
ecj-9795	32	355	effect	effect	NOUN
ecj-9795	32	356	of	of	ADP
ecj-9795	32	357	anticoagulation	anticoagulation	NOUN
ecj-9795	32	358	on	on	ADP
ecj-9795	32	359	the	the	DET
ecj-9795	32	360	in	in	ADP
ecj-9795	32	361	-	-	PUNCT
ecj-9795	32	362	hospital	hospital	NOUN
ecj-9795	32	363	mortality	mortality	NOUN
ecj-9795	32	364	of	of	ADP
ecj-9795	32	365	covid-19	covid-19	PROPN
ecj-9795	32	366	.	.	PUNCT
ecj-9795	33	1	materials	material	NOUN
ecj-9795	33	2	and	and	CCONJ
ecj-9795	33	3	methods	method	NOUN
ecj-9795	33	4	we	we	PRON
ecj-9795	33	5	conducted	conduct	VERB
ecj-9795	33	6	an	an	DET
ecj-9795	33	7	observational	observational	ADJ
ecj-9795	33	8	study	study	NOUN
ecj-9795	33	9	collecting	collect	VERB
ecj-9795	33	10	data	datum	NOUN
ecj-9795	33	11	of	of	ADP
ecj-9795	33	12	351	351	NUM
ecj-9795	33	13	adult	adult	NOUN
ecj-9795	33	14	patients	patient	NOUN
ecj-9795	33	15	consecutively	consecutively	ADV
ecj-9795	33	16	admitted	admit	VERB
ecj-9795	33	17	to	to	ADP
ecj-9795	33	18	castel	castel	PROPN
ecj-9795	33	19	san	san	PROPN
ecj-9795	33	20	giovanni	giovanni	PROPN
ecj-9795	33	21	hospital	hospital	NOUN
ecj-9795	33	22	from	from	ADP
ecj-9795	33	23	february	february	PROPN
ecj-9795	33	24	29th	29th	NOUN
ecj-9795	33	25	to	to	ADP
ecj-9795	33	26	april	april	PROPN
ecj-9795	33	27	7th	7th	NOUN
ecj-9795	33	28	,	,	PUNCT
ecj-9795	33	29	2020	2020	NUM
ecj-9795	33	30	with	with	ADP
ecj-9795	33	31	confirmed	confirm	VERB
ecj-9795	33	32	covid-19	covid-19	PROPN
ecj-9795	33	33	pneumonia	pneumonia	NOUN
ecj-9795	33	34	.	.	PUNCT
ecj-9795	34	1	257/351	257/351	NUM
ecj-9795	34	2	patients	patient	NOUN
ecj-9795	34	3	were	be	AUX
ecj-9795	34	4	included	include	VERB
ecj-9795	34	5	in	in	ADP
ecj-9795	34	6	this	this	DET
ecj-9795	34	7	study	study	NOUN
ecj-9795	34	8	.	.	PUNCT
ecj-9795	35	1	the	the	DET
ecj-9795	35	2	covid-19	covid-19	PROPN
ecj-9795	35	3	diagnosis	diagnosis	NOUN
ecj-9795	35	4	was	be	AUX
ecj-9795	35	5	made	make	VERB
ecj-9795	35	6	according	accord	VERB
ecj-9795	35	7	to	to	ADP
ecj-9795	35	8	the	the	DET
ecj-9795	35	9	world	world	PROPN
ecj-9795	35	10	health	health	PROPN
ecj-9795	35	11	organization	organization	PROPN
ecj-9795	35	12	interim	interim	ADJ
ecj-9795	35	13	guidelines	guideline	NOUN
ecj-9795	35	14	and	and	CCONJ
ecj-9795	35	15	was	be	AUX
ecj-9795	35	16	confirmed	confirm	VERB
ecj-9795	35	17	by	by	ADP
ecj-9795	35	18	rna	rna	NOUN
ecj-9795	35	19	detection	detection	NOUN
ecj-9795	35	20	of	of	ADP
ecj-9795	35	21	sars	sar	NOUN
ecj-9795	35	22	-	-	PUNCT
ecj-9795	35	23	cov-2	cov-2	NOUN
ecj-9795	35	24	from	from	ADP
ecj-9795	35	25	oropharyngeal	oropharyngeal	ADJ
ecj-9795	35	26	and	and	CCONJ
ecj-9795	35	27	nasopharyngeal	nasopharyngeal	ADJ
ecj-9795	35	28	swab	swab	NOUN
ecj-9795	35	29	sample.6	sample.6	VERB
ecj-9795	35	30	high	high	ADJ
ecj-9795	35	31	resolution	resolution	NOUN
ecj-9795	35	32	computed	compute	VERB
ecj-9795	35	33	tomography	tomography	NOUN
ecj-9795	35	34	(	(	PUNCT
ecj-9795	35	35	hrct	hrct	PROPN
ecj-9795	35	36	)	)	PUNCT
ecj-9795	35	37	scan	scan	ADJ
ecj-9795	35	38	diagnosis	diagnosis	NOUN
ecj-9795	35	39	of	of	ADP
ecj-9795	35	40	pulmonary	pulmonary	ADJ
ecj-9795	35	41	pneumonia	pneumonia	NOUN
ecj-9795	35	42	was	be	AUX
ecj-9795	35	43	performed	perform	VERB
ecj-9795	35	44	in	in	ADP
ecj-9795	35	45	all	all	DET
ecj-9795	35	46	100	100	NUM
ecj-9795	35	47	patients	patient	NOUN
ecj-9795	35	48	.	.	PUNCT
ecj-9795	36	1	exclusion	exclusion	NOUN
ecj-9795	36	2	criteria	criterion	NOUN
ecj-9795	36	3	were	be	AUX
ecj-9795	36	4	age	age	NOUN
ecj-9795	36	5	<	<	X
ecj-9795	36	6	18	18	NUM
ecj-9795	36	7	years	year	NOUN
ecj-9795	36	8	,	,	PUNCT
ecj-9795	36	9	hospital	hospital	NOUN
ecj-9795	36	10	stay	stay	VERB
ecj-9795	36	11	<	<	X
ecj-9795	36	12	7	7	NUM
ecj-9795	36	13	days	day	NOUN
ecj-9795	36	14	,	,	PUNCT
ecj-9795	36	15	patient	patient	NOUN
ecj-9795	36	16	on	on	ADP
ecj-9795	36	17	dialysis	dialysis	NOUN
ecj-9795	36	18	and	and	CCONJ
ecj-9795	36	19	patients	patient	NOUN
ecj-9795	36	20	who	who	PRON
ecj-9795	36	21	had	have	AUX
ecj-9795	36	22	been	be	AUX
ecj-9795	36	23	transferred	transfer	VERB
ecj-9795	36	24	to	to	ADP
ecj-9795	36	25	other	other	ADJ
ecj-9795	36	26	centers	center	NOUN
ecj-9795	36	27	for	for	ADP
ecj-9795	36	28	further	further	ADJ
ecj-9795	36	29	treatment	treatment	NOUN
ecj-9795	36	30	for	for	ADP
ecj-9795	36	31	which	which	PRON
ecj-9795	36	32	we	we	PRON
ecj-9795	36	33	could	could	AUX
ecj-9795	36	34	not	not	PART
ecj-9795	36	35	collect	collect	VERB
ecj-9795	36	36	data	datum	NOUN
ecj-9795	36	37	.	.	PUNCT
ecj-9795	37	1	we	we	PRON
ecj-9795	37	2	collected	collect	VERB
ecj-9795	37	3	data	datum	NOUN
ecj-9795	37	4	on	on	ADP
ecj-9795	37	5	age	age	NOUN
ecj-9795	37	6	,	,	PUNCT
ecj-9795	37	7	sex	sex	NOUN
ecj-9795	37	8	,	,	PUNCT
ecj-9795	37	9	comorbidity	comorbidity	NOUN
ecj-9795	37	10	(	(	PUNCT
ecj-9795	37	11	arterial	arterial	NOUN
ecj-9795	37	12	hypertension	hypertension	NOUN
ecj-9795	37	13	,	,	PUNCT
ecj-9795	37	14	diabetes	diabetes	NOUN
ecj-9795	37	15	mellitus	mellitus	NOUN
ecj-9795	37	16	,	,	PUNCT
ecj-9795	37	17	cardiovascular	cardiovascular	ADJ
ecj-9795	37	18	disease	disease	NOUN
ecj-9795	37	19	,	,	PUNCT
ecj-9795	37	20	chronic	chronic	ADJ
ecj-9795	37	21	or	or	CCONJ
ecj-9795	37	22	paroxysmal	paroxysmal	ADJ
ecj-9795	37	23	atrial	atrial	ADJ
ecj-9795	37	24	fibrillation	fibrillation	NOUN
ecj-9795	37	25	,	,	PUNCT
ecj-9795	37	26	copd	copd	NOUN
ecj-9795	37	27	,	,	PUNCT
ecj-9795	37	28	chronic	chronic	ADJ
ecj-9795	37	29	kidney	kidney	NOUN
ecj-9795	37	30	disease	disease	NOUN
ecj-9795	37	31	,	,	PUNCT
ecj-9795	37	32	history	history	NOUN
ecj-9795	37	33	of	of	ADP
ecj-9795	37	34	cancer	cancer	NOUN
ecj-9795	37	35	,	,	PUNCT
ecj-9795	37	36	obesity	obesity	NOUN
ecj-9795	37	37	,	,	PUNCT
ecj-9795	37	38	smoke	smoke	NOUN
ecj-9795	37	39	,	,	PUNCT
ecj-9795	37	40	dyslipidemia	dyslipidemia	NOUN
ecj-9795	37	41	)	)	PUNCT
ecj-9795	37	42	and	and	CCONJ
ecj-9795	37	43	in	in	ADP
ecj-9795	37	44	hospital	hospital	NOUN
ecj-9795	37	45	therapy	therapy	NOUN
ecj-9795	37	46	(	(	PUNCT
ecj-9795	37	47	corticosteroid	corticosteroid	ADJ
ecj-9795	37	48	,	,	PUNCT
ecj-9795	37	49	azithromycin	azithromycin	PROPN
ecj-9795	37	50	,	,	PUNCT
ecj-9795	37	51	hydroxychloroquine	hydroxychloroquine	PROPN
ecj-9795	37	52	,	,	PUNCT
ecj-9795	37	53	tocilizumab	tocilizumab	NOUN
ecj-9795	37	54	,	,	PUNCT
ecj-9795	37	55	anti	anti	ADJ
ecj-9795	37	56	-	-	ADJ
ecj-9795	37	57	viral	viral	ADJ
ecj-9795	37	58	therapy	therapy	NOUN
ecj-9795	37	59	and	and	CCONJ
ecj-9795	37	60	oxygen	oxygen	NOUN
ecj-9795	37	61	support	support	NOUN
ecj-9795	37	62	)	)	PUNCT
ecj-9795	37	63	.	.	PUNCT
ecj-9795	38	1	all	all	DET
ecj-9795	38	2	patients	patient	NOUN
ecj-9795	38	3	included	include	VERB
ecj-9795	38	4	received	receive	VERB
ecj-9795	38	5	lmwh	lmwh	NOUN
ecj-9795	38	6	within	within	ADP
ecj-9795	38	7	24	24	NUM
ecj-9795	38	8	hours	hour	NOUN
ecj-9795	38	9	of	of	ADP
ecj-9795	38	10	admission	admission	NOUN
ecj-9795	38	11	until	until	ADP
ecj-9795	38	12	march	march	PROPN
ecj-9795	38	13	16th	16th	NOUN
ecj-9795	38	14	.	.	PUNCT
ecj-9795	39	1	lmwh	lmwh	PROPN
ecj-9795	39	2	was	be	AUX
ecj-9795	39	3	administered	administer	VERB
ecj-9795	39	4	at	at	ADP
ecj-9795	39	5	a	a	DET
ecj-9795	39	6	prophylactic	prophylactic	ADJ
ecj-9795	39	7	dose	dose	NOUN
ecj-9795	39	8	of	of	ADP
ecj-9795	39	9	4000	4000	NUM
ecj-9795	39	10	ui	ui	NOUN
ecj-9795	40	1	once	once	ADV
ecj-9795	40	2	per	per	ADP
ecj-9795	40	3	day	day	NOUN
ecj-9795	40	4	[	[	X
ecj-9795	40	5	prophylaxis	prophylaxis	NOUN
ecj-9795	40	6	of	of	ADP
ecj-9795	40	7	deep	deep	ADJ
ecj-9795	40	8	vein	vein	ADJ
ecj-9795	40	9	thrombosis	thrombosis	NOUN
ecj-9795	40	10	(	(	PUNCT
ecj-9795	40	11	dvt)/pulmonary	dvt)/pulmonary	ADJ
ecj-9795	40	12	embolism	embolism	NOUN
ecj-9795	40	13	(	(	PUNCT
ecj-9795	40	14	pe	pe	INTJ
ecj-9795	40	15	)	)	PUNCT
ecj-9795	40	16	in	in	ADP
ecj-9795	40	17	bed	bed	NOUN
ecj-9795	40	18	ridden	ride	VERB
ecj-9795	40	19	patients	patient	NOUN
ecj-9795	40	20	]	]	PUNCT
ecj-9795	40	21	for	for	ADP
ecj-9795	40	22	at	at	ADV
ecj-9795	40	23	least	least	ADV
ecj-9795	40	24	7	7	NUM
ecj-9795	40	25	days.17,18	days.17,18	NOUN
ecj-9795	40	26	after	after	ADP
ecj-9795	40	27	a	a	DET
ecj-9795	40	28	collegial	collegial	ADJ
ecj-9795	40	29	discussion	discussion	NOUN
ecj-9795	40	30	between	between	ADP
ecj-9795	40	31	the	the	DET
ecj-9795	40	32	main	main	ADJ
ecj-9795	40	33	directors	director	NOUN
ecj-9795	40	34	of	of	ADP
ecj-9795	40	35	the	the	DET
ecj-9795	40	36	covid	covid	PROPN
ecj-9795	40	37	center	center	NOUN
ecj-9795	40	38	operating	operate	VERB
ecj-9795	40	39	units	unit	NOUN
ecj-9795	40	40	,	,	PUNCT
ecj-9795	40	41	based	base	VERB
ecj-9795	40	42	on	on	ADP
ecj-9795	40	43	the	the	DET
ecj-9795	40	44	evidence	evidence	NOUN
ecj-9795	40	45	of	of	ADP
ecj-9795	40	46	the	the	DET
ecj-9795	40	47	anti	anti	ADJ
ecj-9795	40	48	-	-	ADJ
ecj-9795	40	49	inflammatory	inflammatory	ADJ
ecj-9795	40	50	effect	effect	NOUN
ecj-9795	40	51	of	of	ADP
ecj-9795	40	52	heparin	heparin	NOUN
ecj-9795	40	53	and	and	CCONJ
ecj-9795	40	54	given	give	VERB
ecj-9795	40	55	the	the	DET
ecj-9795	40	56	initial	initial	ADJ
ecj-9795	40	57	evidence	evidence	NOUN
ecj-9795	40	58	of	of	ADP
ecj-9795	40	59	important	important	ADJ
ecj-9795	40	60	states	state	NOUN
ecj-9795	40	61	of	of	ADP
ecj-9795	40	62	hypercoagulability	hypercoagulability	NOUN
ecj-9795	40	63	,	,	PUNCT
ecj-9795	40	64	it	it	PRON
ecj-9795	40	65	was	be	AUX
ecj-9795	40	66	decided	decide	VERB
ecj-9795	40	67	to	to	PART
ecj-9795	40	68	contact	contact	VERB
ecj-9795	40	69	the	the	DET
ecj-9795	40	70	local	local	ADJ
ecj-9795	40	71	authority	authority	NOUN
ecj-9795	40	72	(	(	PUNCT
ecj-9795	40	73	healthcare	healthcare	NOUN
ecj-9795	40	74	directorate	directorate	NOUN
ecj-9795	40	75	of	of	ADP
ecj-9795	40	76	piacenza	piacenza	NOUN
ecj-9795	40	77	)	)	PUNCT
ecj-9795	40	78	and	and	CCONJ
ecj-9795	40	79	ask	ask	VERB
ecj-9795	40	80	for	for	ADP
ecj-9795	40	81	consent	consent	NOUN
ecj-9795	40	82	to	to	ADP
ecj-9795	40	83	use	use	NOUN
ecj-9795	40	84	of	of	ADP
ecj-9795	40	85	therapeutic	therapeutic	ADJ
ecj-9795	40	86	,	,	PUNCT
ecj-9795	40	87	anticoagulant	anticoagulant	NOUN
ecj-9795	40	88	dose	dose	NOUN
ecj-9795	40	89	of	of	ADP
ecj-9795	40	90	lmwh	lmwh	PROPN
ecj-9795	40	91	(	(	PUNCT
ecj-9795	40	92	t	t	NOUN
ecj-9795	40	93	-	-	PUNCT
ecj-9795	40	94	lmwh	lmwh	NOUN
ecj-9795	40	95	)	)	PUNCT
ecj-9795	40	96	in	in	ADP
ecj-9795	40	97	all	all	DET
ecj-9795	40	98	covid	covid	NOUN
ecj-9795	40	99	patients	patient	NOUN
ecj-9795	40	100	within	within	ADP
ecj-9795	40	101	24	24	NUM
ecj-9795	40	102	from	from	ADP
ecj-9795	40	103	the	the	DET
ecj-9795	40	104	admission	admission	NOUN
ecj-9795	40	105	.	.	PUNCT
ecj-9795	41	1	obviously	obviously	ADV
ecj-9795	41	2	the	the	DET
ecj-9795	41	3	t	t	PROPN
ecj-9795	41	4	-	-	PUNCT
ecj-9795	41	5	lmwh	lmwh	NOUN
ecj-9795	41	6	was	be	AUX
ecj-9795	41	7	adjusted	adjust	VERB
ecj-9795	41	8	for	for	ADP
ecj-9795	41	9	patient	patient	NOUN
ecj-9795	41	10	’s	’s	PART
ecj-9795	41	11	weight	weight	NOUN
ecj-9795	41	12	and	and	CCONJ
ecj-9795	41	13	estimated	estimate	VERB
ecj-9795	41	14	glomerular	glomerular	ADJ
ecj-9795	41	15	filtration	filtration	NOUN
ecj-9795	41	16	rate	rate	NOUN
ecj-9795	41	17	(	(	PUNCT
ecj-9795	41	18	egfr).17,18	egfr).17,18	PRON
ecj-9795	41	19	patients	patient	NOUN
ecj-9795	41	20	with	with	ADP
ecj-9795	41	21	has	have	AUX
ecj-9795	41	22	-	-	PUNCT
ecj-9795	41	23	bled	bleed	VERB
ecj-9795	41	24	risk	risk	NOUN
ecj-9795	41	25	>	>	NOUN
ecj-9795	41	26	3	3	NUM
ecj-9795	41	27	were	be	AUX
ecj-9795	41	28	treated	treat	VERB
ecj-9795	41	29	with	with	ADP
ecj-9795	41	30	p	p	NOUN
ecj-9795	41	31	-	-	PUNCT
ecj-9795	41	32	lmwh	lmwh	NOUN
ecj-9795	41	33	.	.	PUNCT
ecj-9795	42	1	the	the	DET
ecj-9795	42	2	new	new	ADJ
ecj-9795	42	3	therapeutic	therapeutic	ADJ
ecj-9795	42	4	protocol	protocol	NOUN
ecj-9795	42	5	started	start	VERB
ecj-9795	42	6	on	on	ADP
ecj-9795	42	7	16th	16th	ADJ
ecj-9795	42	8	march	march	NOUN
ecj-9795	42	9	.	.	PUNCT
ecj-9795	43	1	data	datum	NOUN
ecj-9795	43	2	collection	collection	NOUN
ecj-9795	43	3	data	datum	NOUN
ecj-9795	43	4	were	be	AUX
ecj-9795	43	5	extracted	extract	VERB
ecj-9795	43	6	from	from	ADP
ecj-9795	43	7	electronic	electronic	ADJ
ecj-9795	43	8	medical	medical	ADJ
ecj-9795	43	9	records	record	NOUN
ecj-9795	43	10	and	and	CCONJ
ecj-9795	43	11	included	include	VERB
ecj-9795	43	12	age	age	NOUN
ecj-9795	43	13	,	,	PUNCT
ecj-9795	43	14	gender	gender	NOUN
ecj-9795	43	15	,	,	PUNCT
ecj-9795	43	16	clinical	clinical	ADJ
ecj-9795	43	17	characteristics	characteristic	NOUN
ecj-9795	43	18	,	,	PUNCT
ecj-9795	43	19	in	in	ADP
ecj-9795	43	20	-	-	PUNCT
ecj-9795	43	21	hospital	hospital	NOUN
ecj-9795	43	22	pharmacological	pharmacological	NOUN
ecj-9795	43	23	treatments	treatment	NOUN
ecj-9795	43	24	and	and	CCONJ
ecj-9795	43	25	type	type	NOUN
ecj-9795	43	26	of	of	ADP
ecj-9795	43	27	oxygenation	oxygenation	NOUN
ecj-9795	43	28	/	/	SYM
ecj-9795	43	29	ventilation	ventilation	NOUN
ecj-9795	43	30	needed	need	VERB
ecj-9795	43	31	.	.	PUNCT
ecj-9795	44	1	the	the	DET
ecj-9795	44	2	comorbidities	comorbiditie	NOUN
ecj-9795	44	3	extracted	extract	VERB
ecj-9795	44	4	were	be	AUX
ecj-9795	44	5	arterial	arterial	ADJ
ecj-9795	44	6	hypertension	hypertension	NOUN
ecj-9795	44	7	,	,	PUNCT
ecj-9795	44	8	diabetes	diabetes	NOUN
ecj-9795	44	9	mellitus	mellitus	NOUN
ecj-9795	44	10	,	,	PUNCT
ecj-9795	44	11	cardiovascular	cardiovascular	ADJ
ecj-9795	44	12	diseases	disease	NOUN
ecj-9795	44	13	(	(	PUNCT
ecj-9795	44	14	defined	define	VERB
ecj-9795	44	15	as	as	ADP
ecj-9795	44	16	history	history	NOUN
ecj-9795	44	17	of	of	ADP
ecj-9795	44	18	myocardial	myocardial	ADJ
ecj-9795	44	19	infarction	infarction	NOUN
ecj-9795	44	20	,	,	PUNCT
ecj-9795	44	21	ischemic	ischemic	ADJ
ecj-9795	44	22	stroke	stroke	NOUN
ecj-9795	44	23	,	,	PUNCT
ecj-9795	44	24	and	and	CCONJ
ecj-9795	44	25	peripheral	peripheral	ADJ
ecj-9795	44	26	atheromasia	atheromasia	NOUN
ecj-9795	44	27	)	)	PUNCT
ecj-9795	44	28	,	,	PUNCT
ecj-9795	44	29	atrial	atrial	ADJ
ecj-9795	44	30	fibrillation	fibrillation	NOUN
ecj-9795	44	31	,	,	PUNCT
ecj-9795	44	32	chronic	chronic	ADJ
ecj-9795	44	33	obstructive	obstructive	ADJ
ecj-9795	44	34	pulmonary	pulmonary	ADJ
ecj-9795	44	35	disease	disease	NOUN
ecj-9795	44	36	,	,	PUNCT
ecj-9795	44	37	chronic	chronic	ADJ
ecj-9795	44	38	kidney	kidney	NOUN
ecj-9795	44	39	disease	disease	NOUN
ecj-9795	44	40	(	(	PUNCT
ecj-9795	44	41	cockroft	cockroft	NOUN
ecj-9795	44	42	-	-	PUNCT
ecj-9795	44	43	gault	gault	NOUN
ecj-9795	44	44	e	e	PROPN
ecj-9795	44	45	-	-	NOUN
ecj-9795	44	46	gfr	gfr	NOUN
ecj-9795	44	47	<	<	X
ecj-9795	44	48	60	60	NUM
ecj-9795	44	49	ml	ml	NOUN
ecj-9795	44	50	/	/	SYM
ecj-9795	44	51	min/1.73m2	min/1.73m2	PROPN
ecj-9795	44	52	)	)	PUNCT
ecj-9795	44	53	and	and	CCONJ
ecj-9795	44	54	the	the	DET
ecj-9795	44	55	presence	presence	NOUN
ecj-9795	44	56	of	of	ADP
ecj-9795	44	57	active	active	ADJ
ecj-9795	44	58	or	or	CCONJ
ecj-9795	44	59	previous	previous	ADJ
ecj-9795	44	60	cancer	cancer	NOUN
ecj-9795	44	61	.	.	PUNCT
ecj-9795	45	1	bleeding	bleed	VERB
ecj-9795	45	2	events	event	NOUN
ecj-9795	45	3	were	be	AUX
ecj-9795	45	4	also	also	ADV
ecj-9795	45	5	extracted	extract	VERB
ecj-9795	45	6	and	and	CCONJ
ecj-9795	45	7	classified	classify	VERB
ecj-9795	45	8	according	accord	VERB
ecj-9795	45	9	to	to	ADP
ecj-9795	45	10	the	the	DET
ecj-9795	45	11	international	international	ADJ
ecj-9795	45	12	society	society	NOUN
ecj-9795	45	13	of	of	ADP
ecj-9795	45	14	thrombosis	thrombosis	NOUN
ecj-9795	45	15	and	and	CCONJ
ecj-9795	45	16	hemostasis	hemostasis	NOUN
ecj-9795	45	17	(	(	PUNCT
ecj-9795	45	18	isth	isth	NOUN
ecj-9795	45	19	)	)	PUNCT
ecj-9795	45	20	definition	definition	NOUN
ecj-9795	45	21	of	of	ADP
ecj-9795	45	22	bleeding.19	bleeding.19	NOUN
ecj-9795	45	23	statistical	statistical	ADJ
ecj-9795	45	24	analysis	analysis	NOUN
ecj-9795	45	25	we	we	PRON
ecj-9795	45	26	considered	consider	VERB
ecj-9795	45	27	as	as	ADP
ecj-9795	45	28	independent	independent	ADJ
ecj-9795	45	29	variables	variable	NOUN
ecj-9795	45	30	age	age	NOUN
ecj-9795	45	31	,	,	PUNCT
ecj-9795	45	32	sex	sex	NOUN
ecj-9795	45	33	and	and	CCONJ
ecj-9795	45	34	a	a	DET
ecj-9795	45	35	set	set	NOUN
ecj-9795	45	36	of	of	ADP
ecj-9795	45	37	variables	variable	NOUN
ecj-9795	45	38	described	describe	VERB
ecj-9795	45	39	in	in	ADP
ecj-9795	45	40	comorbidities	comorbiditie	NOUN
ecj-9795	45	41	and	and	CCONJ
ecj-9795	45	42	in	in	ADP
ecj-9795	45	43	-	-	PUNCT
ecj-9795	45	44	hospital	hospital	NOUN
ecj-9795	45	45	treatments	treatment	NOUN
ecj-9795	45	46	listed	list	VERB
ecj-9795	45	47	in	in	ADP
ecj-9795	45	48	table	table	NOUN
ecj-9795	45	49	1	1	NUM
ecj-9795	45	50	.	.	PUNCT
ecj-9795	45	51	to	to	PART
ecj-9795	45	52	explore	explore	VERB
ecj-9795	45	53	the	the	DET
ecj-9795	45	54	impact	impact	NOUN
ecj-9795	45	55	of	of	ADP
ecj-9795	45	56	all	all	DET
ecj-9795	45	57	these	these	DET
ecj-9795	45	58	variables	variable	NOUN
ecj-9795	45	59	on	on	ADP
ecj-9795	45	60	mortality	mortality	NOUN
ecj-9795	45	61	,	,	PUNCT
ecj-9795	45	62	we	we	PRON
ecj-9795	45	63	first	first	ADV
ecj-9795	45	64	performed	perform	VERB
ecj-9795	45	65	univariate	univariate	ADJ
ecj-9795	45	66	analysis	analysis	NOUN
ecj-9795	45	67	estimating	estimate	VERB
ecj-9795	45	68	the	the	DET
ecj-9795	45	69	odds	odd	NOUN
ecj-9795	45	70	ratios	ratio	NOUN
ecj-9795	45	71	of	of	ADP
ecj-9795	45	72	mortality	mortality	NOUN
ecj-9795	45	73	,	,	PUNCT
ecj-9795	45	74	for	for	ADP
ecj-9795	45	75	each	each	DET
ecj-9795	45	76	variable	variable	NOUN
ecj-9795	45	77	,	,	PUNCT
ecj-9795	45	78	along	along	ADP
ecj-9795	45	79	with	with	ADP
ecj-9795	45	80	their	their	PRON
ecj-9795	45	81	confidence	confidence	NOUN
ecj-9795	45	82	intervals	interval	NOUN
ecj-9795	45	83	.	.	PUNCT
ecj-9795	46	1	then	then	ADV
ecj-9795	46	2	,	,	PUNCT
ecj-9795	46	3	a	a	DET
ecj-9795	46	4	multivariate	multivariate	NOUN
ecj-9795	46	5	logistic	logistic	ADJ
ecj-9795	46	6	regression	regression	NOUN
ecj-9795	46	7	model	model	NOUN
ecj-9795	46	8	was	be	AUX
ecj-9795	46	9	used	use	VERB
ecj-9795	46	10	including	include	VERB
ecj-9795	46	11	significant	significant	ADJ
ecj-9795	46	12	variables	variable	NOUN
ecj-9795	46	13	identified	identify	VERB
ecj-9795	46	14	in	in	ADP
ecj-9795	46	15	univariate	univariate	ADJ
ecj-9795	46	16	analyses	analysis	NOUN
ecj-9795	46	17	.	.	PUNCT
ecj-9795	47	1	being	be	AUX
ecj-9795	47	2	lmwh	lmwh	ADJ
ecj-9795	47	3	the	the	DET
ecj-9795	47	4	only	only	ADJ
ecj-9795	47	5	one	one	NUM
ecj-9795	47	6	therapy	therapy	NOUN
ecj-9795	47	7	affecting	affect	VERB
ecj-9795	47	8	survival	survival	NOUN
ecj-9795	47	9	rate	rate	NOUN
ecj-9795	47	10	,	,	PUNCT
ecj-9795	47	11	we	we	PRON
ecj-9795	47	12	subdivided	subdivide	VERB
ecj-9795	47	13	the	the	DET
ecj-9795	47	14	population	population	NOUN
ecj-9795	47	15	in	in	ADP
ecj-9795	47	16	two	two	NUM
ecj-9795	47	17	groups	group	NOUN
ecj-9795	47	18	,	,	PUNCT
ecj-9795	47	19	p	p	NOUN
ecj-9795	47	20	and	and	CCONJ
ecj-9795	47	21	t	t	NOUN
ecj-9795	47	22	-	-	PUNCT
ecj-9795	47	23	lmwh	lmwh	NOUN
ecj-9795	47	24	,	,	PUNCT
ecj-9795	47	25	and	and	CCONJ
ecj-9795	47	26	then	then	ADV
ecj-9795	47	27	compared	compare	VERB
ecj-9795	47	28	the	the	DET
ecj-9795	47	29	two	two	NUM
ecj-9795	47	30	groups	group	NOUN
ecj-9795	47	31	of	of	ADP
ecj-9795	47	32	patients	patient	NOUN
ecj-9795	47	33	using	use	VERB
ecj-9795	47	34	two	two	NUM
ecj-9795	47	35	sample	sample	NOUN
ecj-9795	47	36	tests	test	NOUN
ecj-9795	47	37	:	:	PUNCT
ecj-9795	47	38	z	z	NOUN
ecj-9795	47	39	test	test	NOUN
ecj-9795	47	40	for	for	ADP
ecj-9795	47	41	dichotomous	dichotomous	ADJ
ecj-9795	47	42	variables	variable	NOUN
ecj-9795	47	43	,	,	PUNCT
ecj-9795	47	44	chi	chi	ADJ
ecj-9795	47	45	-	-	PUNCT
ecj-9795	47	46	square	square	ADJ
ecj-9795	47	47	test	test	NOUN
ecj-9795	47	48	for	for	ADP
ecj-9795	47	49	categorical	categorical	ADJ
ecj-9795	47	50	variables	variable	NOUN
ecj-9795	47	51	,	,	PUNCT
ecj-9795	47	52	while	while	SCONJ
ecj-9795	47	53	wilicoxon	wilicoxon	ADJ
ecj-9795	47	54	mann	mann	PROPN
ecj-9795	47	55	-	-	PUNCT
ecj-9795	47	56	whitney	whitney	PROPN
ecj-9795	47	57	was	be	AUX
ecj-9795	47	58	used	use	VERB
ecj-9795	47	59	for	for	ADP
ecj-9795	47	60	the	the	DET
ecj-9795	47	61	comparison	comparison	NOUN
ecj-9795	47	62	of	of	ADP
ecj-9795	47	63	distributions	distribution	NOUN
ecj-9795	47	64	of	of	ADP
ecj-9795	47	65	numerical	numerical	ADJ
ecj-9795	47	66	variables	variable	NOUN
ecj-9795	47	67	.	.	PUNCT
ecj-9795	48	1	for	for	ADP
ecj-9795	48	2	lmwh	lmwh	NOUN
ecj-9795	48	3	dose	dose	NOUN
ecj-9795	48	4	we	we	PRON
ecj-9795	48	5	also	also	ADV
ecj-9795	48	6	used	use	VERB
ecj-9795	48	7	a	a	DET
ecj-9795	48	8	z	z	NOUN
ecj-9795	48	9	-	-	PUNCT
ecj-9795	48	10	test	test	NOUN
ecj-9795	48	11	for	for	ADP
ecj-9795	48	12	comparing	compare	VERB
ecj-9795	48	13	proportions	proportion	NOUN
ecj-9795	48	14	,	,	PUNCT
ecj-9795	48	15	along	along	ADP
ecj-9795	48	16	with	with	ADP
ecj-9795	48	17	analysis	analysis	NOUN
ecj-9795	48	18	of	of	ADP
ecj-9795	48	19	its	its	PRON
ecj-9795	48	20	impact	impact	NOUN
ecj-9795	48	21	on	on	ADP
ecj-9795	48	22	patients	patient	NOUN
ecj-9795	48	23	survival	survival	VERB
ecj-9795	48	24	over	over	ADP
ecj-9795	48	25	the	the	DET
ecj-9795	48	26	observation	observation	NOUN
ecj-9795	48	27	period	period	NOUN
ecj-9795	48	28	.	.	PUNCT
ecj-9795	49	1	to	to	ADP
ecj-9795	49	2	this	this	DET
ecj-9795	49	3	latter	latter	ADJ
ecj-9795	49	4	aim	aim	NOUN
ecj-9795	49	5	,	,	PUNCT
ecj-9795	49	6	a	a	DET
ecj-9795	49	7	graphical	graphical	ADJ
ecj-9795	49	8	representation	representation	NOUN
ecj-9795	49	9	of	of	ADP
ecj-9795	49	10	the	the	DET
ecj-9795	49	11	kaplan	kaplan	PROPN
ecj-9795	49	12	-	-	PUNCT
ecj-9795	49	13	meier	meier	PROPN
ecj-9795	49	14	curves	curve	NOUN
ecj-9795	49	15	,	,	PUNCT
ecj-9795	49	16	separated	separate	VERB
ecj-9795	49	17	for	for	ADP
ecj-9795	49	18	the	the	DET
ecj-9795	49	19	two	two	NUM
ecj-9795	49	20	groups	group	NOUN
ecj-9795	49	21	,	,	PUNCT
ecj-9795	49	22	was	be	AUX
ecj-9795	49	23	done	do	VERB
ecj-9795	49	24	and	and	CCONJ
ecj-9795	49	25	compared	compare	VERB
ecj-9795	49	26	using	use	VERB
ecj-9795	49	27	long	long	ADJ
ecj-9795	49	28	-	-	PUNCT
ecj-9795	49	29	rank	rank	NOUN
ecj-9795	49	30	or	or	CCONJ
ecj-9795	49	31	mantel	mantel	NOUN
ecj-9795	49	32	-	-	PUNCT
ecj-9795	49	33	haenszel	haenszel	NOUN
ecj-9795	49	34	test	test	NOUN
ecj-9795	49	35	.	.	PUNCT
ecj-9795	50	1	the	the	DET
ecj-9795	50	2	z	z	NOUN
ecj-9795	50	3	test	test	NOUN
ecj-9795	50	4	(	(	PUNCT
ecj-9795	50	5	with	with	ADP
ecj-9795	50	6	continuity	continuity	NOUN
ecj-9795	50	7	correction	correction	NOUN
ecj-9795	50	8	)	)	PUNCT
ecj-9795	50	9	was	be	AUX
ecj-9795	50	10	also	also	ADV
ecj-9795	50	11	applied	apply	VERB
ecj-9795	50	12	to	to	ADP
ecj-9795	50	13	the	the	DET
ecj-9795	50	14	analysis	analysis	NOUN
ecj-9795	50	15	of	of	ADP
ecj-9795	50	16	samples	sample	NOUN
ecj-9795	50	17	stratified	stratify	VERB
ecj-9795	50	18	according	accord	VERB
ecj-9795	50	19	to	to	ADP
ecj-9795	50	20	the	the	DET
ecj-9795	50	21	ventilation	ventilation	NOUN
ecj-9795	50	22	level	level	NOUN
ecj-9795	50	23	.	.	PUNCT
ecj-9795	51	1	moreover	moreover	ADV
ecj-9795	51	2	a	a	DET
ecj-9795	51	3	cox	cox	PROPN
ecj-9795	51	4	regression	regression	NOUN
ecj-9795	51	5	model	model	NOUN
ecj-9795	51	6	was	be	AUX
ecj-9795	51	7	used	use	VERB
ecj-9795	51	8	to	to	ADP
ecj-9795	51	9	adjusting	adjust	VERB
ecj-9795	51	10	results	result	NOUN
ecj-9795	51	11	for	for	ADP
ecj-9795	51	12	drug	drug	NOUN
ecj-9795	51	13	intake	intake	NOUN
ecj-9795	51	14	,	,	PUNCT
ecj-9795	51	15	focusing	focus	VERB
ecj-9795	51	16	on	on	ADP
ecj-9795	51	17	those	those	PRON
ecj-9795	51	18	that	that	PRON
ecj-9795	51	19	statistically	statistically	ADV
ecj-9795	51	20	differ	differ	VERB
ecj-9795	51	21	between	between	ADP
ecj-9795	51	22	the	the	DET
ecj-9795	51	23	two	two	NUM
ecj-9795	51	24	groups	group	NOUN
ecj-9795	51	25	.	.	PUNCT
ecj-9795	52	1	all	all	DET
ecj-9795	52	2	statistical	statistical	ADJ
ecj-9795	52	3	computation	computation	NOUN
ecj-9795	52	4	were	be	AUX
ecj-9795	52	5	carried	carry	VERB
ecj-9795	52	6	out	out	ADP
ecj-9795	52	7	using	use	VERB
ecj-9795	52	8	the	the	DET
ecj-9795	52	9	software	software	NOUN
ecj-9795	52	10	r	r	NOUN
ecj-9795	52	11	version	version	NOUN
ecj-9795	52	12	3.5.1	3.5.1	NUM
ecj-9795	52	13	results	result	NOUN
ecj-9795	52	14	between	between	ADP
ecj-9795	52	15	february	february	PROPN
ecj-9795	52	16	29th	29th	NOUN
ecj-9795	52	17	and	and	CCONJ
ecj-9795	52	18	april	april	PROPN
ecj-9795	52	19	7th	7th	NOUN
ecj-9795	52	20	,	,	PUNCT
ecj-9795	52	21	2020	2020	NUM
ecj-9795	52	22	,	,	PUNCT
ecj-9795	52	23	351	351	NUM
ecj-9795	52	24	patients	patient	NOUN
ecj-9795	52	25	were	be	AUX
ecj-9795	52	26	admitted	admit	VERB
ecj-9795	52	27	to	to	ADP
ecj-9795	52	28	castel	castel	PROPN
ecj-9795	52	29	san	san	PROPN
ecj-9795	52	30	giovanni	giovanni	PROPN
ecj-9795	52	31	hospital	hospital	PROPN
ecj-9795	52	32	.	.	PUNCT
ecj-9795	53	1	ninety	ninety	NUM
ecj-9795	53	2	-	-	PUNCT
ecj-9795	53	3	four	four	NUM
ecj-9795	53	4	patients	patient	NOUN
ecj-9795	53	5	were	be	AUX
ecj-9795	53	6	excluded	exclude	VERB
ecj-9795	53	7	from	from	ADP
ecj-9795	53	8	the	the	DET
ecj-9795	53	9	analysis	analysis	NOUN
ecj-9795	53	10	for	for	ADP
ecj-9795	53	11	the	the	DET
ecj-9795	53	12	following	follow	VERB
ecj-9795	53	13	reasons	reason	NOUN
ecj-9795	53	14	:	:	PUNCT
ecj-9795	53	15	within	within	SCONJ
ecj-9795	53	16	7	7	NUM
ecj-9795	53	17	days	day	NOUN
ecj-9795	53	18	30	30	NUM
ecj-9795	53	19	of	of	ADP
ecj-9795	53	20	them	they	PRON
ecj-9795	53	21	were	be	AUX
ecj-9795	53	22	discharged	discharge	VERB
ecj-9795	53	23	,	,	PUNCT
ecj-9795	53	24	43	43	NUM
ecj-9795	53	25	died	die	VERB
ecj-9795	53	26	and	and	CCONJ
ecj-9795	53	27	17	17	NUM
ecj-9795	53	28	were	be	AUX
ecj-9795	53	29	transferred	transfer	VERB
ecj-9795	53	30	to	to	ADP
ecj-9795	53	31	other	other	ADJ
ecj-9795	53	32	care	care	NOUN
ecj-9795	53	33	units	unit	NOUN
ecj-9795	53	34	and	and	CCONJ
ecj-9795	53	35	we	we	PRON
ecj-9795	53	36	had	have	VERB
ecj-9795	53	37	no	no	DET
ecj-9795	53	38	data	datum	NOUN
ecj-9795	53	39	to	to	PART
ecj-9795	53	40	collect	collect	VERB
ecj-9795	53	41	,	,	PUNCT
ecj-9795	53	42	3	3	NUM
ecj-9795	53	43	were	be	AUX
ecj-9795	53	44	not	not	PART
ecj-9795	53	45	covid-19	covid-19	PROPN
ecj-9795	53	46	confirmed	confirm	VERB
ecj-9795	53	47	patients	patient	NOUN
ecj-9795	53	48	and	and	CCONJ
ecj-9795	53	49	1	1	NUM
ecj-9795	53	50	patient	patient	NOUN
ecj-9795	53	51	was	be	AUX
ecj-9795	53	52	undergoing	undergo	VERB
ecj-9795	53	53	hemodialysis	hemodialysis	NOUN
ecj-9795	53	54	and	and	CCONJ
ecj-9795	53	55	excluded	exclude	VERB
ecj-9795	53	56	.	.	PUNCT
ecj-9795	54	1	one	one	NUM
ecj-9795	54	2	hundred	hundred	NUM
ecj-9795	54	3	thirty	thirty	NUM
ecj-9795	54	4	-	-	PUNCT
ecj-9795	54	5	one	one	NUM
ecj-9795	54	6	(	(	PUNCT
ecj-9795	54	7	51	51	NUM
ecj-9795	54	8	%	%	NOUN
ecj-9795	54	9	)	)	PUNCT
ecj-9795	54	10	received	receive	VERB
ecj-9795	54	11	prophylactic	prophylactic	ADJ
ecj-9795	54	12	lmwh	lmwh	NOUN
ecj-9795	54	13	and	and	CCONJ
ecj-9795	54	14	126	126	NUM
ecj-9795	54	15	patients	patient	NOUN
ecj-9795	54	16	(	(	PUNCT
ecj-9795	54	17	49	49	NUM
ecj-9795	54	18	%	%	NOUN
ecj-9795	54	19	)	)	PUNCT
ecj-9795	54	20	received	receive	VERB
ecj-9795	54	21	lmwh	lmwh	NOUN
ecj-9795	54	22	(	(	PUNCT
ecj-9795	54	23	each	each	DET
ecj-9795	54	24	clinician	clinician	NOUN
ecj-9795	54	25	adjusted	adjust	VERB
ecj-9795	54	26	the	the	DET
ecj-9795	54	27	therapeutic	therapeutic	ADJ
ecj-9795	54	28	dose	dose	NOUN
ecj-9795	54	29	of	of	ADP
ecj-9795	54	30	heparin	heparin	NOUN
ecj-9795	54	31	based	base	VERB
ecj-9795	54	32	on	on	ADP
ecj-9795	54	33	each	each	DET
ecj-9795	54	34	patient	patient	NOUN
ecj-9795	54	35	’s	’s	PART
ecj-9795	54	36	weight	weight	NOUN
ecj-9795	54	37	and	and	CCONJ
ecj-9795	54	38	egfr	egfr	NOUN
ecj-9795	54	39	)	)	PUNCT
ecj-9795	54	40	.	.	PUNCT
ecj-9795	55	1	two	two	NUM
ecj-9795	55	2	hundred	hundred	NUM
ecj-9795	55	3	-	-	PUNCT
ecj-9795	55	4	thirty	thirty	NUM
ecj-9795	55	5	-	-	PUNCT
ecj-9795	55	6	two	two	NUM
ecj-9795	55	7	patients	patient	NOUN
ecj-9795	55	8	(	(	PUNCT
ecj-9795	55	9	90.3	90.3	NUM
ecj-9795	55	10	%	%	NOUN
ecj-9795	55	11	)	)	PUNCT
ecj-9795	55	12	received	receive	VERB
ecj-9795	55	13	empiric	empiric	ADJ
ecj-9795	55	14	antibiotic	antibiotic	ADJ
ecj-9795	55	15	treatment	treatment	NOUN
ecj-9795	55	16	(	(	PUNCT
ecj-9795	55	17	azithromycin	azithromycin	NOUN
ecj-9795	55	18	500	500	NUM
ecj-9795	55	19	mg	mg	NUM
ecj-9795	55	20	/	/	SYM
ecj-9795	55	21	day	day	NOUN
ecj-9795	55	22	for	for	ADP
ecj-9795	55	23	at	at	ADV
ecj-9795	55	24	least	least	ADV
ecj-9795	55	25	5	5	NUM
ecj-9795	55	26	days	day	NOUN
ecj-9795	55	27	)	)	PUNCT
ecj-9795	55	28	,	,	PUNCT
ecj-9795	55	29	237	237	NUM
ecj-9795	55	30	patients	patient	NOUN
ecj-9795	55	31	(	(	PUNCT
ecj-9795	55	32	92.2	92.2	NUM
ecj-9795	55	33	%	%	NOUN
ecj-9795	55	34	)	)	PUNCT
ecj-9795	55	35	received	receive	VERB
ecj-9795	55	36	hydroxychloroquine	hydroxychloroquine	NOUN
ecj-9795	55	37	(	(	PUNCT
ecj-9795	55	38	200	200	NUM
ecj-9795	55	39	mg	mg	NOUN
ecj-9795	55	40	twice	twice	DET
ecj-9795	55	41	a	a	DET
ecj-9795	55	42	day	day	NOUN
ecj-9795	55	43	for	for	ADP
ecj-9795	55	44	at	at	ADV
ecj-9795	55	45	least	least	ADV
ecj-9795	55	46	5	5	NUM
ecj-9795	55	47	days	day	NOUN
ecj-9795	55	48	)	)	PUNCT
ecj-9795	55	49	,	,	PUNCT
ecj-9795	55	50	146	146	NUM
ecj-9795	55	51	patients	patient	NOUN
ecj-9795	55	52	(	(	PUNCT
ecj-9795	55	53	55.7	55.7	NUM
ecj-9795	55	54	%	%	NOUN
ecj-9795	55	55	)	)	PUNCT
ecj-9795	55	56	received	receive	VERB
ecj-9795	55	57	corticosteroids	corticosteroid	NOUN
ecj-9795	55	58	(	(	PUNCT
ecj-9795	55	59	methylprednisolone	methylprednisolone	NOUN
ecj-9795	55	60	1	1	NUM
ecj-9795	55	61	mg	mg	NUM
ecj-9795	55	62	/	/	SYM
ecj-9795	55	63	kg	kg	PROPN
ecj-9795	55	64	twice	twice	DET
ecj-9795	55	65	a	a	DET
ecj-9795	55	66	day	day	NOUN
ecj-9795	55	67	i.v	i.v	PROPN
ecj-9795	55	68	.	.	PUNCT
ecj-9795	56	1	or	or	CCONJ
ecj-9795	56	2	dexamethasone	dexamethasone	NOUN
ecj-9795	56	3	40	40	NUM
ecj-9795	56	4	mg	mg	PROPN
ecj-9795	56	5	i.v	i.v	PROPN
ecj-9795	56	6	.	.	PUNCT
ecj-9795	57	1	once	once	ADV
ecj-9795	57	2	a	a	DET
ecj-9795	57	3	day	day	NOUN
ecj-9795	57	4	for	for	ADP
ecj-9795	57	5	3	3	NUM
ecj-9795	57	6	days	day	NOUN
ecj-9795	57	7	followed	follow	VERB
ecj-9795	57	8	by	by	ADP
ecj-9795	57	9	decreasing	decrease	VERB
ecj-9795	57	10	dosage	dosage	NOUN
ecj-9795	57	11	)	)	PUNCT
ecj-9795	57	12	,	,	PUNCT
ecj-9795	57	13	236	236	NUM
ecj-9795	57	14	patients	patient	NOUN
ecj-9795	57	15	(	(	PUNCT
ecj-9795	57	16	91.8	91.8	NUM
ecj-9795	57	17	%	%	NOUN
ecj-9795	57	18	)	)	PUNCT
ecj-9795	57	19	received	receive	VERB
ecj-9795	57	20	anti	anti	ADJ
ecj-9795	57	21	-	-	ADJ
ecj-9795	57	22	retroviral	retroviral	ADJ
ecj-9795	57	23	therapy	therapy	NOUN
ecj-9795	57	24	(	(	PUNCT
ecj-9795	57	25	darunavir	darunavir	PROPN
ecj-9795	57	26	/	/	SYM
ecj-9795	57	27	cobicistat	cobicistat	PROPN
ecj-9795	57	28	800	800	NUM
ecj-9795	57	29	+	+	NUM
ecj-9795	57	30	150	150	NUM
ecj-9795	57	31	mg	mg	NUM
ecj-9795	57	32	,	,	PUNCT
ecj-9795	57	33	1	1	NUM
ecj-9795	57	34	tablet	tablet	NOUN
ecj-9795	57	35	for	for	ADP
ecj-9795	57	36	7	7	NUM
ecj-9795	57	37	days	day	NOUN
ecj-9795	57	38	and/or	and/or	CCONJ
ecj-9795	57	39	lopinavir	lopinavir	PROPN
ecj-9795	57	40	/	/	SYM
ecj-9795	57	41	ritonavir	ritonavir	PROPN
ecj-9795	57	42	200	200	NUM
ecj-9795	57	43	+	+	NUM
ecj-9795	57	44	50	50	NUM
ecj-9795	57	45	mg	mg	NOUN
ecj-9795	57	46	,	,	PUNCT
ecj-9795	57	47	1	1	NUM
ecj-9795	57	48	tablet	tablet	NOUN
ecj-9795	57	49	twice	twice	DET
ecj-9795	57	50	a	a	DET
ecj-9795	57	51	day	day	NOUN
ecj-9795	57	52	for	for	ADP
ecj-9795	57	53	7	7	NUM
ecj-9795	57	54	days	day	NOUN
ecj-9795	57	55	)	)	PUNCT
ecj-9795	57	56	.	.	PUNCT
ecj-9795	58	1	twenty	twenty	NUM
ecj-9795	58	2	-	-	PUNCT
ecj-9795	58	3	five	five	NUM
ecj-9795	58	4	patients	patient	NOUN
ecj-9795	58	5	(	(	PUNCT
ecj-9795	58	6	9.5	9.5	NUM
ecj-9795	58	7	%	%	NOUN
ecj-9795	58	8	)	)	PUNCT
ecj-9795	58	9	were	be	AUX
ecj-9795	58	10	eligible	eligible	ADJ
ecj-9795	58	11	for	for	ADP
ecj-9795	58	12	treatment	treatment	NOUN
ecj-9795	58	13	with	with	ADP
ecj-9795	58	14	tocilizumab	tocilizumab	NOUN
ecj-9795	58	15	(	(	PUNCT
ecj-9795	58	16	8	8	NUM
ecj-9795	58	17	mg	mg	NUM
ecj-9795	58	18	/	/	SYM
ecj-9795	58	19	kg	kg	PROPN
ecj-9795	58	20	i.v	i.v	PROPN
ecj-9795	58	21	.	.	PUNCT
ecj-9795	59	1	in	in	ADP
ecj-9795	59	2	a	a	DET
ecj-9795	59	3	single	single	ADJ
ecj-9795	59	4	or	or	CCONJ
ecj-9795	59	5	double	double	ADJ
ecj-9795	59	6	dose	dose	NOUN
ecj-9795	59	7	)	)	PUNCT
ecj-9795	59	8	.	.	PUNCT
ecj-9795	60	1	d	d	X
ecj-9795	60	2	-	-	PUNCT
ecj-9795	60	3	dimer	dimer	ADJ
ecj-9795	60	4	levels	level	NOUN
ecj-9795	60	5	were	be	AUX
ecj-9795	60	6	collected	collect	VERB
ecj-9795	60	7	in	in	ADP
ecj-9795	60	8	93	93	NUM
ecj-9795	60	9	patients	patient	NOUN
ecj-9795	60	10	,	,	PUNCT
ecj-9795	60	11	and	and	CCONJ
ecj-9795	60	12	the	the	DET
ecj-9795	60	13	mean	mean	ADJ
ecj-9795	60	14	peak	peak	NOUN
ecj-9795	60	15	level	level	NOUN
ecj-9795	60	16	was	be	AUX
ecj-9795	60	17	5241	5241	NUM
ecj-9795	60	18	μg	μg	NOUN
ecj-9795	60	19	/	/	SYM
ecj-9795	60	20	ml	ml	PROPN
ecj-9795	60	21	;	;	PUNCT
ecj-9795	60	22	the	the	DET
ecj-9795	60	23	median	median	ADJ
ecj-9795	60	24	level	level	NOUN
ecj-9795	60	25	was	be	AUX
ecj-9795	60	26	1489	1489	NUM
ecj-9795	60	27	μg	μg	NOUN
ecj-9795	60	28	/	/	SYM
ecj-9795	60	29	ml	ml	NOUN
ecj-9795	60	30	.	.	PUNCT
ecj-9795	61	1	all	all	DET
ecj-9795	61	2	patients	patient	NOUN
ecj-9795	61	3	required	require	VERB
ecj-9795	61	4	oxygen	oxygen	NOUN
ecj-9795	61	5	therapy	therapy	NOUN
ecj-9795	61	6	:	:	PUNCT
ecj-9795	61	7	135	135	NUM
ecj-9795	61	8	patients	patient	NOUN
ecj-9795	61	9	(	(	PUNCT
ecj-9795	61	10	52,5	52,5	NUM
ecj-9795	61	11	%	%	NOUN
ecj-9795	61	12	)	)	PUNCT
ecj-9795	61	13	needed	need	VERB
ecj-9795	61	14	nasal	nasal	PROPN
ecj-9795	61	15	cannulas	cannula	NOUN
ecj-9795	61	16	with	with	ADP
ecj-9795	61	17	oxygen	oxygen	NOUN
ecj-9795	61	18	flow	flow	NOUN
ecj-9795	61	19	≤6	≤6	PROPN
ecj-9795	61	20	l	l	PROPN
ecj-9795	61	21	/	/	SYM
ecj-9795	61	22	min	min	PROPN
ecj-9795	61	23	or	or	CCONJ
ecj-9795	61	24	non	non	ADJ
ecj-9795	61	25	-	-	ADJ
ecj-9795	61	26	rebreather	rebreather	ADJ
ecj-9795	61	27	mask	mask	NOUN
ecj-9795	61	28	with	with	ADP
ecj-9795	61	29	oxygen	oxygen	NOUN
ecj-9795	61	30	flow	flow	NOUN
ecj-9795	61	31	from	from	ADP
ecj-9795	61	32	10	10	NUM
ecj-9795	61	33	to	to	PART
ecj-9795	61	34	15	15	NUM
ecj-9795	61	35	l	l	NOUN
ecj-9795	61	36	/	/	SYM
ecj-9795	61	37	min	min	NOUN
ecj-9795	61	38	(	(	PUNCT
ecj-9795	61	39	vent	vent	NOUN
ecj-9795	61	40	1	1	NUM
ecj-9795	61	41	)	)	PUNCT
ecj-9795	61	42	;	;	PUNCT
ecj-9795	61	43	67	67	NUM
ecj-9795	61	44	patients	patient	NOUN
ecj-9795	61	45	(	(	PUNCT
ecj-9795	61	46	26.1	26.1	NUM
ecj-9795	61	47	%	%	NOUN
ecj-9795	61	48	)	)	PUNCT
ecj-9795	61	49	required	require	VERB
ecj-9795	61	50	non	non	ADJ
ecj-9795	61	51	-	-	ADJ
ecj-9795	61	52	invasive	invasive	ADJ
ecj-9795	61	53	mechan	mechan	NOUN
ecj-9795	61	54	article	article	NOUN
ecj-9795	61	55	[	[	X
ecj-9795	61	56	emergency	emergency	NOUN
ecj-9795	61	57	care	care	NOUN
ecj-9795	61	58	journal	journal	PROPN
ecj-9795	61	59	2021	2021	NUM
ecj-9795	61	60	;	;	PUNCT
ecj-9795	61	61	17:9795	17:9795	NUM
ecj-9795	61	62	]	]	PUNCT
ecj-9795	62	1	[	[	X
ecj-9795	62	2	page	page	NOUN
ecj-9795	62	3	27	27	NUM
ecj-9795	62	4	]	]	PUNCT
ecj-9795	62	5	non	non	ADJ
ecj-9795	62	6	-co	-co	PROPN
ecj-9795	62	7	mmerc	mmerc	PROPN
ecj-9795	62	8	ial	ial	PROPN
ecj-9795	62	9	us	us	PROPN
ecj-9795	62	10	e	e	NOUN
ecj-9795	62	11	o	o	NOUN
ecj-9795	62	12	nly	nly	ADV
ecj-9795	62	13	ical	ical	ADJ
ecj-9795	62	14	ventilation	ventilation	NOUN
ecj-9795	62	15	with	with	ADP
ecj-9795	62	16	helmet	helmet	NOUN
ecj-9795	62	17	c	c	NOUN
ecj-9795	62	18	-	-	PUNCT
ecj-9795	62	19	pap	pap	NOUN
ecj-9795	62	20	(	(	PUNCT
ecj-9795	62	21	vent	vent	NOUN
ecj-9795	62	22	2	2	NUM
ecj-9795	62	23	)	)	PUNCT
ecj-9795	62	24	and	and	CCONJ
ecj-9795	62	25	55	55	NUM
ecj-9795	62	26	patients	patient	NOUN
ecj-9795	62	27	(	(	PUNCT
ecj-9795	62	28	21.4	21.4	NUM
ecj-9795	62	29	%	%	NOUN
ecj-9795	62	30	)	)	PUNCT
ecj-9795	62	31	required	require	VERB
ecj-9795	62	32	invasive	invasive	ADJ
ecj-9795	62	33	mechanical	mechanical	ADJ
ecj-9795	62	34	ventilation	ventilation	NOUN
ecj-9795	62	35	(	(	PUNCT
ecj-9795	62	36	vent	vent	NOUN
ecj-9795	62	37	3	3	NUM
ecj-9795	62	38	)	)	PUNCT
ecj-9795	62	39	.	.	PUNCT
ecj-9795	63	1	patients	patient	NOUN
ecj-9795	63	2	treated	treat	VERB
ecj-9795	63	3	with	with	ADP
ecj-9795	63	4	prophylactic	prophylactic	ADJ
ecj-9795	63	5	and	and	CCONJ
ecj-9795	63	6	therapeutic	therapeutic	ADJ
ecj-9795	63	7	lmwh	lmwh	NOUN
ecj-9795	63	8	were	be	AUX
ecj-9795	63	9	compared	compare	VERB
ecj-9795	63	10	for	for	ADP
ecj-9795	63	11	demographic	demographic	ADJ
ecj-9795	63	12	and	and	CCONJ
ecj-9795	63	13	clinical	clinical	ADJ
ecj-9795	63	14	characteristics	characteristic	NOUN
ecj-9795	63	15	(	(	PUNCT
ecj-9795	63	16	table	table	NOUN
ecj-9795	63	17	1	1	NUM
ecj-9795	63	18	)	)	PUNCT
ecj-9795	63	19	.	.	PUNCT
ecj-9795	64	1	in	in	ADP
ecj-9795	64	2	-	-	PUNCT
ecj-9795	64	3	hospital	hospital	NOUN
ecj-9795	64	4	mortality	mortality	NOUN
ecj-9795	64	5	of	of	ADP
ecj-9795	64	6	patients	patient	NOUN
ecj-9795	64	7	treated	treat	VERB
ecj-9795	64	8	with	with	ADP
ecj-9795	64	9	therapeutic	therapeutic	ADJ
ecj-9795	64	10	lmwh	lmwh	NOUN
ecj-9795	64	11	vs.	vs.	ADP
ecj-9795	64	12	prophylactic	prophylactic	ADJ
ecj-9795	64	13	lmwh	lmwh	NOUN
ecj-9795	64	14	during	during	ADP
ecj-9795	64	15	hospitalization	hospitalization	NOUN
ecj-9795	64	16	,	,	PUNCT
ecj-9795	64	17	49	49	NUM
ecj-9795	64	18	patients	patient	NOUN
ecj-9795	64	19	included	include	VERB
ecj-9795	64	20	died	die	VERB
ecj-9795	64	21	(	(	PUNCT
ecj-9795	64	22	49/257	49/257	NUM
ecj-9795	64	23	,	,	PUNCT
ecj-9795	64	24	19.1	19.1	NUM
ecj-9795	64	25	%	%	NOUN
ecj-9795	64	26	)	)	PUNCT
ecj-9795	64	27	.	.	PUNCT
ecj-9795	65	1	univariate	univariate	ADJ
ecj-9795	65	2	logistic	logistic	ADJ
ecj-9795	65	3	regression	regression	NOUN
ecj-9795	65	4	with	with	ADP
ecj-9795	65	5	odd	odd	ADJ
ecj-9795	65	6	ratios	ratio	NOUN
ecj-9795	65	7	and	and	CCONJ
ecj-9795	65	8	95	95	NUM
ecj-9795	65	9	%	%	NOUN
ecj-9795	65	10	confidence	confidence	NOUN
ecj-9795	65	11	intervals	interval	NOUN
ecj-9795	65	12	first	first	ADV
ecj-9795	65	13	documented	document	VERB
ecj-9795	65	14	the	the	DET
ecj-9795	65	15	impact	impact	NOUN
ecj-9795	65	16	of	of	ADP
ecj-9795	65	17	heparin	heparin	NOUN
ecj-9795	65	18	,	,	PUNCT
ecj-9795	65	19	older	old	ADJ
ecj-9795	65	20	age	age	NOUN
ecj-9795	65	21	and	and	CCONJ
ecj-9795	65	22	invasive	invasive	ADJ
ecj-9795	65	23	ventilation	ventilation	NOUN
ecj-9795	65	24	on	on	ADP
ecj-9795	65	25	mortality	mortality	NOUN
ecj-9795	65	26	(	(	PUNCT
ecj-9795	65	27	table	table	NOUN
ecj-9795	65	28	2	2	NUM
ecj-9795	65	29	)	)	PUNCT
ecj-9795	65	30	.	.	PUNCT
ecj-9795	66	1	multivariate	multivariate	NOUN
ecj-9795	66	2	logistic	logistic	ADJ
ecj-9795	66	3	regression	regression	NOUN
ecj-9795	66	4	analysis	analysis	NOUN
ecj-9795	66	5	documented	document	VERB
ecj-9795	66	6	that	that	SCONJ
ecj-9795	66	7	older	old	ADJ
ecj-9795	66	8	age	age	NOUN
ecj-9795	66	9	and	and	CCONJ
ecj-9795	66	10	invasive	invasive	ADJ
ecj-9795	66	11	mechanical	mechanical	ADJ
ecj-9795	66	12	ventilation	ventilation	NOUN
ecj-9795	66	13	were	be	AUX
ecj-9795	66	14	associated	associate	VERB
ecj-9795	66	15	with	with	ADP
ecj-9795	66	16	an	an	DET
ecj-9795	66	17	increased	increase	VERB
ecj-9795	66	18	risk	risk	NOUN
ecj-9795	66	19	of	of	ADP
ecj-9795	66	20	death	death	NOUN
ecj-9795	66	21	and	and	CCONJ
ecj-9795	66	22	reinforced	reinforce	VERB
ecj-9795	66	23	the	the	DET
ecj-9795	66	24	statistical	statistical	ADJ
ecj-9795	66	25	significance	significance	NOUN
ecj-9795	66	26	of	of	ADP
ecj-9795	66	27	the	the	DET
ecj-9795	66	28	impact	impact	NOUN
ecj-9795	66	29	of	of	ADP
ecj-9795	66	30	lmwh	lmwh	NOUN
ecj-9795	66	31	on	on	ADP
ecj-9795	66	32	survival	survival	NOUN
ecj-9795	66	33	(	(	PUNCT
ecj-9795	66	34	table	table	NOUN
ecj-9795	66	35	3	3	NUM
ecj-9795	66	36	)	)	PUNCT
ecj-9795	66	37	.	.	PUNCT
ecj-9795	67	1	moreover	moreover	ADV
ecj-9795	67	2	,	,	PUNCT
ecj-9795	67	3	comparing	compare	VERB
ecj-9795	67	4	p	p	NOUN
ecj-9795	67	5	and	and	CCONJ
ecj-9795	67	6	t	t	NOUN
ecj-9795	67	7	-	-	PUNCT
ecj-9795	67	8	lmwh	lmwh	NOUN
ecj-9795	67	9	groups	group	NOUN
ecj-9795	67	10	and	and	CCONJ
ecj-9795	67	11	the	the	DET
ecj-9795	67	12	impact	impact	NOUN
ecj-9795	67	13	on	on	ADP
ecj-9795	67	14	patients	patient	NOUN
ecj-9795	67	15	survival	survival	VERB
ecj-9795	67	16	over	over	ADP
ecj-9795	67	17	the	the	DET
ecj-9795	67	18	observational	observational	ADJ
ecj-9795	67	19	period	period	NOUN
ecj-9795	67	20	,	,	PUNCT
ecj-9795	67	21	kaplan	kaplan	PROPN
ecj-9795	67	22	meier	meier	PROPN
ecj-9795	67	23	curve	curve	PROPN
ecj-9795	67	24	showed	show	VERB
ecj-9795	67	25	an	an	DET
ecj-9795	67	26	higher	high	ADJ
ecj-9795	67	27	survival	survival	NOUN
ecj-9795	67	28	probability	probability	NOUN
ecj-9795	67	29	in	in	ADP
ecj-9795	67	30	the	the	DET
ecj-9795	67	31	t	t	NOUN
ecj-9795	67	32	-	-	PUNCT
ecj-9795	67	33	lmwh	lmwh	NOUN
ecj-9795	67	34	and	and	CCONJ
ecj-9795	67	35	the	the	DET
ecj-9795	67	36	difference	difference	NOUN
ecj-9795	67	37	between	between	ADP
ecj-9795	67	38	the	the	DET
ecj-9795	67	39	two	two	NUM
ecj-9795	67	40	groups	group	NOUN
ecj-9795	67	41	was	be	AUX
ecj-9795	67	42	statistically	statistically	ADV
ecj-9795	67	43	significant	significant	ADJ
ecj-9795	67	44	according	accord	VERB
ecj-9795	67	45	to	to	ADP
ecj-9795	67	46	the	the	DET
ecj-9795	67	47	log	log	NOUN
ecj-9795	67	48	-	-	PUNCT
ecj-9795	67	49	rank	rank	NOUN
ecj-9795	67	50	or	or	CCONJ
ecj-9795	67	51	mantel	mantel	NOUN
ecj-9795	67	52	-	-	PUNCT
ecj-9795	67	53	haenszel	haenszel	NOUN
ecj-9795	67	54	test	test	NOUN
ecj-9795	67	55	(	(	PUNCT
ecj-9795	67	56	p<0.0001	p<0.0001	NOUN
ecj-9795	67	57	;	;	PUNCT
ecj-9795	67	58	figure	figure	NOUN
ecj-9795	67	59	1	1	NUM
ecj-9795	67	60	)	)	PUNCT
ecj-9795	67	61	.	.	PUNCT
ecj-9795	68	1	using	use	VERB
ecj-9795	68	2	a	a	DET
ecj-9795	68	3	multivariate	multivariate	NOUN
ecj-9795	68	4	regression	regression	NOUN
ecj-9795	68	5	model	model	NOUN
ecj-9795	68	6	and	and	CCONJ
ecj-9795	68	7	adjusting	adjust	VERB
ecj-9795	68	8	the	the	DET
ecj-9795	68	9	date	date	NOUN
ecj-9795	68	10	for	for	ADP
ecj-9795	68	11	the	the	DET
ecj-9795	68	12	two	two	NUM
ecj-9795	68	13	drugs	drug	NOUN
ecj-9795	68	14	that	that	PRON
ecj-9795	68	15	significantly	significantly	ADV
ecj-9795	68	16	varied	varied	ADJ
ecj-9795	68	17	between	between	ADP
ecj-9795	68	18	the	the	DET
ecj-9795	68	19	two	two	NUM
ecj-9795	68	20	groups	group	NOUN
ecj-9795	68	21	,	,	PUNCT
ecj-9795	68	22	t	t	PROPN
ecj-9795	68	23	-	-	PUNCT
ecj-9795	68	24	lmwh	lmwh	NOUN
ecj-9795	68	25	was	be	AUX
ecj-9795	68	26	the	the	DET
ecj-9795	68	27	only	only	ADJ
ecj-9795	68	28	drug	drug	NOUN
ecj-9795	68	29	impacting	impact	VERB
ecj-9795	68	30	on	on	ADP
ecj-9795	68	31	survival	survival	NOUN
ecj-9795	68	32	(	(	PUNCT
ecj-9795	68	33	table	table	NOUN
ecj-9795	68	34	4	4	NUM
ecj-9795	68	35	)	)	PUNCT
ecj-9795	68	36	.	.	PUNCT
ecj-9795	69	1	in	in	ADP
ecj-9795	69	2	a	a	DET
ecj-9795	69	3	stratified	stratified	ADJ
ecj-9795	69	4	analysis	analysis	NOUN
ecj-9795	69	5	by	by	ADP
ecj-9795	69	6	ventilation	ventilation	NOUN
ecj-9795	69	7	type	type	NOUN
ecj-9795	69	8	,	,	PUNCT
ecj-9795	69	9	the	the	DET
ecj-9795	69	10	subgroup	subgroup	NOUN
ecj-9795	69	11	of	of	ADP
ecj-9795	69	12	patients	patient	NOUN
ecj-9795	69	13	187	187	NUM
ecj-9795	69	14	who	who	PRON
ecj-9795	69	15	benefited	benefit	VERB
ecj-9795	69	16	from	from	ADP
ecj-9795	69	17	tlmwh	tlmwh	NOUN
ecj-9795	69	18	was	be	AUX
ecj-9795	69	19	that	that	SCONJ
ecj-9795	69	20	in	in	ADP
ecj-9795	69	21	non	non	ADJ
ecj-9795	69	22	-	-	ADJ
ecj-9795	69	23	invasive	invasive	ADJ
ecj-9795	69	24	mechanical	mechanical	ADJ
ecj-9795	69	25	ventilation	ventilation	NOUN
ecj-9795	69	26	(	(	PUNCT
ecj-9795	69	27	table	table	NOUN
ecj-9795	69	28	5	5	NUM
ecj-9795	69	29	)	)	PUNCT
ecj-9795	69	30	.	.	PUNCT
ecj-9795	70	1	safety	safety	NOUN
ecj-9795	70	2	of	of	ADP
ecj-9795	70	3	therapeutic	therapeutic	ADJ
ecj-9795	70	4	lmwh	lmwh	NOUN
ecj-9795	70	5	two	two	NUM
ecj-9795	70	6	major	major	ADJ
ecj-9795	70	7	and	and	CCONJ
ecj-9795	70	8	one	one	NUM
ecj-9795	70	9	minor	minor	ADJ
ecj-9795	70	10	bleeding	bleeding	NOUN
ecj-9795	70	11	episodes	episode	NOUN
ecj-9795	70	12	were	be	AUX
ecj-9795	70	13	recorded	record	VERB
ecj-9795	70	14	in	in	ADP
ecj-9795	70	15	patients	patient	NOUN
ecj-9795	70	16	treated	treat	VERB
ecj-9795	70	17	with	with	ADP
ecj-9795	70	18	therapeutic	therapeutic	ADJ
ecj-9795	70	19	lmwh	lmwh	NOUN
ecj-9795	70	20	dosage	dosage	NOUN
ecj-9795	70	21	(	(	PUNCT
ecj-9795	70	22	3/126	3/126	NUM
ecj-9795	70	23	;	;	PUNCT
ecj-9795	70	24	2.4	2.4	NUM
ecj-9795	70	25	%	%	NOUN
ecj-9795	70	26	):	):	PUNCT
ecj-9795	70	27	two	two	NUM
ecj-9795	70	28	patients	patient	NOUN
ecj-9795	70	29	presented	present	VERB
ecj-9795	70	30	psoas	psoas	ADJ
ecj-9795	70	31	muscle	muscle	NOUN
ecj-9795	70	32	hematoma	hematoma	NOUN
ecj-9795	70	33	that	that	SCONJ
ecj-9795	70	34	required	require	VERB
ecj-9795	70	35	transfusion	transfusion	NOUN
ecj-9795	70	36	of	of	ADP
ecj-9795	70	37	two	two	NUM
ecj-9795	70	38	units	unit	NOUN
ecj-9795	70	39	of	of	ADP
ecj-9795	70	40	packed	packed	ADJ
ecj-9795	70	41	red	red	ADJ
ecj-9795	70	42	blood	blood	NOUN
ecj-9795	70	43	cells	cell	NOUN
ecj-9795	70	44	,	,	PUNCT
ecj-9795	70	45	and	and	CCONJ
ecj-9795	70	46	one	one	NUM
ecj-9795	70	47	patient	patient	ADJ
ecj-9795	70	48	gluteus	gluteus	NOUN
ecj-9795	70	49	muscle	muscle	NOUN
ecj-9795	70	50	hematoma	hematoma	NOUN
ecj-9795	70	51	that	that	PRON
ecj-9795	70	52	recovered	recover	VERB
ecj-9795	70	53	spontaneously	spontaneously	ADV
ecj-9795	70	54	.	.	PUNCT
ecj-9795	71	1	no	no	DET
ecj-9795	71	2	patient	patient	NOUN
ecj-9795	71	3	needed	need	VERB
ecj-9795	71	4	invasive	invasive	ADJ
ecj-9795	71	5	treatment	treatment	NOUN
ecj-9795	71	6	.	.	PUNCT
ecj-9795	72	1	article	article	NOUN
ecj-9795	72	2	figure	figure	VERB
ecj-9795	72	3	1	1	NUM
ecj-9795	72	4	.	.	PUNCT
ecj-9795	73	1	kaplan	kaplan	PROPN
ecj-9795	73	2	–	–	PUNCT
ecj-9795	73	3	meier	meier	PROPN
ecj-9795	73	4	survival	survival	NOUN
ecj-9795	73	5	curves	curve	NOUN
ecj-9795	73	6	of	of	ADP
ecj-9795	73	7	patients	patient	NOUN
ecj-9795	73	8	treated	treat	VERB
ecj-9795	73	9	with	with	ADP
ecj-9795	73	10	prophylactic	prophylactic	ADJ
ecj-9795	73	11	(	(	PUNCT
ecj-9795	73	12	p	p	NOUN
ecj-9795	73	13	-	-	PUNCT
ecj-9795	73	14	lmwh	lmwh	NOUN
ecj-9795	73	15	)	)	PUNCT
ecj-9795	73	16	or	or	CCONJ
ecj-9795	73	17	therapeutic	therapeutic	ADJ
ecj-9795	73	18	(	(	PUNCT
ecj-9795	73	19	t	t	NOUN
ecj-9795	73	20	-	-	PUNCT
ecj-9795	73	21	lmwh	lmwh	NOUN
ecj-9795	73	22	)	)	PUNCT
ecj-9795	73	23	doses	dose	NOUN
ecj-9795	73	24	of	of	ADP
ecj-9795	73	25	low	low	ADJ
ecj-9795	73	26	molecular	molecular	ADJ
ecj-9795	73	27	weight	weight	NOUN
ecj-9795	73	28	heparin	heparin	NOUN
ecj-9795	73	29	.	.	PUNCT
ecj-9795	74	1	table	table	NOUN
ecj-9795	74	2	1	1	NUM
ecj-9795	74	3	.	.	PUNCT
ecj-9795	75	1	demographic	demographic	ADJ
ecj-9795	75	2	,	,	PUNCT
ecj-9795	75	3	clinical	clinical	ADJ
ecj-9795	75	4	characteristics	characteristic	NOUN
ecj-9795	75	5	and	and	CCONJ
ecj-9795	75	6	treatment	treatment	NOUN
ecj-9795	75	7	of	of	ADP
ecj-9795	75	8	the	the	DET
ecj-9795	75	9	study	study	NOUN
ecj-9795	75	10	population	population	NOUN
ecj-9795	75	11	and	and	CCONJ
ecj-9795	75	12	comparisons	comparison	NOUN
ecj-9795	75	13	between	between	ADP
ecj-9795	75	14	patients	patient	NOUN
ecj-9795	75	15	treated	treat	VERB
ecj-9795	75	16	with	with	ADP
ecj-9795	75	17	plmwh	plmwh	NOUN
ecj-9795	75	18	(	(	PUNCT
ecj-9795	75	19	n=131	n=131	NUM
ecj-9795	75	20	)	)	PUNCT
ecj-9795	75	21	and	and	CCONJ
ecj-9795	75	22	tlmwh	tlmwh	NOUN
ecj-9795	75	23	(	(	PUNCT
ecj-9795	75	24	n=126	n=126	NOUN
ecj-9795	75	25	)	)	PUNCT
ecj-9795	75	26	.	.	PUNCT
ecj-9795	76	1	overall	overall	ADJ
ecj-9795	76	2	sample	sample	NOUN
ecj-9795	76	3	p	p	NOUN
ecj-9795	76	4	-	-	PUNCT
ecj-9795	76	5	lmwh	lmwh	ADJ
ecj-9795	76	6	t	t	PROPN
ecj-9795	76	7	-	-	PUNCT
ecj-9795	76	8	lmwh	lmwh	NOUN
ecj-9795	76	9	p	p	NOUN
ecj-9795	76	10	variables	variable	NOUN
ecj-9795	76	11	mean	mean	VERB
ecj-9795	76	12	±	±	NUM
ecj-9795	76	13	sd	sd	NOUN
ecj-9795	76	14	or	or	CCONJ
ecj-9795	76	15	n	n	PROPN
ecj-9795	76	16	(	(	PUNCT
ecj-9795	76	17	%	%	INTJ
ecj-9795	76	18	)	)	PUNCT
ecj-9795	76	19	mean	mean	NOUN
ecj-9795	76	20	±	±	NUM
ecj-9795	76	21	sd	sd	NOUN
ecj-9795	76	22	or	or	CCONJ
ecj-9795	76	23	n	n	PROPN
ecj-9795	76	24	(	(	PUNCT
ecj-9795	76	25	%	%	INTJ
ecj-9795	76	26	)	)	PUNCT
ecj-9795	77	1	mean	mean	NOUN
ecj-9795	77	2	±	±	NUM
ecj-9795	77	3	sd	sd	NOUN
ecj-9795	77	4	or	or	CCONJ
ecj-9795	77	5	n	n	PROPN
ecj-9795	77	6	(	(	PUNCT
ecj-9795	77	7	%	%	INTJ
ecj-9795	77	8	)	)	PUNCT
ecj-9795	77	9	age	age	NOUN
ecj-9795	77	10	(	(	PUNCT
ecj-9795	77	11	years	year	NOUN
ecj-9795	77	12	)	)	PUNCT
ecj-9795	77	13	69.3	69.3	NUM
ecj-9795	78	1	+	+	NUM
ecj-9795	78	2	10.7	10.7	NUM
ecj-9795	78	3	69.4	69.4	NUM
ecj-9795	78	4	(	(	PUNCT
ecj-9795	78	5	11.9	11.9	NUM
ecj-9795	78	6	)	)	PUNCT
ecj-9795	78	7	69.2	69.2	NUM
ecj-9795	78	8	(	(	PUNCT
ecj-9795	78	9	9.5	9.5	NUM
ecj-9795	78	10	)	)	PUNCT
ecj-9795	78	11	0.836	0.836	NUM
ecj-9795	78	12	°	°	PART
ecj-9795	78	13	gender	gender	NOUN
ecj-9795	78	14	0.583^	0.583^	NOUN
ecj-9795	78	15	male	male	NOUN
ecj-9795	78	16	174	174	NUM
ecj-9795	78	17	(	(	PUNCT
ecj-9795	78	18	67.7	67.7	NUM
ecj-9795	78	19	)	)	SYM
ecj-9795	78	20	91	91	NUM
ecj-9795	78	21	(	(	PUNCT
ecj-9795	78	22	69.5	69.5	NUM
ecj-9795	78	23	)	)	SYM
ecj-9795	78	24	83	83	NUM
ecj-9795	78	25	(	(	PUNCT
ecj-9795	78	26	65.9	65.9	NUM
ecj-9795	78	27	)	)	PUNCT
ecj-9795	78	28	female	female	ADJ
ecj-9795	78	29	83	83	NUM
ecj-9795	78	30	(	(	PUNCT
ecj-9795	78	31	32.3	32.3	NUM
ecj-9795	78	32	)	)	PUNCT
ecj-9795	78	33	40	40	NUM
ecj-9795	78	34	(	(	PUNCT
ecj-9795	78	35	30.5	30.5	NUM
ecj-9795	78	36	)	)	PUNCT
ecj-9795	78	37	43	43	NUM
ecj-9795	78	38	(	(	PUNCT
ecj-9795	78	39	34.1	34.1	NUM
ecj-9795	78	40	)	)	PUNCT
ecj-9795	78	41	arterial	arterial	ADJ
ecj-9795	78	42	hypertension	hypertension	NOUN
ecj-9795	78	43	162	162	NUM
ecj-9795	78	44	(	(	PUNCT
ecj-9795	78	45	63.0	63.0	NUM
ecj-9795	78	46	)	)	PUNCT
ecj-9795	78	47	83	83	NUM
ecj-9795	78	48	(	(	PUNCT
ecj-9795	78	49	63.4	63.4	NUM
ecj-9795	78	50	)	)	PUNCT
ecj-9795	78	51	79	79	NUM
ecj-9795	78	52	(	(	PUNCT
ecj-9795	78	53	62.7	62.7	NUM
ecj-9795	78	54	)	)	PUNCT
ecj-9795	78	55	0.913^	0.913^	NOUN
ecj-9795	78	56	diabetes	diabetes	NOUN
ecj-9795	78	57	mellitus	mellitus	NOUN
ecj-9795	78	58	type	type	VERB
ecj-9795	78	59	2	2	NUM
ecj-9795	78	60	46	46	NUM
ecj-9795	78	61	(	(	PUNCT
ecj-9795	78	62	17.9	17.9	NUM
ecj-9795	78	63	)	)	SYM
ecj-9795	78	64	25	25	NUM
ecj-9795	78	65	(	(	PUNCT
ecj-9795	78	66	19.1	19.1	NUM
ecj-9795	78	67	)	)	PUNCT
ecj-9795	78	68	21	21	NUM
ecj-9795	78	69	(	(	PUNCT
ecj-9795	78	70	16.7	16.7	NUM
ecj-9795	78	71	)	)	PUNCT
ecj-9795	78	72	0.613^	0.613^	NOUN
ecj-9795	78	73	cardiovascular	cardiovascular	ADJ
ecj-9795	78	74	disease	disease	NOUN
ecj-9795	78	75	44	44	NUM
ecj-9795	78	76	(	(	PUNCT
ecj-9795	78	77	17.1	17.1	NUM
ecj-9795	78	78	)	)	SYM
ecj-9795	78	79	28	28	NUM
ecj-9795	78	80	(	(	PUNCT
ecj-9795	78	81	21.4	21.4	NUM
ecj-9795	78	82	)	)	PUNCT
ecj-9795	78	83	16	16	NUM
ecj-9795	78	84	(	(	PUNCT
ecj-9795	78	85	12.7	12.7	NUM
ecj-9795	78	86	)	)	PUNCT
ecj-9795	78	87	0.065^	0.065^	NOUN
ecj-9795	78	88	dyslipidaemia	dyslipidaemia	NOUN
ecj-9795	78	89	37	37	NUM
ecj-9795	78	90	(	(	PUNCT
ecj-9795	78	91	14.4	14.4	NUM
ecj-9795	78	92	)	)	PUNCT
ecj-9795	78	93	19	19	NUM
ecj-9795	78	94	(	(	PUNCT
ecj-9795	78	95	15.0	15.0	NUM
ecj-9795	78	96	)	)	PUNCT
ecj-9795	78	97	18	18	NUM
ecj-9795	78	98	(	(	PUNCT
ecj-9795	78	99	14.3	14.3	NUM
ecj-9795	78	100	)	)	PUNCT
ecj-9795	79	1	0.879^	0.879^	NOUN
ecj-9795	79	2	obesity	obesity	NOUN
ecj-9795	79	3	25	25	NUM
ecj-9795	79	4	(	(	PUNCT
ecj-9795	79	5	9.7	9.7	NUM
ecj-9795	79	6	)	)	PUNCT
ecj-9795	79	7	12	12	NUM
ecj-9795	79	8	(	(	PUNCT
ecj-9795	79	9	9.2	9.2	NUM
ecj-9795	79	10	)	)	PUNCT
ecj-9795	79	11	13	13	NUM
ecj-9795	79	12	(	(	PUNCT
ecj-9795	79	13	10.3	10.3	NUM
ecj-9795	79	14	)	)	PUNCT
ecj-9795	79	15	0.754^	0.754^	NOUN
ecj-9795	79	16	smoke	smoke	NOUN
ecj-9795	79	17	21	21	NUM
ecj-9795	79	18	(	(	PUNCT
ecj-9795	79	19	8.2	8.2	NUM
ecj-9795	79	20	)	)	PUNCT
ecj-9795	79	21	12	12	NUM
ecj-9795	79	22	(	(	PUNCT
ecj-9795	79	23	9.4	9.4	NUM
ecj-9795	79	24	)	)	PUNCT
ecj-9795	79	25	9	9	NUM
ecj-9795	79	26	(	(	PUNCT
ecj-9795	79	27	7.1	7.1	NUM
ecj-9795	79	28	)	)	PUNCT
ecj-9795	80	1	0.518^	0.518^	NOUN
ecj-9795	80	2	chronic	chronic	ADJ
ecj-9795	80	3	or	or	CCONJ
ecj-9795	80	4	paroxysmal	paroxysmal	ADJ
ecj-9795	80	5	atrial	atrial	ADJ
ecj-9795	80	6	fibrillation	fibrillation	NOUN
ecj-9795	80	7	33	33	NUM
ecj-9795	80	8	(	(	PUNCT
ecj-9795	80	9	12.8	12.8	NUM
ecj-9795	80	10	)	)	PUNCT
ecj-9795	80	11	17	17	NUM
ecj-9795	80	12	(	(	PUNCT
ecj-9795	80	13	13.0	13.0	NUM
ecj-9795	80	14	)	)	PUNCT
ecj-9795	80	15	16	16	NUM
ecj-9795	80	16	(	(	PUNCT
ecj-9795	80	17	12.8	12.8	NUM
ecj-9795	80	18	)	)	PUNCT
ecj-9795	80	19	0.966^	0.966^	NOUN
ecj-9795	80	20	chronic	chronic	ADJ
ecj-9795	80	21	obstructive	obstructive	ADJ
ecj-9795	80	22	pulmonary	pulmonary	ADJ
ecj-9795	80	23	disease	disease	NOUN
ecj-9795	80	24	22	22	NUM
ecj-9795	80	25	(	(	PUNCT
ecj-9795	80	26	8.6	8.6	NUM
ecj-9795	80	27	)	)	PUNCT
ecj-9795	80	28	13	13	NUM
ecj-9795	80	29	(	(	PUNCT
ecj-9795	80	30	9.9	9.9	NUM
ecj-9795	80	31	)	)	PUNCT
ecj-9795	80	32	9	9	NUM
ecj-9795	80	33	(	(	PUNCT
ecj-9795	80	34	7.1	7.1	NUM
ecj-9795	80	35	)	)	PUNCT
ecj-9795	80	36	0.426^	0.426^	PROPN
ecj-9795	80	37	chronic	chronic	ADJ
ecj-9795	80	38	kidney	kidney	NOUN
ecj-9795	80	39	disease	disease	NOUN
ecj-9795	80	40	22	22	NUM
ecj-9795	80	41	(	(	PUNCT
ecj-9795	80	42	8.6	8.6	NUM
ecj-9795	80	43	)	)	PUNCT
ecj-9795	80	44	14	14	NUM
ecj-9795	80	45	(	(	PUNCT
ecj-9795	80	46	10.8	10.8	NUM
ecj-9795	80	47	)	)	PUNCT
ecj-9795	80	48	8	8	NUM
ecj-9795	80	49	(	(	PUNCT
ecj-9795	80	50	6.3	6.3	NUM
ecj-9795	80	51	)	)	PUNCT
ecj-9795	80	52	0.207^	0.207^	NOUN
ecj-9795	80	53	history	history	NOUN
ecj-9795	80	54	of	of	ADP
ecj-9795	80	55	cancer	cancer	NOUN
ecj-9795	80	56	18	18	NUM
ecj-9795	80	57	(	(	PUNCT
ecj-9795	80	58	7.0	7.0	NUM
ecj-9795	80	59	)	)	PUNCT
ecj-9795	80	60	11	11	NUM
ecj-9795	80	61	(	(	PUNCT
ecj-9795	80	62	8.4	8.4	NUM
ecj-9795	80	63	)	)	PUNCT
ecj-9795	80	64	7	7	NUM
ecj-9795	80	65	(	(	PUNCT
ecj-9795	80	66	5.6	5.6	NUM
ecj-9795	80	67	)	)	PUNCT
ecj-9795	80	68	0.372^	0.372^	NOUN
ecj-9795	80	69	in	in	ADP
ecj-9795	80	70	-	-	PUNCT
ecj-9795	80	71	hospital	hospital	NOUN
ecj-9795	80	72	treatment	treatment	NOUN
ecj-9795	80	73	azithromycin	azithromycin	NOUN
ecj-9795	80	74	232	232	NUM
ecj-9795	80	75	(	(	PUNCT
ecj-9795	80	76	90.3	90.3	NUM
ecj-9795	80	77	)	)	PUNCT
ecj-9795	80	78	108	108	NUM
ecj-9795	80	79	(	(	PUNCT
ecj-9795	80	80	82.4	82.4	NUM
ecj-9795	80	81	)	)	PUNCT
ecj-9795	80	82	114	114	NUM
ecj-9795	80	83	(	(	PUNCT
ecj-9795	80	84	90.5	90.5	NUM
ecj-9795	80	85	)	)	PUNCT
ecj-9795	80	86	0.061^	0.061^	NOUN
ecj-9795	80	87	hydroxychloroquine	hydroxychloroquine	NOUN
ecj-9795	80	88	237	237	NUM
ecj-9795	80	89	(	(	PUNCT
ecj-9795	80	90	92.2	92.2	NUM
ecj-9795	80	91	)	)	PUNCT
ecj-9795	80	92	114	114	NUM
ecj-9795	80	93	(	(	PUNCT
ecj-9795	80	94	87.0	87.0	NUM
ecj-9795	80	95	)	)	PUNCT
ecj-9795	80	96	123	123	NUM
ecj-9795	80	97	(	(	PUNCT
ecj-9795	80	98	97.6	97.6	NUM
ecj-9795	80	99	)	)	PUNCT
ecj-9795	80	100	0.002^	0.002^	NOUN
ecj-9795	80	101	corticosteroid	corticosteroid	ADJ
ecj-9795	80	102	146	146	NUM
ecj-9795	80	103	(	(	PUNCT
ecj-9795	80	104	56.8	56.8	NUM
ecj-9795	80	105	)	)	PUNCT
ecj-9795	80	106	44	44	NUM
ecj-9795	80	107	(	(	PUNCT
ecj-9795	80	108	33.6	33.6	NUM
ecj-9795	80	109	)	)	PUNCT
ecj-9795	80	110	102	102	NUM
ecj-9795	80	111	(	(	PUNCT
ecj-9795	80	112	81.0	81.0	NUM
ecj-9795	80	113	)	)	PUNCT
ecj-9795	80	114	<	<	X
ecj-9795	80	115	0.001^	0.001^	ADJ
ecj-9795	80	116	anti	anti	ADJ
ecj-9795	80	117	-	-	ADJ
ecj-9795	80	118	viral	viral	ADJ
ecj-9795	80	119	therapy	therapy	NOUN
ecj-9795	80	120	lopinavir	lopinavir	PROPN
ecj-9795	80	121	/	/	SYM
ecj-9795	80	122	ritonavir	ritonavir	PROPN
ecj-9795	80	123	and/or	and/or	CCONJ
ecj-9795	80	124	darunavir	darunavir	PROPN
ecj-9795	80	125	/	/	SYM
ecj-9795	80	126	cobicistat	cobicistat	PROPN
ecj-9795	80	127	236	236	NUM
ecj-9795	80	128	(	(	PUNCT
ecj-9795	80	129	91.8	91.8	NUM
ecj-9795	80	130	)	)	PUNCT
ecj-9795	80	131	118	118	NUM
ecj-9795	80	132	(	(	PUNCT
ecj-9795	80	133	90.1	90.1	NUM
ecj-9795	80	134	)	)	PUNCT
ecj-9795	80	135	119	119	NUM
ecj-9795	80	136	(	(	PUNCT
ecj-9795	80	137	94.4	94.4	NUM
ecj-9795	80	138	)	)	PUNCT
ecj-9795	80	139	0.191^	0.191^	NOUN
ecj-9795	80	140	tocilizumab	tocilizumab	NOUN
ecj-9795	80	141	25	25	NUM
ecj-9795	80	142	(	(	PUNCT
ecj-9795	80	143	9.7	9.7	NUM
ecj-9795	80	144	)	)	SYM
ecj-9795	80	145	2	2	NUM
ecj-9795	80	146	(	(	PUNCT
ecj-9795	80	147	1.5	1.5	NUM
ecj-9795	80	148	)	)	PUNCT
ecj-9795	80	149	23	23	NUM
ecj-9795	80	150	(	(	PUNCT
ecj-9795	80	151	18.3	18.3	NUM
ecj-9795	80	152	)	)	PUNCT
ecj-9795	80	153	<	<	X
ecj-9795	80	154	0.001^	0.001^	ADJ
ecj-9795	80	155	oxygen	oxygen	NOUN
ecj-9795	80	156	support	support	NOUN
ecj-9795	80	157	0.066^	0.066^	NOUN
ecj-9795	80	158	vent	vent	NOUN
ecj-9795	80	159	1	1	NUM
ecj-9795	80	160	135	135	NUM
ecj-9795	80	161	(	(	PUNCT
ecj-9795	80	162	52.5	52.5	NUM
ecj-9795	80	163	)	)	SYM
ecj-9795	80	164	78	78	NUM
ecj-9795	80	165	(	(	PUNCT
ecj-9795	80	166	59.5	59.5	NUM
ecj-9795	80	167	)	)	PUNCT
ecj-9795	80	168	57	57	NUM
ecj-9795	80	169	(	(	PUNCT
ecj-9795	80	170	42.5	42.5	NUM
ecj-9795	80	171	)	)	PUNCT
ecj-9795	80	172	vent	vent	NOUN
ecj-9795	80	173	2	2	NUM
ecj-9795	80	174	67	67	NUM
ecj-9795	80	175	(	(	PUNCT
ecj-9795	80	176	26.1	26.1	NUM
ecj-9795	80	177	)	)	SYM
ecj-9795	80	178	28	28	NUM
ecj-9795	80	179	(	(	PUNCT
ecj-9795	80	180	21.4	21.4	NUM
ecj-9795	80	181	)	)	PUNCT
ecj-9795	80	182	39	39	NUM
ecj-9795	80	183	(	(	PUNCT
ecj-9795	80	184	31.0	31.0	NUM
ecj-9795	80	185	)	)	PUNCT
ecj-9795	80	186	vent	vent	VERB
ecj-9795	80	187	3	3	NUM
ecj-9795	80	188	55	55	NUM
ecj-9795	80	189	(	(	PUNCT
ecj-9795	80	190	21.4	21.4	NUM
ecj-9795	80	191	)	)	PUNCT
ecj-9795	80	192	25	25	NUM
ecj-9795	80	193	(	(	PUNCT
ecj-9795	80	194	19.1	19.1	NUM
ecj-9795	80	195	)	)	PUNCT
ecj-9795	80	196	30	30	NUM
ecj-9795	80	197	(	(	PUNCT
ecj-9795	80	198	23.8	23.8	NUM
ecj-9795	80	199	)	)	PUNCT
ecj-9795	80	200	p	p	NOUN
ecj-9795	80	201	-	-	PUNCT
ecj-9795	80	202	lmwh	lmwh	NOUN
ecj-9795	80	203	:	:	PUNCT
ecj-9795	80	204	prophylactic	prophylactic	ADJ
ecj-9795	80	205	low	low	ADJ
ecj-9795	80	206	molecular	molecular	ADJ
ecj-9795	80	207	weight	weight	NOUN
ecj-9795	80	208	heparin	heparin	NOUN
ecj-9795	80	209	dose	dose	NOUN
ecj-9795	80	210	4000	4000	NUM
ecj-9795	80	211	ui	ui	NOUN
ecj-9795	81	1	once	once	ADV
ecj-9795	81	2	a	a	DET
ecj-9795	81	3	day	day	NOUN
ecj-9795	81	4	;	;	PUNCT
ecj-9795	81	5	tlmwh	tlmwh	NOUN
ecj-9795	81	6	:	:	PUNCT
ecj-9795	81	7	therapeutic	therapeutic	ADJ
ecj-9795	81	8	low	low	ADJ
ecj-9795	81	9	molecular	molecular	ADJ
ecj-9795	81	10	weight	weight	NOUN
ecj-9795	81	11	heparin	heparin	NOUN
ecj-9795	81	12	dose	dose	NOUN
ecj-9795	81	13	adjusted	adjust	VERB
ecj-9795	81	14	for	for	ADP
ecj-9795	81	15	weight	weight	NOUN
ecj-9795	81	16	and/or	and/or	CCONJ
ecj-9795	81	17	egfr	egfr	NOUN
ecj-9795	81	18	of	of	ADP
ecj-9795	81	19	each	each	DET
ecj-9795	81	20	patient	patient	NOUN
ecj-9795	81	21	.	.	PUNCT
ecj-9795	82	1	vent	vent	NOUN
ecj-9795	82	2	1	1	NUM
ecj-9795	82	3	:	:	PUNCT
ecj-9795	82	4	nasal	nasal	NOUN
ecj-9795	82	5	cannula	cannula	NOUN
ecj-9795	82	6	with	with	ADP
ecj-9795	82	7	oxygen	oxygen	NOUN
ecj-9795	82	8	flow	flow	NOUN
ecj-9795	82	9	<	<	X
ecj-9795	82	10	6l	6l	NUM
ecj-9795	82	11	/	/	SYM
ecj-9795	82	12	min	min	NOUN
ecj-9795	82	13	or	or	CCONJ
ecj-9795	82	14	non	non	ADJ
ecj-9795	82	15	-	-	ADJ
ecj-9795	82	16	rebreather	rebreather	ADJ
ecj-9795	82	17	mask	mask	NOUN
ecj-9795	82	18	with	with	ADP
ecj-9795	82	19	oxygen	oxygen	NOUN
ecj-9795	82	20	flow	flow	NOUN
ecj-9795	82	21	from	from	ADP
ecj-9795	82	22	10	10	NUM
ecj-9795	82	23	to	to	ADP
ecj-9795	82	24	15l	15l	NUM
ecj-9795	82	25	/	/	SYM
ecj-9795	82	26	min	min	NOUN
ecj-9795	82	27	;	;	PUNCT
ecj-9795	82	28	vent	vent	NOUN
ecj-9795	82	29	2	2	NUM
ecj-9795	82	30	:	:	PUNCT
ecj-9795	82	31	non	non	ADJ
ecj-9795	82	32	-	-	ADJ
ecj-9795	82	33	invasive	invasive	ADJ
ecj-9795	82	34	mechanical	mechanical	ADJ
ecj-9795	82	35	ventilation	ventilation	NOUN
ecj-9795	82	36	(	(	PUNCT
ecj-9795	82	37	helmet	helmet	NOUN
ecj-9795	82	38	c	c	NOUN
ecj-9795	82	39	-	-	PUNCT
ecj-9795	82	40	pap	pap	NOUN
ecj-9795	82	41	)	)	PUNCT
ecj-9795	82	42	;	;	PUNCT
ecj-9795	82	43	vent	vent	VERB
ecj-9795	82	44	3	3	NUM
ecj-9795	82	45	:	:	PUNCT
ecj-9795	82	46	invasive	invasive	ADJ
ecj-9795	82	47	mechanical	mechanical	ADJ
ecj-9795	82	48	ventilation	ventilation	NOUN
ecj-9795	82	49	.	.	PUNCT
ecj-9795	83	1	^chi	^chi	ADJ
ecj-9795	83	2	-	-	PUNCT
ecj-9795	83	3	square	square	ADJ
ecj-9795	83	4	test	test	NOUN
ecj-9795	83	5	.	.	PUNCT
ecj-9795	84	1	°	°	ADP
ecj-9795	84	2	t	t	NOUN
ecj-9795	84	3	-	-	PUNCT
ecj-9795	84	4	test	test	NOUN
ecj-9795	84	5	.	.	PUNCT
ecj-9795	85	1	[	[	X
ecj-9795	85	2	page	page	NOUN
ecj-9795	85	3	28	28	NUM
ecj-9795	85	4	]	]	PUNCT
ecj-9795	86	1	[	[	X
ecj-9795	86	2	emergency	emergency	NOUN
ecj-9795	86	3	care	care	NOUN
ecj-9795	86	4	journal	journal	PROPN
ecj-9795	86	5	2021	2021	NUM
ecj-9795	86	6	;	;	PUNCT
ecj-9795	86	7	17:9795	17:9795	NUM
ecj-9795	86	8	]	]	X
ecj-9795	86	9	non	non	ADJ
ecj-9795	86	10	-co	-co	PROPN
ecj-9795	86	11	mmerc	mmerc	PROPN
ecj-9795	86	12	ial	ial	PROPN
ecj-9795	86	13	us	us	PROPN
ecj-9795	86	14	e	e	NOUN
ecj-9795	86	15	o	o	NOUN
ecj-9795	86	16	nly	nly	ADV
ecj-9795	86	17	discussion	discussion	NOUN
ecj-9795	86	18	during	during	ADP
ecj-9795	86	19	this	this	DET
ecj-9795	86	20	“	"	PUNCT
ecj-9795	86	21	war	war	NOUN
ecj-9795	86	22	”	"	PUNCT
ecj-9795	86	23	against	against	ADP
ecj-9795	86	24	the	the	DET
ecj-9795	86	25	rapidly	rapidly	ADV
ecj-9795	86	26	spread	spread	NOUN
ecj-9795	86	27	of	of	ADP
ecj-9795	86	28	covid-19	covid-19	PROPN
ecj-9795	86	29	,	,	PUNCT
ecj-9795	86	30	we	we	PRON
ecj-9795	86	31	had	have	AUX
ecj-9795	86	32	not	not	PART
ecj-9795	86	33	data	data	NOUN
ecj-9795	86	34	-	-	PUNCT
ecj-9795	86	35	driven	drive	VERB
ecj-9795	86	36	therapeutic	therapeutic	ADJ
ecj-9795	86	37	strategies	strategy	NOUN
ecj-9795	86	38	.	.	PUNCT
ecj-9795	87	1	castel	castel	PROPN
ecj-9795	87	2	san	san	PROPN
ecj-9795	87	3	giovanni	giovanni	PROPN
ecj-9795	87	4	hospital	hospital	NOUN
ecj-9795	87	5	became	become	VERB
ecj-9795	87	6	the	the	DET
ecj-9795	87	7	first	first	ADJ
ecj-9795	87	8	covid	covid	PROPN
ecj-9795	87	9	centre	centre	PROPN
ecj-9795	87	10	in	in	ADP
ecj-9795	87	11	italy	italy	PROPN
ecj-9795	87	12	and	and	CCONJ
ecj-9795	87	13	we	we	PRON
ecj-9795	87	14	had	have	VERB
ecj-9795	87	15	only	only	ADV
ecj-9795	87	16	few	few	ADJ
ecj-9795	87	17	preclinical	preclinical	ADJ
ecj-9795	87	18	evidence	evidence	NOUN
ecj-9795	87	19	to	to	PART
ecj-9795	87	20	guide	guide	VERB
ecj-9795	87	21	our	our	PRON
ecj-9795	87	22	treatment	treatment	NOUN
ecj-9795	87	23	strategies	strategy	NOUN
ecj-9795	87	24	.	.	PUNCT
ecj-9795	88	1	as	as	ADV
ecj-9795	88	2	yet	yet	ADV
ecj-9795	88	3	,	,	PUNCT
ecj-9795	88	4	there	there	PRON
ecj-9795	88	5	are	be	VERB
ecj-9795	88	6	no	no	DET
ecj-9795	88	7	exhaustive	exhaustive	ADJ
ecj-9795	88	8	data	datum	NOUN
ecj-9795	88	9	on	on	ADP
ecj-9795	88	10	the	the	DET
ecj-9795	88	11	risk	risk	NOUN
ecj-9795	88	12	factor	factor	NOUN
ecj-9795	88	13	associated	associate	VERB
ecj-9795	88	14	with	with	ADP
ecj-9795	88	15	covid-19	covid-19	PROPN
ecj-9795	88	16	,	,	PUNCT
ecj-9795	88	17	due	due	ADJ
ecj-9795	88	18	to	to	ADP
ecj-9795	88	19	extremely	extremely	ADV
ecj-9795	88	20	different	different	ADJ
ecj-9795	88	21	clinical	clinical	ADJ
ecj-9795	88	22	settings	setting	NOUN
ecj-9795	88	23	and	and	CCONJ
ecj-9795	88	24	insufficient	insufficient	ADJ
ecj-9795	88	25	follow	follow	NOUN
ecj-9795	88	26	-	-	PUNCT
ecj-9795	88	27	up	up	NOUN
ecj-9795	88	28	.	.	PUNCT
ecj-9795	89	1	a	a	DET
ecj-9795	89	2	meta	meta	ADJ
ecj-9795	89	3	-	-	PUNCT
ecj-9795	89	4	analysis	analysis	NOUN
ecj-9795	89	5	of	of	ADP
ecj-9795	89	6	eight	eight	NUM
ecj-9795	89	7	studies	study	NOUN
ecj-9795	89	8	including	include	VERB
ecj-9795	89	9	46248	46248	NUM
ecj-9795	89	10	patients	patient	NOUN
ecj-9795	89	11	with	with	ADP
ecj-9795	89	12	laboratory	laboratory	NOUN
ecj-9795	89	13	confirmed	confirm	VERB
ecj-9795	89	14	covid-19	covid-19	PROPN
ecj-9795	89	15	indicated	indicate	VERB
ecj-9795	89	16	that	that	SCONJ
ecj-9795	89	17	those	those	PRON
ecj-9795	89	18	with	with	ADP
ecj-9795	89	19	the	the	DET
ecj-9795	89	20	most	most	ADV
ecj-9795	89	21	severe	severe	ADJ
ecj-9795	89	22	disease	disease	NOUN
ecj-9795	89	23	were	be	AUX
ecj-9795	89	24	more	more	ADV
ecj-9795	89	25	likely	likely	ADJ
ecj-9795	89	26	to	to	PART
ecj-9795	89	27	have	have	VERB
ecj-9795	89	28	hypertension	hypertension	NOUN
ecj-9795	89	29	,	,	PUNCT
ecj-9795	89	30	respiratory	respiratory	ADJ
ecj-9795	89	31	disease	disease	NOUN
ecj-9795	89	32	and	and	CCONJ
ecj-9795	89	33	cardiovascular	cardiovascular	ADJ
ecj-9795	89	34	disease	disease	NOUN
ecj-9795	89	35	.	.	PUNCT
ecj-9795	90	1	in	in	ADP
ecj-9795	90	2	other	other	ADJ
ecj-9795	90	3	studies	study	NOUN
ecj-9795	90	4	,	,	PUNCT
ecj-9795	90	5	obesity	obesity	NOUN
ecj-9795	90	6	and	and	CCONJ
ecj-9795	90	7	smoking	smoking	NOUN
ecj-9795	90	8	were	be	AUX
ecj-9795	90	9	associated	associate	VERB
ecj-9795	90	10	with	with	ADP
ecj-9795	90	11	increased	increase	VERB
ecj-9795	90	12	risks.20,21	risks.20,21	NOUN
ecj-9795	90	13	our	our	PRON
ecj-9795	90	14	study	study	NOUN
ecj-9795	90	15	,	,	PUNCT
ecj-9795	90	16	reported	report	VERB
ecj-9795	90	17	an	an	DET
ecj-9795	90	18	higher	high	ADJ
ecj-9795	90	19	mortality	mortality	NOUN
ecj-9795	90	20	risk	risk	NOUN
ecj-9795	90	21	in	in	ADP
ecj-9795	90	22	older	old	ADJ
ecj-9795	90	23	patients	patient	NOUN
ecj-9795	90	24	and	and	CCONJ
ecj-9795	90	25	in	in	ADP
ecj-9795	90	26	patients	patient	NOUN
ecj-9795	90	27	who	who	PRON
ecj-9795	90	28	needed	need	VERB
ecj-9795	90	29	invasive	invasive	ADJ
ecj-9795	90	30	ventilation	ventilation	NOUN
ecj-9795	90	31	support	support	NOUN
ecj-9795	90	32	(	(	PUNCT
ecj-9795	90	33	indirectly	indirectly	ADV
ecj-9795	90	34	related	relate	VERB
ecj-9795	90	35	to	to	ADP
ecj-9795	90	36	the	the	DET
ecj-9795	90	37	extent	extent	NOUN
ecj-9795	90	38	of	of	ADP
ecj-9795	90	39	lung	lung	NOUN
ecj-9795	90	40	involvement	involvement	NOUN
ecj-9795	90	41	)	)	PUNCT
ecj-9795	90	42	.	.	PUNCT
ecj-9795	91	1	sars	sar	NOUN
ecj-9795	91	2	-	-	PUNCT
ecj-9795	91	3	cov-2	cov-2	PART
ecj-9795	91	4	infection	infection	NOUN
ecj-9795	91	5	has	have	AUX
ecj-9795	91	6	been	be	AUX
ecj-9795	91	7	shown	show	VERB
ecj-9795	91	8	to	to	PART
ecj-9795	91	9	induce	induce	VERB
ecj-9795	91	10	diffuse	diffuse	ADJ
ecj-9795	91	11	endothelial	endothelial	ADJ
ecj-9795	91	12	inflammation	inflammation	NOUN
ecj-9795	91	13	due	due	ADP
ecj-9795	91	14	to	to	ADP
ecj-9795	91	15	direct	direct	VERB
ecj-9795	91	16	viral	viral	ADJ
ecj-9795	91	17	infection	infection	NOUN
ecj-9795	91	18	of	of	ADP
ecj-9795	91	19	the	the	DET
ecj-9795	91	20	endothelial	endothelial	ADJ
ecj-9795	91	21	cells	cell	NOUN
ecj-9795	91	22	in	in	ADP
ecj-9795	91	23	different	different	ADJ
ecj-9795	91	24	organs	organ	NOUN
ecj-9795	91	25	of	of	ADP
ecj-9795	91	26	the	the	DET
ecj-9795	91	27	human	human	PROPN
ecj-9795	91	28	body.22	body.22	PROPN
ecj-9795	91	29	the	the	DET
ecj-9795	91	30	endothelial	endothelial	ADJ
ecj-9795	91	31	damage	damage	NOUN
ecj-9795	91	32	is	be	AUX
ecj-9795	91	33	the	the	DET
ecj-9795	91	34	main	main	ADJ
ecj-9795	91	35	determinant	determinant	NOUN
ecj-9795	91	36	of	of	ADP
ecj-9795	91	37	micro	micro	ADJ
ecj-9795	91	38	vascular	vascular	ADJ
ecj-9795	91	39	dysfunction	dysfunction	NOUN
ecj-9795	91	40	that	that	PRON
ecj-9795	91	41	led	lead	VERB
ecj-9795	91	42	to	to	ADP
ecj-9795	91	43	a	a	DET
ecj-9795	91	44	vasoconstriction	vasoconstriction	NOUN
ecj-9795	91	45	and	and	CCONJ
ecj-9795	91	46	a	a	DET
ecj-9795	91	47	subsequent	subsequent	ADJ
ecj-9795	91	48	organ	organ	NOUN
ecj-9795	91	49	ischemia	ischemia	NOUN
ecj-9795	91	50	,	,	PUNCT
ecj-9795	91	51	inflammation	inflammation	NOUN
ecj-9795	91	52	,	,	PUNCT
ecj-9795	91	53	tissue	tissue	NOUN
ecj-9795	91	54	edema	edema	NOUN
ecj-9795	91	55	and	and	CCONJ
ecj-9795	91	56	a	a	DET
ecj-9795	91	57	procoagulant	procoagulant	NOUN
ecj-9795	91	58	state.23	state.23	ADV
ecj-9795	91	59	early	early	ADJ
ecj-9795	91	60	application	application	NOUN
ecj-9795	91	61	of	of	ADP
ecj-9795	91	62	anticoagulant	anticoagulant	ADJ
ecj-9795	91	63	therapy	therapy	NOUN
ecj-9795	91	64	in	in	ADP
ecj-9795	91	65	covid-19	covid-19	PROPN
ecj-9795	91	66	was	be	AUX
ecj-9795	91	67	suggesting	suggest	VERB
ecj-9795	91	68	first	first	ADV
ecj-9795	91	69	in	in	ADP
ecj-9795	91	70	china	china	PROPN
ecj-9795	91	71	for	for	ADP
ecj-9795	91	72	improving	improve	VERB
ecj-9795	91	73	outcome	outcome	NOUN
ecj-9795	91	74	.	.	PUNCT
ecj-9795	92	1	beyond	beyond	ADP
ecj-9795	92	2	anticoagulation	anticoagulation	NOUN
ecj-9795	92	3	,	,	PUNCT
ecj-9795	92	4	there	there	PRON
ecj-9795	92	5	may	may	AUX
ecj-9795	92	6	be	be	AUX
ecj-9795	92	7	alternative	alternative	ADJ
ecj-9795	92	8	beneficial	beneficial	ADJ
ecj-9795	92	9	mechanisms	mechanism	NOUN
ecj-9795	92	10	of	of	ADP
ecj-9795	92	11	action	action	NOUN
ecj-9795	92	12	for	for	ADP
ecj-9795	92	13	heparin	heparin	NOUN
ecj-9795	92	14	in	in	ADP
ecj-9795	92	15	patients	patient	NOUN
ecj-9795	92	16	with	with	ADP
ecj-9795	92	17	covid-19	covid-19	PROPN
ecj-9795	92	18	including	include	VERB
ecj-9795	92	19	direct	direct	ADJ
ecj-9795	92	20	sars	sar	NOUN
ecj-9795	92	21	-	-	PUNCT
ecj-9795	92	22	cov-2	cov-2	NOUN
ecj-9795	92	23	antiviral	antiviral	ADJ
ecj-9795	92	24	activity	activity	NOUN
ecj-9795	92	25	of	of	ADP
ecj-9795	92	26	unfractionated	unfractionate	VERB
ecj-9795	92	27	heparin	heparin	ADJ
ecj-9795	92	28	therapy	therapy	NOUN
ecj-9795	92	29	.	.	PUNCT
ecj-9795	93	1	its	its	PRON
ecj-9795	93	2	effect	effect	NOUN
ecj-9795	93	3	could	could	AUX
ecj-9795	93	4	be	be	AUX
ecj-9795	93	5	partially	partially	ADV
ecj-9795	93	6	due	due	ADJ
ecj-9795	93	7	to	to	ADP
ecj-9795	93	8	this	this	DET
ecj-9795	93	9	theoretical	theoretical	ADJ
ecj-9795	93	10	antiviral	antiviral	ADJ
ecj-9795	93	11	activity	activity	NOUN
ecj-9795	93	12	,	,	PUNCT
ecj-9795	93	13	article	article	NOUN
ecj-9795	93	14	[	[	X
ecj-9795	93	15	emergency	emergency	NOUN
ecj-9795	93	16	care	care	NOUN
ecj-9795	93	17	journal	journal	PROPN
ecj-9795	93	18	2021	2021	NUM
ecj-9795	93	19	;	;	PUNCT
ecj-9795	93	20	17:9795	17:9795	NUM
ecj-9795	93	21	]	]	PUNCT
ecj-9795	94	1	[	[	X
ecj-9795	94	2	page	page	NOUN
ecj-9795	94	3	29	29	NUM
ecj-9795	94	4	]	]	PUNCT
ecj-9795	94	5	table	table	NOUN
ecj-9795	94	6	2	2	NUM
ecj-9795	94	7	.	.	PUNCT
ecj-9795	94	8	univariate	univariate	ADJ
ecj-9795	94	9	regression	regression	NOUN
ecj-9795	94	10	analysis	analysis	NOUN
ecj-9795	94	11	–	–	PUNCT
ecj-9795	94	12	odd	odd	ADJ
ecj-9795	94	13	ratios	ratio	NOUN
ecj-9795	94	14	and	and	CCONJ
ecj-9795	94	15	95	95	NUM
ecj-9795	94	16	%	%	NOUN
ecj-9795	94	17	confidence	confidence	NOUN
ecj-9795	94	18	interval	interval	NOUN
ecj-9795	94	19	for	for	ADP
ecj-9795	94	20	mortality	mortality	NOUN
ecj-9795	94	21	odds	odd	NOUN
ecj-9795	94	22	ratio	ratio	NOUN
ecj-9795	94	23	95	95	NUM
ecj-9795	94	24	%	%	NOUN
ecj-9795	94	25	confidence	confidence	NOUN
ecj-9795	94	26	interval	interval	NOUN
ecj-9795	94	27	(	(	PUNCT
ecj-9795	94	28	2.5	2.5	NUM
ecj-9795	94	29	%	%	NOUN
ecj-9795	94	30	)	)	PUNCT
ecj-9795	94	31	(	(	PUNCT
ecj-9795	94	32	97.5	97.5	NUM
ecj-9795	94	33	%	%	NOUN
ecj-9795	94	34	)	)	PUNCT
ecj-9795	94	35	heparin	heparin	NOUN
ecj-9795	94	36	0.52	0.52	NUM
ecj-9795	94	37	0.29	0.29	NUM
ecj-9795	94	38	0.91	0.91	NUM
ecj-9795	94	39	sex	sex	NOUN
ecj-9795	94	40	1.21	1.21	NUM
ecj-9795	94	41	0.66	0.66	NUM
ecj-9795	94	42	2.27	2.27	NUM
ecj-9795	94	43	age	age	NOUN
ecj-9795	94	44	(	(	PUNCT
ecj-9795	94	45	y	y	NOUN
ecj-9795	94	46	)	)	PUNCT
ecj-9795	94	47	1.06	1.06	NUM
ecj-9795	94	48	1.03	1.03	NUM
ecj-9795	94	49	1.10	1.10	NUM
ecj-9795	94	50	vent	vent	NOUN
ecj-9795	94	51	(	(	PUNCT
ecj-9795	94	52	level	level	NOUN
ecj-9795	94	53	2	2	NUM
ecj-9795	94	54	)	)	PUNCT
ecj-9795	94	55	2.31	2.31	NUM
ecj-9795	94	56	1.14	1.14	NUM
ecj-9795	94	57	4.67	4.67	NUM
ecj-9795	94	58	vent	vent	NOUN
ecj-9795	94	59	(	(	PUNCT
ecj-9795	94	60	level	level	NOUN
ecj-9795	94	61	3	3	NUM
ecj-9795	94	62	)	)	PUNCT
ecj-9795	94	63	4.20	4.20	NUM
ecj-9795	94	64	2.08	2.08	NUM
ecj-9795	94	65	8.61	8.61	NUM
ecj-9795	94	66	cardiovascular	cardiovascular	ADJ
ecj-9795	94	67	disease	disease	NOUN
ecj-9795	94	68	1.80	1.80	NUM
ecj-9795	94	69	0.89	0.89	NUM
ecj-9795	94	70	3.55	3.55	NUM
ecj-9795	94	71	hypertension	hypertension	NOUN
ecj-9795	94	72	2.14	2.14	NUM
ecj-9795	94	73	1.16	1.16	NUM
ecj-9795	94	74	4.13	4.13	NUM
ecj-9795	94	75	chronic	chronic	ADJ
ecj-9795	94	76	kidney	kidney	NOUN
ecj-9795	94	77	disease	disease	NOUN
ecj-9795	94	78	1.45	1.45	NUM
ecj-9795	94	79	0.53	0.53	NUM
ecj-9795	94	80	3.62	3.62	NUM
ecj-9795	94	81	history	history	NOUN
ecj-9795	94	82	of	of	ADP
ecj-9795	94	83	tumors	tumor	NOUN
ecj-9795	94	84	2.55	2.55	NUM
ecj-9795	94	85	0.93	0.93	NUM
ecj-9795	94	86	6.78	6.78	NUM
ecj-9795	94	87	chronic	chronic	ADJ
ecj-9795	94	88	obstructive	obstructive	ADJ
ecj-9795	94	89	pulmonary	pulmonary	ADJ
ecj-9795	94	90	disease	disease	NOUN
ecj-9795	94	91	(	(	PUNCT
ecj-9795	94	92	copd	copd	NOUN
ecj-9795	94	93	)	)	PUNCT
ecj-9795	94	94	1.78	1.78	NUM
ecj-9795	94	95	0.68	0.68	NUM
ecj-9795	94	96	4.39	4.39	NUM
ecj-9795	94	97	diabetes	diabetes	NOUN
ecj-9795	94	98	mellitus	mellitus	PROPN
ecj-9795	94	99	ii	ii	PROPN
ecj-9795	94	100	0.67	0.67	NUM
ecj-9795	94	101	0.29	0.29	NUM
ecj-9795	94	102	1.43	1.43	NUM
ecj-9795	94	103	corticosteroid	corticosteroid	VERB
ecj-9795	94	104	1.55	1.55	NUM
ecj-9795	94	105	0.87	0.87	NUM
ecj-9795	94	106	2.80	2.80	NUM
ecj-9795	94	107	antiviral_t	antiviral_t	NOUN
ecj-9795	94	108	1.38	1.38	NUM
ecj-9795	94	109	0.49	0.49	NUM
ecj-9795	94	110	4.98	4.98	NUM
ecj-9795	94	111	tocilizumab	tocilizumab	NOUN
ecj-9795	94	112	0.72	0.72	NUM
ecj-9795	94	113	0.23	0.23	NUM
ecj-9795	94	114	1.86	1.86	NUM
ecj-9795	94	115	heparin	heparin	NOUN
ecj-9795	94	116	(	(	PUNCT
ecj-9795	94	117	including	include	VERB
ecj-9795	94	118	therapeutic	therapeutic	ADJ
ecj-9795	94	119	and	and	CCONJ
ecj-9795	94	120	prophylactic	prophylactic	ADJ
ecj-9795	94	121	low	low	ADJ
ecj-9795	94	122	molecular	molecular	ADJ
ecj-9795	94	123	weight	weight	NOUN
ecj-9795	94	124	heparin	heparin	NOUN
ecj-9795	94	125	)	)	PUNCT
ecj-9795	94	126	.	.	PUNCT
ecj-9795	95	1	vent	vent	NOUN
ecj-9795	95	2	1	1	NUM
ecj-9795	95	3	:	:	PUNCT
ecj-9795	95	4	nasal	nasal	NOUN
ecj-9795	95	5	cannula	cannula	NOUN
ecj-9795	95	6	with	with	ADP
ecj-9795	95	7	oxygen	oxygen	NOUN
ecj-9795	95	8	flow	flow	NOUN
ecj-9795	95	9	<	<	X
ecj-9795	95	10	6l	6l	NUM
ecj-9795	95	11	/	/	SYM
ecj-9795	95	12	min	min	NOUN
ecj-9795	95	13	or	or	CCONJ
ecj-9795	95	14	non	non	ADJ
ecj-9795	95	15	-	-	ADJ
ecj-9795	95	16	rebreather	rebreather	ADJ
ecj-9795	95	17	mask	mask	NOUN
ecj-9795	95	18	with	with	ADP
ecj-9795	95	19	oxygen	oxygen	NOUN
ecj-9795	95	20	flow	flow	NOUN
ecj-9795	95	21	from	from	ADP
ecj-9795	95	22	10	10	NUM
ecj-9795	95	23	to	to	ADP
ecj-9795	95	24	15l	15l	NUM
ecj-9795	95	25	/	/	SYM
ecj-9795	95	26	min	min	NOUN
ecj-9795	95	27	;	;	PUNCT
ecj-9795	95	28	vent	vent	NOUN
ecj-9795	95	29	2	2	NUM
ecj-9795	95	30	:	:	PUNCT
ecj-9795	95	31	non	non	ADJ
ecj-9795	95	32	-	-	ADJ
ecj-9795	95	33	invasive	invasive	ADJ
ecj-9795	95	34	mechanical	mechanical	ADJ
ecj-9795	95	35	ventilation	ventilation	NOUN
ecj-9795	95	36	(	(	PUNCT
ecj-9795	95	37	helmet	helmet	NOUN
ecj-9795	95	38	c	c	NOUN
ecj-9795	95	39	-	-	PUNCT
ecj-9795	95	40	pap	pap	NOUN
ecj-9795	95	41	)	)	PUNCT
ecj-9795	95	42	;	;	PUNCT
ecj-9795	95	43	vent	vent	VERB
ecj-9795	95	44	3	3	NUM
ecj-9795	95	45	:	:	PUNCT
ecj-9795	95	46	invasive	invasive	ADJ
ecj-9795	95	47	mechanical	mechanical	ADJ
ecj-9795	95	48	ventilation	ventilation	NOUN
ecj-9795	95	49	.	.	PUNCT
ecj-9795	96	1	table	table	NOUN
ecj-9795	96	2	3	3	NUM
ecj-9795	96	3	.	.	X
ecj-9795	96	4	multivariate	multivariate	NOUN
ecj-9795	96	5	logistic	logistic	ADJ
ecj-9795	96	6	regression	regression	NOUN
ecj-9795	96	7	analysis	analysis	NOUN
ecj-9795	96	8	and	and	CCONJ
ecj-9795	96	9	estimated	estimate	VERB
ecj-9795	96	10	coefficients	coefficient	NOUN
ecj-9795	96	11	.	.	PUNCT
ecj-9795	97	1	estimate	estimate	VERB
ecj-9795	97	2	std	std	PROPN
ecj-9795	97	3	.	.	NOUN
ecj-9795	97	4	error	error	NOUN
ecj-9795	97	5	z	z	NOUN
ecj-9795	97	6	value	value	NOUN
ecj-9795	97	7	pr(>|z|	pr(>|z|	NOUN
ecj-9795	97	8	)	)	PUNCT
ecj-9795	98	1	p	p	NOUN
ecj-9795	98	2	(	(	PUNCT
ecj-9795	98	3	intercept	intercept	NOUN
ecj-9795	98	4	)	)	PUNCT
ecj-9795	98	5	-10.563	-10.563	PROPN
ecj-9795	98	6	2.054	2.054	NUM
ecj-9795	98	7	-5.142	-5.142	PROPN
ecj-9795	99	1	0.0000	0.0000	NUM
ecj-9795	99	2	*	*	PUNCT
ecj-9795	99	3	*	*	PUNCT
ecj-9795	99	4	*	*	PUNCT
ecj-9795	99	5	heparin	heparin	ADJ
ecj-9795	99	6	-1.200	-1.200	PUNCT
ecj-9795	99	7	0.414	0.414	NUM
ecj-9795	99	8	-2.896	-2.896	NOUN
ecj-9795	99	9	0.0038	0.0038	NUM
ecj-9795	99	10	*	*	PUNCT
ecj-9795	99	11	*	*	PUNCT
ecj-9795	99	12	sex	sex	NOUN
ecj-9795	99	13	(	(	PUNCT
ecj-9795	99	14	male	male	NOUN
ecj-9795	99	15	)	)	PUNCT
ecj-9795	99	16	0.222	0.222	NUM
ecj-9795	99	17	0.392	0.392	NUM
ecj-9795	99	18	0.566	0.566	NUM
ecj-9795	99	19	0.5711	0.5711	NUM
ecj-9795	99	20	age	age	NOUN
ecj-9795	99	21	0.108	0.108	NUM
ecj-9795	99	22	0.024	0.024	NUM
ecj-9795	99	23	4.455	4.455	NUM
ecj-9795	99	24	0.0000	0.0000	NUM
ecj-9795	99	25	*	*	PUNCT
ecj-9795	99	26	*	*	PUNCT
ecj-9795	99	27	*	*	PUNCT
ecj-9795	99	28	vent	vent	NOUN
ecj-9795	99	29	(	(	PUNCT
ecj-9795	99	30	level	level	NOUN
ecj-9795	99	31	2	2	NUM
ecj-9795	99	32	)	)	PUNCT
ecj-9795	99	33	1.094	1.094	NUM
ecj-9795	99	34	0.454	0.454	NUM
ecj-9795	99	35	2.409	2.409	NUM
ecj-9795	99	36	0.0160	0.0160	NUM
ecj-9795	99	37	*	*	PUNCT
ecj-9795	99	38	vent	vent	NOUN
ecj-9795	99	39	(	(	PUNCT
ecj-9795	99	40	level	level	NOUN
ecj-9795	99	41	3	3	NUM
ecj-9795	99	42	)	)	PUNCT
ecj-9795	99	43	2.413	2.413	NUM
ecj-9795	99	44	0.517	0.517	NUM
ecj-9795	99	45	4.665	4.665	NUM
ecj-9795	99	46	0.0000	0.0000	NUM
ecj-9795	99	47	*	*	PUNCT
ecj-9795	99	48	*	*	PUNCT
ecj-9795	99	49	*	*	PUNCT
ecj-9795	99	50	cardiovascular	cardiovascular	ADJ
ecj-9795	99	51	disease	disease	NOUN
ecj-9795	99	52	0.414	0.414	NUM
ecj-9795	99	53	0.448	0.448	NUM
ecj-9795	99	54	0.925	0.925	NUM
ecj-9795	99	55	0.3552	0.3552	NUM
ecj-9795	99	56	hypertension	hypertension	NOUN
ecj-9795	99	57	0.078	0.078	NUM
ecj-9795	99	58	0.399	0.399	NUM
ecj-9795	99	59	0.195	0.195	NUM
ecj-9795	99	60	0.8454	0.8454	NUM
ecj-9795	99	61	chronic	chronic	ADJ
ecj-9795	99	62	kidney	kidney	NOUN
ecj-9795	99	63	disease	disease	NOUN
ecj-9795	99	64	0,081	0,081	NUM
ecj-9795	99	65	0.594	0.594	NUM
ecj-9795	99	66	0.136	0.136	NUM
ecj-9795	99	67	0.8917	0.8917	NUM
ecj-9795	99	68	history	history	NOUN
ecj-9795	99	69	of	of	ADP
ecj-9795	99	70	tumors	tumor	NOUN
ecj-9795	99	71	1.082	1.082	NUM
ecj-9795	99	72	0.617	0.617	NUM
ecj-9795	99	73	1.755	1.755	NUM
ecj-9795	99	74	0.0793	0.0793	NUM
ecj-9795	99	75	chronic	chronic	ADJ
ecj-9795	99	76	lung	lung	NOUN
ecj-9795	99	77	disease	disease	NOUN
ecj-9795	99	78	0.773	0.773	NUM
ecj-9795	99	79	0.586	0.586	NUM
ecj-9795	99	80	1.318	1.318	NUM
ecj-9795	99	81	0.1874	0.1874	NUM
ecj-9795	99	82	diabetes	diabetes	NOUN
ecj-9795	99	83	mellitus	mellitus	PROPN
ecj-9795	99	84	ii	ii	PROPN
ecj-9795	99	85	-0.585	-0.585	NUM
ecj-9795	99	86	0.470	0.470	NUM
ecj-9795	99	87	-1.243	-1.243	NOUN
ecj-9795	99	88	0.2139	0.2139	NUM
ecj-9795	99	89	corticosteroid	corticosteroid	ADJ
ecj-9795	99	90	0.565	0.565	NUM
ecj-9795	99	91	0.421	0.421	NUM
ecj-9795	99	92	1.342	1.342	NUM
ecj-9795	99	93	0.1797	0.1797	NUM
ecj-9795	99	94	antiviral_t	antiviral_t	NOUN
ecj-9795	99	95	0.717	0.717	NUM
ecj-9795	99	96	0.719	0.719	NUM
ecj-9795	99	97	0.998	0.998	NUM
ecj-9795	99	98	0.3181	0.3181	NUM
ecj-9795	99	99	tocilizumab	tocilizumab	NOUN
ecj-9795	99	100	0.153	0.153	NUM
ecj-9795	99	101	0.624	0.624	NUM
ecj-9795	99	102	0.245	0.245	NUM
ecj-9795	99	103	0.8065	0.8065	NUM
ecj-9795	99	104	signif	signif	NOUN
ecj-9795	99	105	.	.	PUNCT
ecj-9795	100	1	codes	code	NOUN
ecj-9795	100	2	:	:	PUNCT
ecj-9795	100	3	0	0	NUM
ecj-9795	100	4	‘	'	PUNCT
ecj-9795	100	5	*	*	PUNCT
ecj-9795	100	6	*	*	PUNCT
ecj-9795	100	7	*	*	NOUN
ecj-9795	100	8	’	'	PUNCT
ecj-9795	100	9	0.001	0.001	NUM
ecj-9795	100	10	‘	'	PUNCT
ecj-9795	100	11	*	*	NOUN
ecj-9795	100	12	*	*	NOUN
ecj-9795	100	13	’	'	PUNCT
ecj-9795	100	14	0.01	0.01	NUM
ecj-9795	100	15	‘	'	PUNCT
ecj-9795	100	16	*	*	NOUN
ecj-9795	100	17	’	'	PUNCT
ecj-9795	100	18	0.05	0.05	NUM
ecj-9795	100	19	‘	'	PUNCT
ecj-9795	100	20	.	.	PUNCT
ecj-9795	100	21	’	'	PUNCT
ecj-9795	101	1	0.1	0.1	NUM
ecj-9795	101	2	‘	'	PUNCT
ecj-9795	101	3	’	'	PUNCT
ecj-9795	101	4	1	1	NUM
ecj-9795	101	5	.	.	X
ecj-9795	101	6	heparin	heparin	NOUN
ecj-9795	101	7	(	(	PUNCT
ecj-9795	101	8	including	include	VERB
ecj-9795	101	9	therapeutic	therapeutic	ADJ
ecj-9795	101	10	and	and	CCONJ
ecj-9795	101	11	prophylactic	prophylactic	ADJ
ecj-9795	101	12	low	low	ADJ
ecj-9795	101	13	molecular	molecular	ADJ
ecj-9795	101	14	weight	weight	NOUN
ecj-9795	101	15	heparin	heparin	NOUN
ecj-9795	101	16	)	)	PUNCT
ecj-9795	101	17	.	.	PUNCT
ecj-9795	102	1	vent	vent	NOUN
ecj-9795	102	2	1	1	NUM
ecj-9795	102	3	:	:	PUNCT
ecj-9795	102	4	nasal	nasal	NOUN
ecj-9795	102	5	cannula	cannula	NOUN
ecj-9795	102	6	with	with	ADP
ecj-9795	102	7	oxygen	oxygen	NOUN
ecj-9795	102	8	flow	flow	NOUN
ecj-9795	102	9	<	<	X
ecj-9795	102	10	6	6	NUM
ecj-9795	102	11	l	l	NOUN
ecj-9795	102	12	/	/	SYM
ecj-9795	102	13	min	min	PROPN
ecj-9795	102	14	or	or	CCONJ
ecj-9795	102	15	non	non	ADJ
ecj-9795	102	16	-	-	ADJ
ecj-9795	102	17	rebreather	rebreather	ADJ
ecj-9795	102	18	mask	mask	NOUN
ecj-9795	102	19	with	with	ADP
ecj-9795	102	20	oxygen	oxygen	NOUN
ecj-9795	102	21	flow	flow	NOUN
ecj-9795	102	22	from	from	ADP
ecj-9795	102	23	10	10	NUM
ecj-9795	102	24	to	to	PART
ecj-9795	102	25	15	15	NUM
ecj-9795	102	26	l	l	NOUN
ecj-9795	102	27	/	/	SYM
ecj-9795	102	28	min	min	NOUN
ecj-9795	102	29	;	;	PUNCT
ecj-9795	102	30	vent	vent	NOUN
ecj-9795	102	31	2	2	NUM
ecj-9795	102	32	:	:	PUNCT
ecj-9795	102	33	non	non	ADJ
ecj-9795	102	34	-	-	ADJ
ecj-9795	102	35	invasive	invasive	ADJ
ecj-9795	102	36	mechanical	mechanical	ADJ
ecj-9795	102	37	ventilation	ventilation	NOUN
ecj-9795	102	38	(	(	PUNCT
ecj-9795	102	39	helmet	helmet	NOUN
ecj-9795	102	40	c	c	NOUN
ecj-9795	102	41	-	-	PUNCT
ecj-9795	102	42	pap	pap	NOUN
ecj-9795	102	43	)	)	PUNCT
ecj-9795	102	44	;	;	PUNCT
ecj-9795	102	45	vent	vent	VERB
ecj-9795	102	46	3	3	NUM
ecj-9795	102	47	:	:	PUNCT
ecj-9795	102	48	invasive	invasive	ADJ
ecj-9795	102	49	mechanical	mechanical	ADJ
ecj-9795	102	50	ventilation	ventilation	NOUN
ecj-9795	102	51	.	.	PUNCT
ecj-9795	103	1	non	non	ADJ
ecj-9795	104	1	-co	-co	PROPN
ecj-9795	104	2	mmerc	mmerc	PROPN
ecj-9795	104	3	ial	ial	PROPN
ecj-9795	104	4	us	us	PROPN
ecj-9795	104	5	e	e	NOUN
ecj-9795	104	6	o	o	NOUN
ecj-9795	104	7	nly	nly	ADV
ecj-9795	104	8	rather	rather	ADV
ecj-9795	104	9	than	than	ADP
ecj-9795	104	10	solely	solely	ADV
ecj-9795	104	11	due	due	ADJ
ecj-9795	104	12	to	to	ADP
ecj-9795	104	13	its	its	PRON
ecj-9795	104	14	anticoagulant	anticoagulant	ADJ
ecj-9795	104	15	properties	property	NOUN
ecj-9795	104	16	.	.	PUNCT
ecj-9795	105	1	tang	tang	PROPN
ecj-9795	105	2	et	et	PROPN
ecj-9795	106	1	al	al	PROPN
ecj-9795	106	2	.	.	PROPN
ecj-9795	106	3	highlighted	highlight	VERB
ecj-9795	106	4	the	the	DET
ecj-9795	106	5	importance	importance	NOUN
ecj-9795	106	6	of	of	ADP
ecj-9795	106	7	the	the	DET
ecj-9795	106	8	risk	risk	NOUN
ecj-9795	106	9	stratification	stratification	NOUN
ecj-9795	106	10	(	(	PUNCT
ecj-9795	106	11	according	accord	VERB
ecj-9795	106	12	to	to	ADP
ecj-9795	106	13	validated	validated	ADJ
ecj-9795	106	14	score	score	NOUN
ecj-9795	106	15	and	and	CCONJ
ecj-9795	106	16	blood	blood	NOUN
ecj-9795	106	17	parameters	parameter	NOUN
ecj-9795	106	18	)	)	PUNCT
ecj-9795	106	19	pointing	point	VERB
ecj-9795	106	20	out	out	ADP
ecj-9795	106	21	the	the	DET
ecj-9795	106	22	impact	impact	NOUN
ecj-9795	106	23	of	of	ADP
ecj-9795	106	24	the	the	DET
ecj-9795	106	25	anticoagulant	anticoagulant	ADJ
ecj-9795	106	26	therapy	therapy	NOUN
ecj-9795	106	27	in	in	ADP
ecj-9795	106	28	particular	particular	ADJ
ecj-9795	106	29	settings	setting	NOUN
ecj-9795	106	30	;	;	PUNCT
ecj-9795	106	31	similar	similar	ADJ
ecj-9795	106	32	results	result	NOUN
ecj-9795	106	33	were	be	AUX
ecj-9795	106	34	,	,	PUNCT
ecj-9795	106	35	recently	recently	ADV
ecj-9795	106	36	,	,	PUNCT
ecj-9795	106	37	validate	validate	NOUN
ecj-9795	106	38	by	by	ADP
ecj-9795	106	39	a	a	DET
ecj-9795	106	40	multiplatform	multiplatform	NOUN
ecj-9795	106	41	trials	trial	NOUN
ecj-9795	106	42	.	.	PUNCT
ecj-9795	107	1	unfortunately	unfortunately	ADV
ecj-9795	107	2	,	,	PUNCT
ecj-9795	107	3	due	due	ADP
ecj-9795	107	4	to	to	ADP
ecj-9795	107	5	the	the	DET
ecj-9795	107	6	emergency	emergency	NOUN
ecj-9795	107	7	,	,	PUNCT
ecj-9795	107	8	we	we	PRON
ecj-9795	107	9	did	do	AUX
ecj-9795	107	10	n’t	not	PART
ecj-9795	107	11	collect	collect	VERB
ecj-9795	107	12	systematically	systematically	ADV
ecj-9795	107	13	laboratory	laboratory	NOUN
ecj-9795	107	14	parameters	parameter	NOUN
ecj-9795	107	15	,	,	PUNCT
ecj-9795	107	16	therefore	therefore	ADV
ecj-9795	107	17	,	,	PUNCT
ecj-9795	107	18	we	we	PRON
ecj-9795	107	19	were	be	AUX
ecj-9795	107	20	not	not	PART
ecj-9795	107	21	able	able	ADJ
ecj-9795	107	22	to	to	PART
ecj-9795	107	23	stratify	stratify	VERB
ecj-9795	107	24	the	the	DET
ecj-9795	107	25	risk	risk	NOUN
ecj-9795	107	26	of	of	ADP
ecj-9795	107	27	the	the	DET
ecj-9795	107	28	study	study	NOUN
ecj-9795	107	29	population	population	NOUN
ecj-9795	107	30	.	.	PUNCT
ecj-9795	108	1	our	our	PRON
ecj-9795	108	2	personal	personal	ADJ
ecj-9795	108	3	experience	experience	NOUN
ecj-9795	108	4	aims	aim	VERB
ecj-9795	108	5	to	to	PART
ecj-9795	108	6	provide	provide	VERB
ecj-9795	108	7	a	a	DET
ecj-9795	108	8	further	further	ADJ
ecj-9795	108	9	contribution	contribution	NOUN
ecj-9795	108	10	to	to	ADP
ecj-9795	108	11	the	the	DET
ecj-9795	108	12	scientific	scientific	ADJ
ecj-9795	108	13	221	221	NUM
ecj-9795	108	14	evidence	evidence	NOUN
ecj-9795	108	15	in	in	ADP
ecj-9795	108	16	favor	favor	NOUN
ecj-9795	108	17	of	of	ADP
ecj-9795	108	18	the	the	DET
ecj-9795	108	19	use	use	NOUN
ecj-9795	108	20	of	of	ADP
ecj-9795	108	21	t	t	NOUN
ecj-9795	108	22	-	-	PUNCT
ecj-9795	108	23	lmwh	lmwh	NOUN
ecj-9795	108	24	within	within	ADP
ecj-9795	108	25	24	24	NUM
ecj-9795	108	26	hours	hour	NOUN
ecj-9795	108	27	of	of	ADP
ecj-9795	108	28	hospital	hospital	NOUN
ecj-9795	108	29	access	access	NOUN
ecj-9795	108	30	in	in	ADP
ecj-9795	108	31	all	all	DET
ecj-9795	108	32	patients	patient	NOUN
ecj-9795	108	33	with	with	ADP
ecj-9795	108	34	covid-19	covid-19	PROPN
ecj-9795	108	35	infection	infection	NOUN
ecj-9795	108	36	.	.	PUNCT
ecj-9795	109	1	our	our	PRON
ecj-9795	109	2	observational	observational	ADJ
ecj-9795	109	3	study	study	NOUN
ecj-9795	109	4	demonstrated	demonstrate	VERB
ecj-9795	109	5	that	that	SCONJ
ecj-9795	109	6	administration	administration	NOUN
ecj-9795	109	7	of	of	ADP
ecj-9795	109	8	t	t	PROPN
ecj-9795	109	9	lmwh	lmwh	NOUN
ecj-9795	109	10	was	be	AUX
ecj-9795	109	11	associated	associate	VERB
ecj-9795	109	12	with	with	ADP
ecj-9795	109	13	lower	low	ADJ
ecj-9795	109	14	mortality	mortality	NOUN
ecj-9795	109	15	in	in	ADP
ecj-9795	109	16	patients	patient	NOUN
ecj-9795	109	17	admitted	admit	VERB
ecj-9795	109	18	with	with	ADP
ecj-9795	109	19	covid-19	covid-19	PROPN
ecj-9795	109	20	also	also	ADV
ecj-9795	109	21	adjusting	adjust	VERB
ecj-9795	109	22	data	datum	NOUN
ecj-9795	109	23	from	from	ADP
ecj-9795	109	24	other	other	ADJ
ecj-9795	109	25	drug	drug	NOUN
ecj-9795	109	26	intake	intake	NOUN
ecj-9795	109	27	.	.	PUNCT
ecj-9795	110	1	finally	finally	ADV
ecj-9795	110	2	,	,	PUNCT
ecj-9795	110	3	we	we	PRON
ecj-9795	110	4	think	think	VERB
ecj-9795	110	5	that	that	SCONJ
ecj-9795	110	6	the	the	DET
ecj-9795	110	7	therapeutic	therapeutic	ADJ
ecj-9795	110	8	efficacy	efficacy	NOUN
ecj-9795	110	9	of	of	ADP
ecj-9795	110	10	t	t	PROPN
ecj-9795	110	11	-	-	PUNCT
ecj-9795	110	12	lmwh	lmwh	NOUN
ecj-9795	110	13	is	be	AUX
ecj-9795	110	14	evident	evident	ADJ
ecj-9795	110	15	in	in	ADP
ecj-9795	110	16	the	the	DET
ecj-9795	110	17	vent-2	vent-2	NUM
ecj-9795	110	18	group	group	NOUN
ecj-9795	110	19	where	where	SCONJ
ecj-9795	110	20	the	the	DET
ecj-9795	110	21	uncontrolled	uncontrolled	ADJ
ecj-9795	110	22	inflammatory	inflammatory	ADJ
ecj-9795	110	23	response	response	NOUN
ecj-9795	110	24	and	and	CCONJ
ecj-9795	110	25	cytokines	cytokine	VERB
ecj-9795	110	26	storm	storm	NOUN
ecj-9795	110	27	is	be	AUX
ecj-9795	110	28	the	the	DET
ecj-9795	110	29	main	main	ADJ
ecj-9795	110	30	pathophysiological	pathophysiological	ADJ
ecj-9795	110	31	aspect	aspect	NOUN
ecj-9795	110	32	of	of	ADP
ecj-9795	110	33	the	the	DET
ecj-9795	110	34	disease	disease	NOUN
ecj-9795	110	35	,	,	PUNCT
ecj-9795	110	36	which	which	PRON
ecj-9795	110	37	could	could	AUX
ecj-9795	110	38	culminate	culminate	VERB
ecj-9795	110	39	in	in	ADP
ecj-9795	110	40	extensive	extensive	ADJ
ecj-9795	110	41	and	and	CCONJ
ecj-9795	110	42	irreversible	irreversible	ADJ
ecj-9795	110	43	lung	lung	NOUN
ecj-9795	110	44	damage	damage	NOUN
ecj-9795	110	45	requiring	require	VERB
ecj-9795	110	46	intubation	intubation	NOUN
ecj-9795	110	47	.	.	PUNCT
ecj-9795	111	1	in	in	ADP
ecj-9795	111	2	this	this	DET
ecj-9795	111	3	phase	phase	NOUN
ecj-9795	111	4	we	we	PRON
ecj-9795	111	5	can	can	AUX
ecj-9795	111	6	positively	positively	ADV
ecj-9795	111	7	change	change	VERB
ecj-9795	111	8	the	the	DET
ecj-9795	111	9	course	course	NOUN
ecj-9795	111	10	of	of	ADP
ecj-9795	111	11	the	the	DET
ecj-9795	111	12	disease	disease	NOUN
ecj-9795	111	13	and	and	CCONJ
ecj-9795	111	14	the	the	DET
ecj-9795	111	15	history	history	NOUN
ecj-9795	111	16	of	of	ADP
ecj-9795	111	17	our	our	PRON
ecj-9795	111	18	patients	patient	NOUN
ecj-9795	111	19	.	.	PUNCT
ecj-9795	112	1	heparin	heparin	NOUN
ecj-9795	112	2	is	be	AUX
ecj-9795	112	3	easy	easy	ADJ
ecj-9795	112	4	to	to	PART
ecj-9795	112	5	administer	administer	VERB
ecj-9795	112	6	and	and	CCONJ
ecj-9795	112	7	bleeding	bleed	VERB
ecj-9795	112	8	complications	complication	NOUN
ecj-9795	112	9	are	be	AUX
ecj-9795	112	10	unusual	unusual	ADJ
ecj-9795	112	11	.	.	PUNCT
ecj-9795	113	1	radiological	radiological	ADJ
ecj-9795	113	2	features	feature	NOUN
ecj-9795	113	3	on	on	ADP
ecj-9795	113	4	ct	ct	NOUN
ecj-9795	113	5	-	-	PUNCT
ecj-9795	113	6	images	image	NOUN
ecj-9795	113	7	,	,	PUNCT
ecj-9795	113	8	in	in	ADP
ecj-9795	113	9	covid-19	covid-19	PROPN
ecj-9795	113	10	patients	patient	NOUN
ecj-9795	113	11	,	,	PUNCT
ecj-9795	113	12	suggest	suggest	VERB
ecj-9795	113	13	veno	veno	NOUN
ecj-9795	113	14	-	-	PUNCT
ecj-9795	113	15	artero	artero	PROPN
ecj-9795	113	16	thrombosis20,21	thrombosis20,21	PROPN
ecj-9795	113	17	and	and	CCONJ
ecj-9795	113	18	also	also	ADV
ecj-9795	113	19	in	in	ADP
ecj-9795	113	20	autopsy	autopsy	ADJ
ecj-9795	113	21	studies	study	NOUN
ecj-9795	113	22	has	have	AUX
ecj-9795	113	23	been	be	AUX
ecj-9795	113	24	found	find	VERB
ecj-9795	113	25	diffuse	diffuse	ADJ
ecj-9795	113	26	thrombosis	thrombosis	NOUN
ecj-9795	113	27	of	of	ADP
ecj-9795	113	28	the	the	DET
ecj-9795	113	29	peripheral	peripheral	ADJ
ecj-9795	113	30	small	small	ADJ
ecj-9795	113	31	vessels.23	vessels.23	NOUN
ecj-9795	113	32	on	on	ADP
ecj-9795	113	33	the	the	DET
ecj-9795	113	34	basis	basis	NOUN
ecj-9795	113	35	of	of	ADP
ecj-9795	113	36	this	this	DET
ecj-9795	113	37	evidence	evidence	NOUN
ecj-9795	113	38	,	,	PUNCT
ecj-9795	113	39	the	the	DET
ecj-9795	113	40	role	role	NOUN
ecj-9795	113	41	of	of	ADP
ecj-9795	113	42	heparin	heparin	ADJ
ecj-9795	113	43	treatment	treatment	NOUN
ecj-9795	113	44	was	be	AUX
ecj-9795	113	45	debate	debate	NOUN
ecj-9795	113	46	in	in	ADP
ecj-9795	113	47	the	the	DET
ecj-9795	113	48	scientific	scientific	ADJ
ecj-9795	113	49	community	community	NOUN
ecj-9795	113	50	.	.	PUNCT
ecj-9795	114	1	to	to	ADP
ecj-9795	114	2	date	date	NOUN
ecj-9795	114	3	there	there	PRON
ecj-9795	114	4	are	be	VERB
ecj-9795	114	5	a	a	DET
ecj-9795	114	6	lot	lot	NOUN
ecj-9795	114	7	of	of	ADP
ecj-9795	114	8	observational	observational	ADJ
ecj-9795	114	9	evidence	evidence	NOUN
ecj-9795	114	10	and	and	CCONJ
ecj-9795	114	11	some	some	DET
ecj-9795	114	12	randomized	randomized	ADJ
ecj-9795	114	13	trials	trial	NOUN
ecj-9795	114	14	are	be	AUX
ecj-9795	114	15	ongoing	ongoing	ADJ
ecj-9795	114	16	but	but	CCONJ
ecj-9795	114	17	there	there	PRON
ecj-9795	114	18	are	be	VERB
ecj-9795	114	19	no	no	DET
ecj-9795	114	20	solid	solid	ADJ
ecj-9795	114	21	evidences	evidence	NOUN
ecj-9795	114	22	that	that	PRON
ecj-9795	114	23	recommends	recommend	VERB
ecj-9795	114	24	the	the	DET
ecj-9795	114	25	routine	routine	ADJ
ecj-9795	114	26	use	use	NOUN
ecj-9795	114	27	of	of	ADP
ecj-9795	114	28	t	t	NOUN
ecj-9795	114	29	-	-	PUNCT
ecj-9795	114	30	lmwh	lmwh	NOUN
ecj-9795	114	31	due	due	ADP
ecj-9795	114	32	to	to	ADP
ecj-9795	114	33	conflicting	conflicting	ADJ
ecj-9795	114	34	results	result	NOUN
ecj-9795	114	35	related	relate	VERB
ecj-9795	114	36	to	to	ADP
ecj-9795	114	37	:	:	PUNCT
ecj-9795	114	38	different	different	ADJ
ecj-9795	114	39	study	study	NOUN
ecj-9795	114	40	population	population	NOUN
ecj-9795	114	41	,	,	PUNCT
ecj-9795	114	42	therapeutic	therapeutic	ADJ
ecj-9795	114	43	regimens	regimen	NOUN
ecj-9795	114	44	and	and	CCONJ
ecj-9795	114	45	choice	choice	NOUN
ecj-9795	114	46	of	of	ADP
ecj-9795	114	47	anticoagulant	anticoagulant	ADJ
ecj-9795	114	48	therapy	therapy	NOUN
ecj-9795	114	49	(	(	PUNCT
ecj-9795	114	50	sometimes	sometimes	ADV
ecj-9795	114	51	preferring	prefer	VERB
ecj-9795	114	52	intermediate	intermediate	ADJ
ecj-9795	114	53	doses	dose	NOUN
ecj-9795	114	54	of	of	ADP
ecj-9795	114	55	heparin	heparin	NOUN
ecj-9795	114	56	or	or	CCONJ
ecj-9795	114	57	doac	doac	VERB
ecj-9795	114	58	)	)	PUNCT
ecj-9795	114	59	,	,	PUNCT
ecj-9795	114	60	perhaps	perhaps	ADV
ecj-9795	114	61	losing	lose	VERB
ecj-9795	114	62	the	the	DET
ecj-9795	114	63	antinflammatory	antinflammatory	NOUN
ecj-9795	114	64	and	and	CCONJ
ecj-9795	114	65	antiviral	antiviral	ADJ
ecj-9795	114	66	effect	effect	NOUN
ecj-9795	114	67	of	of	ADP
ecj-9795	114	68	heparin	heparin	NOUN
ecj-9795	114	69	and	and	CCONJ
ecj-9795	114	70	increasing	increase	VERB
ecj-9795	114	71	the	the	DET
ecj-9795	114	72	risk	risk	NOUN
ecj-9795	114	73	of	of	ADP
ecj-9795	114	74	interactions	interaction	NOUN
ecj-9795	114	75	with	with	ADP
ecj-9795	114	76	covid-19	covid-19	PROPN
ecj-9795	114	77	treatments	treatment	NOUN
ecj-9795	114	78	;	;	PUNCT
ecj-9795	114	79	active	active	ADJ
ecj-9795	114	80	4banti	4banti	NOUN
ecj-9795	114	81	-	-	NOUN
ecj-9795	114	82	thrombotics	thrombotic	NOUN
ecj-9795	114	83	for	for	ADP
ecj-9795	114	84	adults	adult	NOUN
ecj-9795	114	85	hospitalized	hospitalize	VERB
ecj-9795	114	86	with	with	ADP
ecj-9795	114	87	covid-19	covid-19	PROPN
ecj-9795	114	88	(	(	PUNCT
ecj-9795	114	89	activ-4	activ-4	PROPN
ecj-9795	114	90	)	)	PUNCT
ecj-9795	114	91	;	;	PUNCT
ecj-9795	114	92	hero19hamburg	hero19hamburg	X
ecj-9795	114	93	edoxaban	edoxaban	NOUN
ecj-9795	114	94	for	for	ADP
ecj-9795	114	95	anticoagulation	anticoagulation	NOUN
ecj-9795	114	96	in	in	ADP
ecj-9795	114	97	covid-19	covid-19	PROPN
ecj-9795	114	98	study	study	NOUN
ecj-9795	114	99	(	(	PUNCT
ecj-9795	114	100	hero-19	hero-19	PROPN
ecj-9795	114	101	)	)	PUNCT
ecj-9795	114	102	;	;	PUNCT
ecj-9795	115	1	corona	corona	NOUN
ecj-9795	115	2	virus	virus	NOUN
ecj-9795	115	3	edoxaban	edoxaban	PROPN
ecj-9795	115	4	colchicine	colchicine	PROPN
ecj-9795	115	5	(	(	PUNCT
ecj-9795	115	6	convince	convince	NOUN
ecj-9795	115	7	)	)	PUNCT
ecj-9795	115	8	covid-19	covid-19	PROPN
ecj-9795	115	9	(	(	PUNCT
ecj-9795	115	10	convince	convince	NOUN
ecj-9795	115	11	)	)	PUNCT
ecj-9795	115	12	ongoing.24	ongoing.24	PROPN
ecj-9795	115	13	-	-	PUNCT
ecj-9795	115	14	26	26	NUM
ecj-9795	115	15	limitations	limitation	NOUN
ecj-9795	115	16	in	in	ADP
ecj-9795	115	17	current	current	ADJ
ecj-9795	115	18	study	study	NOUN
ecj-9795	115	19	include	include	VERB
ecj-9795	115	20	the	the	DET
ecj-9795	115	21	potential	potential	ADJ
ecj-9795	115	22	selection	selection	NOUN
ecj-9795	115	23	bias	bias	NOUN
ecj-9795	115	24	as	as	ADP
ecj-9795	115	25	all	all	DET
ecj-9795	115	26	retrospective	retrospective	ADJ
ecj-9795	115	27	study	study	NOUN
ecj-9795	115	28	.	.	PUNCT
ecj-9795	116	1	it	it	PRON
ecj-9795	116	2	is	be	AUX
ecj-9795	116	3	possible	possible	ADJ
ecj-9795	116	4	that	that	SCONJ
ecj-9795	116	5	some	some	DET
ecj-9795	116	6	non	non	ADJ
ecj-9795	116	7	-	-	ADJ
ecj-9795	116	8	pharmacological	pharmacological	ADJ
ecj-9795	116	9	change	change	NOUN
ecj-9795	116	10	took	take	VERB
ecj-9795	116	11	place	place	NOUN
ecj-9795	116	12	in	in	ADP
ecj-9795	116	13	the	the	DET
ecj-9795	116	14	management	management	NOUN
ecj-9795	116	15	of	of	ADP
ecj-9795	116	16	patients	patient	NOUN
ecj-9795	116	17	as	as	SCONJ
ecj-9795	116	18	the	the	DET
ecj-9795	116	19	clinicians	clinician	NOUN
ecj-9795	116	20	were	be	AUX
ecj-9795	116	21	more	more	ADV
ecj-9795	116	22	expert	expert	ADJ
ecj-9795	116	23	to	to	PART
ecj-9795	116	24	treat	treat	VERB
ecj-9795	116	25	this	this	DET
ecj-9795	116	26	disease	disease	NOUN
ecj-9795	116	27	over	over	ADP
ecj-9795	116	28	the	the	DET
ecj-9795	116	29	period	period	NOUN
ecj-9795	116	30	.	.	PUNCT
ecj-9795	117	1	these	these	DET
ecj-9795	117	2	results	result	NOUN
ecj-9795	117	3	should	should	AUX
ecj-9795	117	4	be	be	AUX
ecj-9795	117	5	interpreted	interpret	VERB
ecj-9795	117	6	with	with	ADP
ecj-9795	117	7	caution	caution	NOUN
ecj-9795	117	8	owing	owe	VERB
ecj-9795	117	9	to	to	ADP
ecj-9795	117	10	potential	potential	ADJ
ecj-9795	117	11	bias	bias	NOUN
ecj-9795	117	12	and	and	CCONJ
ecj-9795	117	13	residual	residual	ADJ
ecj-9795	117	14	confounding	confounding	NOUN
ecj-9795	117	15	in	in	ADP
ecj-9795	117	16	this	this	DET
ecj-9795	117	17	observational	observational	ADJ
ecj-9795	117	18	study	study	NOUN
ecj-9795	117	19	with	with	ADP
ecj-9795	117	20	a	a	DET
ecj-9795	117	21	small	small	ADJ
ecj-9795	117	22	sample	sample	NOUN
ecj-9795	117	23	size	size	NOUN
ecj-9795	117	24	.	.	PUNCT
ecj-9795	118	1	conclusions	conclusion	NOUN
ecj-9795	118	2	t	t	PROPN
ecj-9795	118	3	-	-	PUNCT
ecj-9795	118	4	lmwh	lmwh	NOUN
ecj-9795	118	5	improve	improve	VERB
ecj-9795	118	6	survival	survival	NOUN
ecj-9795	118	7	rate	rate	NOUN
ecj-9795	118	8	in	in	ADP
ecj-9795	118	9	covid-19	covid-19	PROPN
ecj-9795	118	10	patients	patient	NOUN
ecj-9795	118	11	and	and	CCONJ
ecj-9795	118	12	seems	seem	VERB
ecj-9795	118	13	to	to	PART
ecj-9795	118	14	be	be	AUX
ecj-9795	118	15	safe	safe	ADJ
ecj-9795	118	16	.	.	PUNCT
ecj-9795	119	1	double	double	ADJ
ecj-9795	119	2	-	-	PUNCT
ecj-9795	119	3	blinded	blind	VERB
ecj-9795	119	4	randomized	randomize	VERB
ecj-9795	119	5	clinical	clinical	ADJ
ecj-9795	119	6	trials	trial	NOUN
ecj-9795	119	7	are	be	AUX
ecj-9795	119	8	still	still	ADV
ecj-9795	119	9	needed	need	VERB
ecj-9795	119	10	to	to	PART
ecj-9795	119	11	confirm	confirm	VERB
ecj-9795	119	12	this	this	DET
ecj-9795	119	13	observational	observational	ADJ
ecj-9795	119	14	retrospective	retrospective	ADJ
ecj-9795	119	15	study	study	NOUN
ecj-9795	119	16	and	and	CCONJ
ecj-9795	119	17	to	to	PART
ecj-9795	119	18	identify	identify	VERB
ecj-9795	119	19	the	the	DET
ecj-9795	119	20	time	time	NOUN
ecj-9795	119	21	,	,	PUNCT
ecj-9795	119	22	the	the	DET
ecj-9795	119	23	dose	dose	NOUN
ecj-9795	119	24	and	and	CCONJ
ecj-9795	119	25	the	the	DET
ecj-9795	119	26	biohumoral	biohumoral	ADJ
ecj-9795	119	27	or	or	CCONJ
ecj-9795	119	28	clinical	clinical	ADJ
ecj-9795	119	29	or	or	CCONJ
ecj-9795	119	30	instrumental	instrumental	ADJ
ecj-9795	119	31	data	datum	NOUN
ecj-9795	119	32	that	that	PRON
ecj-9795	119	33	could	could	AUX
ecj-9795	119	34	guide	guide	VERB
ecj-9795	119	35	the	the	DET
ecj-9795	119	36	correct	correct	ADJ
ecj-9795	119	37	strategy	strategy	NOUN
ecj-9795	119	38	.	.	PUNCT
ecj-9795	120	1	references	reference	NOUN
ecj-9795	120	2	1	1	NUM
ecj-9795	120	3	.	.	PUNCT
ecj-9795	120	4	kalil	kalil	PROPN
ecj-9795	120	5	ac	ac	PROPN
ecj-9795	120	6	.	.	PUNCT
ecj-9795	120	7	treating	treat	VERB
ecj-9795	120	8	covid-19	covid-19	PROPN
ecj-9795	120	9	-	-	PUNCT
ecj-9795	120	10	off	off	ADP
ecj-9795	120	11	-	-	PUNCT
ecj-9795	120	12	label	label	NOUN
ecj-9795	120	13	drug	drug	NOUN
ecj-9795	120	14	use	use	NOUN
ecj-9795	120	15	,	,	PUNCT
ecj-9795	120	16	compassionate	compassionate	ADJ
ecj-9795	120	17	use	use	NOUN
ecj-9795	120	18	,	,	PUNCT
ecj-9795	120	19	and	and	CCONJ
ecj-9795	120	20	randomized	randomize	VERB
ecj-9795	120	21	clinical	clinical	ADJ
ecj-9795	120	22	trials	trial	NOUN
ecj-9795	120	23	during	during	ADP
ecj-9795	120	24	pandemics	pandemic	NOUN
ecj-9795	120	25	.	.	PUNCT
ecj-9795	121	1	jama	jama	PROPN
ecj-9795	121	2	2020;323:1897	2020;323:1897	NUM
ecj-9795	121	3	-	-	SYM
ecj-9795	121	4	8	8	NUM
ecj-9795	121	5	.	.	NOUN
ecj-9795	121	6	2	2	NUM
ecj-9795	121	7	.	.	X
ecj-9795	121	8	chen	chen	PROPN
ecj-9795	121	9	n	n	CCONJ
ecj-9795	121	10	,	,	PUNCT
ecj-9795	121	11	zhou	zhou	PROPN
ecj-9795	121	12	m	m	PROPN
ecj-9795	121	13	,	,	PUNCT
ecj-9795	121	14	dong	dong	PROPN
ecj-9795	121	15	x	x	PROPN
ecj-9795	121	16	,	,	PUNCT
ecj-9795	121	17	et	et	PROPN
ecj-9795	121	18	al	al	PROPN
ecj-9795	121	19	.	.	PROPN
ecj-9795	122	1	epidemiological	epidemiological	ADJ
ecj-9795	122	2	and	and	CCONJ
ecj-9795	122	3	clinical	clinical	ADJ
ecj-9795	122	4	characteristics	characteristic	NOUN
ecj-9795	122	5	of	of	ADP
ecj-9795	122	6	99	99	NUM
ecj-9795	122	7	cases	case	NOUN
ecj-9795	122	8	of	of	ADP
ecj-9795	122	9	280	280	NUM
ecj-9795	122	10	2019	2019	NUM
ecj-9795	122	11	novel	novel	ADJ
ecj-9795	122	12	coronavirus	coronavirus	NOUN
ecj-9795	122	13	pneumonia	pneumonia	NOUN
ecj-9795	122	14	in	in	ADP
ecj-9795	122	15	wuhan	wuhan	PROPN
ecj-9795	122	16	,	,	PUNCT
ecj-9795	122	17	china	china	PROPN
ecj-9795	122	18	:	:	PUNCT
ecj-9795	122	19	a	a	DET
ecj-9795	122	20	descriptive	descriptive	ADJ
ecj-9795	122	21	study	study	NOUN
ecj-9795	122	22	.	.	PUNCT
ecj-9795	123	1	lancet	lancet	PROPN
ecj-9795	123	2	2020;395:507	2020;395:507	NUM
ecj-9795	123	3	-	-	SYM
ecj-9795	123	4	13	13	NUM
ecj-9795	123	5	.	.	PUNCT
ecj-9795	124	1	3	3	X
ecj-9795	124	2	.	.	X
ecj-9795	124	3	huang	huang	PROPN
ecj-9795	124	4	c	c	PROPN
ecj-9795	124	5	,	,	PUNCT
ecj-9795	124	6	wang	wang	PROPN
ecj-9795	124	7	y	y	PROPN
ecj-9795	124	8	,	,	PUNCT
ecj-9795	124	9	li	li	PROPN
ecj-9795	125	1	x	x	PROPN
ecj-9795	125	2	,	,	PUNCT
ecj-9795	125	3	et	et	PROPN
ecj-9795	125	4	al	al	PROPN
ecj-9795	125	5	.	.	PUNCT
ecj-9795	126	1	clinical	clinical	ADJ
ecj-9795	126	2	features	feature	NOUN
ecj-9795	126	3	of	of	ADP
ecj-9795	126	4	patients	patient	NOUN
ecj-9795	126	5	infected	infect	VERB
ecj-9795	126	6	with	with	ADP
ecj-9795	126	7	2019	2019	NUM
ecj-9795	126	8	novel	novel	ADJ
ecj-9795	126	9	coronavirus	coronavirus	NOUN
ecj-9795	126	10	in	in	ADP
ecj-9795	126	11	wuhan	wuhan	PROPN
ecj-9795	126	12	,	,	PUNCT
ecj-9795	126	13	china	china	PROPN
ecj-9795	126	14	.	.	PUNCT
ecj-9795	127	1	lancet	lancet	PROPN
ecj-9795	127	2	2020;395:497	2020;395:497	PROPN
ecj-9795	127	3	-	-	SYM
ecj-9795	127	4	506	506	NUM
ecj-9795	127	5	.	.	NOUN
ecj-9795	127	6	4	4	NUM
ecj-9795	127	7	.	.	NUM
ecj-9795	127	8	tang	tang	PROPN
ecj-9795	127	9	n	n	CCONJ
ecj-9795	127	10	,	,	PUNCT
ecj-9795	127	11	li	li	PROPN
ecj-9795	127	12	d	d	PROPN
ecj-9795	127	13	,	,	PUNCT
ecj-9795	127	14	wang	wang	PROPN
ecj-9795	128	1	x	x	PROPN
ecj-9795	128	2	,	,	PUNCT
ecj-9795	128	3	et	et	PROPN
ecj-9795	128	4	al	al	PROPN
ecj-9795	128	5	.	.	PROPN
ecj-9795	128	6	abnormal	abnormal	ADJ
ecj-9795	128	7	coagulation	coagulation	NOUN
ecj-9795	128	8	parameters	parameter	NOUN
ecj-9795	128	9	are	be	AUX
ecj-9795	128	10	associated	associate	VERB
ecj-9795	128	11	with	with	ADP
ecj-9795	128	12	poor	poor	ADJ
ecj-9795	128	13	prognosis	prognosis	NOUN
ecj-9795	128	14	in	in	ADP
ecj-9795	128	15	patients	patient	NOUN
ecj-9795	128	16	with	with	ADP
ecj-9795	128	17	novel	novel	ADJ
ecj-9795	128	18	coronavirus	coronavirus	NOUN
ecj-9795	128	19	pneumonia	pneumonia	NOUN
ecj-9795	128	20	.	.	PUNCT
ecj-9795	129	1	j	j	PROPN
ecj-9795	129	2	thromb	thromb	PROPN
ecj-9795	129	3	haemost	haemost	VERB
ecj-9795	129	4	2020;18:844	2020;18:844	ADJ
ecj-9795	129	5	-	-	SYM
ecj-9795	129	6	7	7	NUM
ecj-9795	129	7	.	.	NOUN
ecj-9795	129	8	5	5	NUM
ecj-9795	129	9	.	.	PUNCT
ecj-9795	130	1	avila	avila	PROPN
ecj-9795	130	2	j	j	PROPN
ecj-9795	130	3	,	,	PUNCT
ecj-9795	130	4	long	long	PROPN
ecj-9795	130	5	b	b	NOUN
ecj-9795	130	6	,	,	PUNCT
ecj-9795	130	7	holladay	holladay	PROPN
ecj-9795	130	8	b	b	PROPN
ecj-9795	130	9	,	,	PUNCT
ecj-9795	130	10	gottilieb	gottilieb	PROPN
ecj-9795	130	11	m.	m.	PROPN
ecj-9795	130	12	thrombotic	thrombotic	ADJ
ecj-9795	130	13	complications	complication	NOUN
ecj-9795	130	14	of	of	ADP
ecj-9795	130	15	covid-19	covid-19	PROPN
ecj-9795	130	16	,	,	PUNCT
ecj-9795	130	17	am	be	AUX
ecj-9795	130	18	j	j	PROPN
ecj-9795	130	19	emerg	emerg	ADJ
ecj-9795	130	20	medicine	medicine	NOUN
ecj-9795	130	21	2021;39:213	2021;39:213	NOUN
ecj-9795	130	22	-	-	SYM
ecj-9795	130	23	8	8	NUM
ecj-9795	130	24	.	.	NOUN
ecj-9795	131	1	6	6	NUM
ecj-9795	131	2	.	.	X
ecj-9795	132	1	klok	klok	PROPN
ecj-9795	132	2	fa	fa	PROPN
ecj-9795	132	3	,	,	PUNCT
ecj-9795	132	4	kruip	kruip	PROPN
ecj-9795	132	5	mjha	mjha	PROPN
ecj-9795	132	6	,	,	PUNCT
ecj-9795	132	7	van	van	PROPN
ecj-9795	132	8	der	der	PROPN
ecj-9795	132	9	meer	meer	PROPN
ecj-9795	132	10	njm	njm	PROPN
ecj-9795	132	11	,	,	PUNCT
ecj-9795	132	12	et	et	PROPN
ecj-9795	132	13	al	al	PROPN
ecj-9795	132	14	.	.	PROPN
ecj-9795	132	15	incidence	incidence	NOUN
ecj-9795	132	16	of	of	ADP
ecj-9795	132	17	thrombotic	thrombotic	ADJ
ecj-9795	132	18	complications	complication	NOUN
ecj-9795	132	19	in	in	ADP
ecj-9795	132	20	critically	critically	ADV
ecj-9795	132	21	ill	ill	ADJ
ecj-9795	132	22	icu	icu	PROPN
ecj-9795	132	23	patients	patient	NOUN
ecj-9795	132	24	with	with	ADP
ecj-9795	132	25	covid-19	covid-19	PROPN
ecj-9795	132	26	.	.	PUNCT
ecj-9795	132	27	thromb	thromb	PROPN
ecj-9795	132	28	res	re	NOUN
ecj-9795	132	29	2020;191:145	2020;191:145	NUM
ecj-9795	132	30	-	-	SYM
ecj-9795	132	31	7	7	NUM
ecj-9795	132	32	.	.	NOUN
ecj-9795	132	33	7	7	NUM
ecj-9795	132	34	.	.	X
ecj-9795	133	1	reed	reed	PROPN
ecj-9795	133	2	a	a	X
ecj-9795	133	3	,	,	PUNCT
ecj-9795	133	4	howard	howard	PROPN
ecj-9795	133	5	c	c	PROPN
ecj-9795	133	6	,	,	PUNCT
ecj-9795	133	7	barakat	barakat	PROPN
ecj-9795	133	8	m	m	PROPN
ecj-9795	133	9	,	,	PUNCT
ecj-9795	133	10	navi	navi	PROPN
ecj-9795	133	11	a.	a.	NOUN
ecj-9795	133	12	simultaneous	simultaneous	ADJ
ecj-9795	133	13	arterial	arterial	NOUN
ecj-9795	133	14	article	article	NOUN
ecj-9795	133	15	[	[	X
ecj-9795	133	16	page	page	NOUN
ecj-9795	133	17	30	30	NUM
ecj-9795	133	18	]	]	PUNCT
ecj-9795	134	1	[	[	X
ecj-9795	134	2	emergency	emergency	NOUN
ecj-9795	134	3	care	care	NOUN
ecj-9795	134	4	journal	journal	PROPN
ecj-9795	134	5	2021	2021	NUM
ecj-9795	134	6	;	;	PUNCT
ecj-9795	134	7	17:9795	17:9795	NUM
ecj-9795	134	8	]	]	PUNCT
ecj-9795	134	9	table	table	NOUN
ecj-9795	134	10	4	4	NUM
ecj-9795	134	11	.	.	PUNCT
ecj-9795	134	12	hazard	hazard	NOUN
ecj-9795	134	13	ratio	ratio	NOUN
ecj-9795	134	14	of	of	ADP
ecj-9795	134	15	mortality	mortality	NOUN
ecj-9795	134	16	in	in	ADP
ecj-9795	134	17	patients	patient	NOUN
ecj-9795	134	18	treated	treat	VERB
ecj-9795	134	19	with	with	ADP
ecj-9795	134	20	tlmwh	tlmwh	NOUN
ecj-9795	134	21	vs.	vs.	ADP
ecj-9795	134	22	p	p	NOUN
ecj-9795	134	23	-	-	PUNCT
ecj-9795	134	24	lmwh	lmwh	NOUN
ecj-9795	134	25	,	,	PUNCT
ecj-9795	134	26	adjusted	adjust	VERB
ecj-9795	134	27	for	for	ADP
ecj-9795	134	28	concomitant	concomitant	ADJ
ecj-9795	134	29	drug	drug	NOUN
ecj-9795	134	30	intake	intake	NOUN
ecj-9795	134	31	(	(	PUNCT
ecj-9795	134	32	only	only	ADV
ecj-9795	134	33	drugs	drug	NOUN
ecj-9795	134	34	that	that	PRON
ecj-9795	134	35	for	for	ADP
ecj-9795	134	36	drugs	drug	NOUN
ecj-9795	134	37	that	that	PRON
ecj-9795	134	38	significantly	significantly	ADV
ecj-9795	134	39	varied	varied	ADJ
ecj-9795	134	40	between	between	ADP
ecj-9795	134	41	the	the	DET
ecj-9795	134	42	two	two	NUM
ecj-9795	134	43	groups	group	NOUN
ecj-9795	134	44	)	)	PUNCT
ecj-9795	134	45	.	.	PUNCT
ecj-9795	135	1	results	result	NOUN
ecj-9795	135	2	of	of	ADP
ecj-9795	135	3	cox	cox	PROPN
ecj-9795	135	4	regression	regression	PROPN
ecj-9795	135	5	model	model	NOUN
ecj-9795	135	6	.	.	PUNCT
ecj-9795	136	1	b	b	NOUN
ecj-9795	136	2	se(b	se(b	X
ecj-9795	136	3	)	)	PUNCT
ecj-9795	136	4	hr	hr	NOUN
ecj-9795	136	5	95.0	95.0	NUM
ecj-9795	136	6	%	%	NOUN
ecj-9795	136	7	ci	ci	NOUN
ecj-9795	136	8	p	p	ADJ
ecj-9795	136	9	tlmwh	tlmwh	NOUN
ecj-9795	136	10	vs.	vs.	ADP
ecj-9795	136	11	p	p	NOUN
ecj-9795	136	12	-	-	PUNCT
ecj-9795	136	13	lmwh	lmwh	NOUN
ecj-9795	136	14	-1.229	-1.229	PUNCT
ecj-9795	136	15	0.330	0.330	NUM
ecj-9795	136	16	0.293	0.293	NUM
ecj-9795	136	17	0.153	0.153	NUM
ecj-9795	136	18	0.558	0.558	NUM
ecj-9795	136	19	<	<	X
ecj-9795	136	20	0.001	0.001	NUM
ecj-9795	136	21	tocilizumab	tocilizumab	NOUN
ecj-9795	136	22	-0.890	-0.890	NOUN
ecj-9795	136	23	0.742	0.742	NUM
ecj-9795	136	24	0.411	0.411	NUM
ecj-9795	136	25	0.096	0.096	NUM
ecj-9795	136	26	1.757	1.757	NUM
ecj-9795	136	27	0.230	0.230	NUM
ecj-9795	136	28	corticosteroids	corticosteroid	NOUN
ecj-9795	136	29	0.155	0.155	NUM
ecj-9795	136	30	0.317	0.317	NUM
ecj-9795	136	31	1.167	1.167	NUM
ecj-9795	136	32	0.627	0.627	NUM
ecj-9795	136	33	2.173	2.173	NUM
ecj-9795	136	34	0.626	0.626	NUM
ecj-9795	136	35	hydroxychloroquine	hydroxychloroquine	PROPN
ecj-9795	136	36	0.074	0.074	NUM
ecj-9795	136	37	0.603	0.603	NUM
ecj-9795	136	38	0.902	0.902	NUM
ecj-9795	136	39	1.077	1.077	NUM
ecj-9795	136	40	0.330	0.330	NUM
ecj-9795	136	41	3.513	3.513	NUM
ecj-9795	136	42	p	p	ADJ
ecj-9795	136	43	-	-	PUNCT
ecj-9795	136	44	lmwh	lmwh	NOUN
ecj-9795	136	45	:	:	PUNCT
ecj-9795	136	46	low	low	ADJ
ecj-9795	136	47	molecular	molecular	ADJ
ecj-9795	136	48	weight	weight	NOUN
ecj-9795	136	49	heparin	heparin	NOUN
ecj-9795	136	50	at	at	ADP
ecj-9795	136	51	prophylactic	prophylactic	ADJ
ecj-9795	136	52	doses	dose	NOUN
ecj-9795	136	53	4000	4000	NUM
ecj-9795	136	54	once	once	ADV
ecj-9795	136	55	a	a	DET
ecj-9795	136	56	day	day	NOUN
ecj-9795	136	57	;	;	PUNCT
ecj-9795	136	58	tlmwh	tlmwh	NOUN
ecj-9795	136	59	:	:	PUNCT
ecj-9795	136	60	low	low	ADJ
ecj-9795	136	61	molecular	molecular	ADJ
ecj-9795	136	62	weight	weight	NOUN
ecj-9795	136	63	heparin	heparin	NOUN
ecj-9795	136	64	at	at	ADP
ecj-9795	136	65	therapeutic	therapeutic	ADJ
ecj-9795	136	66	doses	dose	NOUN
ecj-9795	136	67	.	.	PUNCT
ecj-9795	137	1	table	table	NOUN
ecj-9795	137	2	5	5	NUM
ecj-9795	137	3	.	.	PUNCT
ecj-9795	137	4	stratified	stratify	VERB
ecj-9795	137	5	analysis	analysis	NOUN
ecj-9795	137	6	by	by	ADP
ecj-9795	137	7	ventilation	ventilation	NOUN
ecj-9795	137	8	type	type	NOUN
ecj-9795	137	9	.	.	PUNCT
ecj-9795	138	1	mortality	mortality	NOUN
ecj-9795	138	2	rate	rate	NOUN
ecj-9795	138	3	n	n	PRON
ecj-9795	138	4	cases	case	VERB
ecj-9795	138	5	p	p	ADJ
ecj-9795	138	6	-	-	PUNCT
ecj-9795	138	7	lmwh	lmwh	ADJ
ecj-9795	138	8	t	t	PROPN
ecj-9795	138	9	-	-	PUNCT
ecj-9795	138	10	lmwh	lmwh	NOUN
ecj-9795	138	11	z	z	NOUN
ecj-9795	138	12	test	test	NOUN
ecj-9795	138	13	p	p	NOUN
ecj-9795	138	14	value	value	NOUN
ecj-9795	138	15	vent	vent	NOUN
ecj-9795	138	16	1	1	NUM
ecj-9795	138	17	135	135	NUM
ecj-9795	138	18	0.167	0.167	NUM
ecj-9795	138	19	0.140	0.140	NUM
ecj-9795	138	20	0.86	0.86	NUM
ecj-9795	138	21	vent	vent	NOUN
ecj-9795	138	22	2	2	NUM
ecj-9795	138	23	67	67	NUM
ecj-9795	138	24	0.571	0.571	NUM
ecj-9795	138	25	0.102	0.102	NUM
ecj-9795	138	26	0.0001	0.0001	NUM
ecj-9795	138	27	vent	vent	NOUN
ecj-9795	138	28	3	3	NUM
ecj-9795	138	29	55	55	NUM
ecj-9795	138	30	0.48	0.48	NUM
ecj-9795	138	31	0.4	0.4	NUM
ecj-9795	138	32	0.747	0.747	NUM
ecj-9795	138	33	p	p	ADJ
ecj-9795	138	34	-	-	PUNCT
ecj-9795	138	35	lmwh	lmwh	NOUN
ecj-9795	138	36	:	:	PUNCT
ecj-9795	138	37	low	low	ADJ
ecj-9795	138	38	molecular	molecular	ADJ
ecj-9795	138	39	weight	weight	NOUN
ecj-9795	138	40	heparin	heparin	NOUN
ecj-9795	138	41	at	at	ADP
ecj-9795	138	42	prophylactic	prophylactic	ADJ
ecj-9795	138	43	doses	dose	NOUN
ecj-9795	138	44	4000	4000	NUM
ecj-9795	139	1	once	once	ADV
ecj-9795	139	2	a	a	DET
ecj-9795	139	3	day	day	NOUN
ecj-9795	139	4	;	;	PUNCT
ecj-9795	139	5	tlmwh	tlmwh	NOUN
ecj-9795	139	6	:	:	PUNCT
ecj-9795	139	7	low	low	ADJ
ecj-9795	139	8	molecular	molecular	ADJ
ecj-9795	139	9	weight	weight	NOUN
ecj-9795	139	10	heparin	heparin	NOUN
ecj-9795	139	11	at	at	ADP
ecj-9795	139	12	therapeutic	therapeutic	ADJ
ecj-9795	139	13	doses	dose	NOUN
ecj-9795	139	14	.	.	PUNCT
ecj-9795	140	1	vent	vent	NOUN
ecj-9795	140	2	1	1	NUM
ecj-9795	140	3	:	:	PUNCT
ecj-9795	140	4	nasal	nasal	NOUN
ecj-9795	140	5	cannula	cannula	NOUN
ecj-9795	140	6	with	with	ADP
ecj-9795	140	7	oxygen	oxygen	NOUN
ecj-9795	140	8	flow	flow	NOUN
ecj-9795	140	9	<	<	X
ecj-9795	140	10	6	6	NUM
ecj-9795	140	11	l	l	NOUN
ecj-9795	140	12	/	/	SYM
ecj-9795	140	13	min	min	PROPN
ecj-9795	140	14	or	or	CCONJ
ecj-9795	140	15	non	non	ADJ
ecj-9795	140	16	-	-	ADJ
ecj-9795	140	17	rebreather	rebreather	ADJ
ecj-9795	140	18	mask	mask	NOUN
ecj-9795	140	19	with	with	ADP
ecj-9795	140	20	oxygen	oxygen	NOUN
ecj-9795	140	21	flow	flow	NOUN
ecj-9795	140	22	from	from	ADP
ecj-9795	140	23	10	10	NUM
ecj-9795	140	24	to	to	ADP
ecj-9795	140	25	15l	15l	NUM
ecj-9795	140	26	/	/	SYM
ecj-9795	140	27	min	min	NOUN
ecj-9795	140	28	;	;	PUNCT
ecj-9795	140	29	vent	vent	NOUN
ecj-9795	140	30	2	2	NUM
ecj-9795	140	31	:	:	PUNCT
ecj-9795	140	32	non	non	ADJ
ecj-9795	140	33	-	-	ADJ
ecj-9795	140	34	invasive	invasive	ADJ
ecj-9795	140	35	mechanical	mechanical	ADJ
ecj-9795	140	36	ventilation	ventilation	NOUN
ecj-9795	140	37	(	(	PUNCT
ecj-9795	140	38	helmet	helmet	NOUN
ecj-9795	140	39	c	c	NOUN
ecj-9795	140	40	-	-	PUNCT
ecj-9795	140	41	pap	pap	NOUN
ecj-9795	140	42	)	)	PUNCT
ecj-9795	140	43	;	;	PUNCT
ecj-9795	140	44	vent	vent	VERB
ecj-9795	140	45	3	3	NUM
ecj-9795	140	46	:	:	PUNCT
ecj-9795	140	47	invasive	invasive	ADJ
ecj-9795	140	48	mechanical	mechanical	ADJ
ecj-9795	140	49	ventilation	ventilation	NOUN
ecj-9795	140	50	.	.	PUNCT
ecj-9795	141	1	non	non	ADJ
ecj-9795	142	1	-co	-co	PROPN
ecj-9795	142	2	mmerc	mmerc	PROPN
ecj-9795	142	3	ial	ial	PROPN
ecj-9795	142	4	us	us	PROPN
ecj-9795	142	5	e	e	NOUN
ecj-9795	142	6	o	o	NOUN
ecj-9795	142	7	nly	nly	ADV
ecj-9795	142	8	and	and	CCONJ
ecj-9795	142	9	venous	venous	ADJ
ecj-9795	142	10	thromboembolic	thromboembolic	ADJ
ecj-9795	142	11	events	event	NOUN
ecj-9795	142	12	associated	associate	VERB
ecj-9795	142	13	with	with	ADP
ecj-9795	142	14	covid19	covid19	NOUN
ecj-9795	142	15	.	.	PUNCT
ecj-9795	143	1	a	a	DET
ecj-9795	143	2	case	case	NOUN
ecj-9795	143	3	report	report	NOUN
ecj-9795	143	4	.	.	PUNCT
ecj-9795	144	1	emerg	emerg	PROPN
ecj-9795	144	2	care	care	NOUN
ecj-9795	144	3	j	j	PROPN
ecj-9795	144	4	2021;17:9718	2021;17:9718	NUM
ecj-9795	144	5	.	.	PROPN
ecj-9795	144	6	8	8	NUM
ecj-9795	144	7	.	.	PUNCT
ecj-9795	145	1	helms	helms	PROPN
ecj-9795	145	2	j	j	PROPN
ecj-9795	145	3	,	,	PUNCT
ecj-9795	145	4	tacquard	tacquard	PROPN
ecj-9795	145	5	c	c	NOUN
ecj-9795	145	6	,	,	PUNCT
ecj-9795	145	7	severac	severac	NOUN
ecj-9795	145	8	f	f	NOUN
ecj-9795	145	9	,	,	PUNCT
ecj-9795	145	10	et	et	PROPN
ecj-9795	145	11	al	al	PROPN
ecj-9795	145	12	.	.	PROPN
ecj-9795	145	13	high	high	ADJ
ecj-9795	145	14	risk	risk	NOUN
ecj-9795	145	15	of	of	ADP
ecj-9795	145	16	thrombosis	thrombosis	NOUN
ecj-9795	145	17	in	in	ADP
ecj-9795	145	18	patients	patient	NOUN
ecj-9795	145	19	with	with	ADP
ecj-9795	145	20	severe	severe	ADJ
ecj-9795	145	21	sars288	sars288	PROPN
ecj-9795	145	22	cov-2	cov-2	PART
ecj-9795	145	23	infection	infection	NOUN
ecj-9795	145	24	:	:	PUNCT
ecj-9795	145	25	a	a	DET
ecj-9795	145	26	multicenter	multicenter	ADJ
ecj-9795	145	27	prospective	prospective	ADJ
ecj-9795	145	28	cohort	cohort	NOUN
ecj-9795	145	29	study	study	NOUN
ecj-9795	145	30	.	.	PUNCT
ecj-9795	146	1	intensive	intensive	ADJ
ecj-9795	146	2	care	care	NOUN
ecj-9795	146	3	med	med	PROPN
ecj-9795	146	4	2020;46:1089	2020;46:1089	NUM
ecj-9795	146	5	-	-	SYM
ecj-9795	146	6	8	8	NUM
ecj-9795	146	7	.	.	NOUN
ecj-9795	146	8	9	9	NUM
ecj-9795	146	9	.	.	X
ecj-9795	146	10	thachil	thachil	PROPN
ecj-9795	146	11	j	j	PROPN
ecj-9795	146	12	,	,	PUNCT
ecj-9795	146	13	tang	tang	PROPN
ecj-9795	146	14	n	n	CCONJ
ecj-9795	146	15	,	,	PUNCT
ecj-9795	146	16	gando	gando	PROPN
ecj-9795	146	17	s	s	PROPN
ecj-9795	146	18	,	,	PUNCT
ecj-9795	146	19	et	et	PROPN
ecj-9795	146	20	al	al	PROPN
ecj-9795	146	21	.	.	PUNCT
ecj-9795	147	1	isth	isth	NOUN
ecj-9795	147	2	interim	interim	ADJ
ecj-9795	147	3	guidance	guidance	NOUN
ecj-9795	147	4	on	on	ADP
ecj-9795	147	5	recognition	recognition	NOUN
ecj-9795	147	6	and	and	CCONJ
ecj-9795	147	7	management	management	NOUN
ecj-9795	147	8	of	of	ADP
ecj-9795	147	9	coagulopathy	coagulopathy	ADJ
ecj-9795	147	10	in	in	ADP
ecj-9795	147	11	covid-19	covid-19	PROPN
ecj-9795	147	12	.	.	PUNCT
ecj-9795	148	1	j	j	PROPN
ecj-9795	148	2	thromb	thromb	PROPN
ecj-9795	148	3	haemost	haemost	VERB
ecj-9795	148	4	2020;18:1023	2020;18:1023	NUM
ecj-9795	148	5	-	-	SYM
ecj-9795	148	6	6	6	NUM
ecj-9795	148	7	.	.	NOUN
ecj-9795	148	8	10	10	NUM
ecj-9795	148	9	.	.	PUNCT
ecj-9795	149	1	world	world	PROPN
ecj-9795	149	2	health	health	PROPN
ecj-9795	149	3	organization	organization	PROPN
ecj-9795	149	4	.	.	PUNCT
ecj-9795	150	1	clinical	clinical	ADJ
ecj-9795	150	2	management	management	NOUN
ecj-9795	150	3	of	of	ADP
ecj-9795	150	4	severe	severe	ADJ
ecj-9795	150	5	acute	acute	ADJ
ecj-9795	150	6	respiratory	respiratory	ADJ
ecj-9795	150	7	infection	infection	NOUN
ecj-9795	150	8	when	when	SCONJ
ecj-9795	150	9	novel	novel	ADJ
ecj-9795	150	10	coronavirus	coronavirus	NOUN
ecj-9795	150	11	(	(	PUNCT
ecj-9795	150	12	�	�	PROPN
ecj-9795	150	13	2019ncov	2019ncov	NUM
ecj-9795	150	14	)	)	PUNCT
ecj-9795	150	15	�	�	PROPN
ecj-9795	150	16	infection	infection	NOUN
ecj-9795	150	17	is	be	AUX
ecj-9795	150	18	suspected	suspect	VERB
ecj-9795	150	19	:	:	PUNCT
ecj-9795	150	20	interim	interim	ADJ
ecj-9795	150	21	guidance	guidance	NOUN
ecj-9795	150	22	,	,	PUNCT
ecj-9795	150	23	28	28	NUM
ecj-9795	150	24	january	january	NOUN
ecj-9795	150	25	2020	2020	NUM
ecj-9795	150	26	.	.	PUNCT
ecj-9795	151	1	world	world	PROPN
ecj-9795	151	2	health	health	PROPN
ecj-9795	151	3	organization	organization	NOUN
ecj-9795	151	4	,	,	PUNCT
ecj-9795	151	5	2020	2020	NUM
ecj-9795	151	6	.	.	PUNCT
ecj-9795	152	1	available	available	ADJ
ecj-9795	152	2	from	from	ADP
ecj-9795	152	3	:	:	PUNCT
ecj-9795	152	4	https://apps.who.int/iris/handle/10665/330893	https://apps.who.int/iris/handle/10665/330893	PROPN
ecj-9795	152	5	11	11	NUM
ecj-9795	152	6	.	.	PUNCT
ecj-9795	152	7	tang	tang	PROPN
ecj-9795	152	8	n	n	CCONJ
ecj-9795	152	9	,	,	PUNCT
ecj-9795	152	10	bai	bai	PROPN
ecj-9795	152	11	h	h	PROPN
ecj-9795	152	12	,	,	PUNCT
ecj-9795	152	13	chen	chen	PROPN
ecj-9795	152	14	x	x	PROPN
ecj-9795	152	15	,	,	PUNCT
ecj-9795	152	16	gong	gong	PROPN
ecj-9795	152	17	j	j	PROPN
ecj-9795	152	18	,	,	PUNCT
ecj-9795	152	19	li	li	PROPN
ecj-9795	152	20	d	d	PROPN
ecj-9795	152	21	,	,	PUNCT
ecj-9795	152	22	sun	sun	PROPN
ecj-9795	152	23	z.	z.	PROPN
ecj-9795	152	24	anticoagulant	anticoagulant	PROPN
ecj-9795	152	25	treatment	treatment	NOUN
ecj-9795	152	26	is	be	AUX
ecj-9795	152	27	associated	associate	VERB
ecj-9795	152	28	with	with	ADP
ecj-9795	152	29	decreased	decrease	VERB
ecj-9795	152	30	mortality	mortality	NOUN
ecj-9795	152	31	in	in	ADP
ecj-9795	152	32	severe	severe	ADJ
ecj-9795	152	33	coronavirus	coronavirus	NOUN
ecj-9795	152	34	disease	disease	NOUN
ecj-9795	152	35	2019	2019	NUM
ecj-9795	152	36	patients	patient	NOUN
ecj-9795	152	37	with	with	ADP
ecj-9795	152	38	coagulopathy	coagulopathy	ADJ
ecj-9795	152	39	.	.	PUNCT
ecj-9795	153	1	j	j	PROPN
ecj-9795	153	2	thromb	thromb	PROPN
ecj-9795	153	3	haemost	haemost	VERB
ecj-9795	153	4	2020;18:1094	2020;18:1094	NUM
ecj-9795	153	5	-	-	SYM
ecj-9795	153	6	9	9	NUM
ecj-9795	153	7	.	.	NOUN
ecj-9795	153	8	12	12	NUM
ecj-9795	153	9	.	.	PUNCT
ecj-9795	154	1	hirsh	hirsh	PROPN
ecj-9795	154	2	j	j	PROPN
ecj-9795	154	3	,	,	PUNCT
ecj-9795	154	4	warkentin	warkentin	NOUN
ecj-9795	154	5	te	te	PROPN
ecj-9795	154	6	,	,	PUNCT
ecj-9795	154	7	shaughnessy	shaughnessy	PROPN
ecj-9795	154	8	sg	sg	PROPN
ecj-9795	154	9	,	,	PUNCT
ecj-9795	154	10	et	et	PROPN
ecj-9795	154	11	al	al	PROPN
ecj-9795	154	12	.	.	PROPN
ecj-9795	154	13	heparin	heparin	ADJ
ecj-9795	154	14	and	and	CCONJ
ecj-9795	154	15	low	low	ADJ
ecj-9795	154	16	-	-	PUNCT
ecj-9795	154	17	molecular	molecular	ADJ
ecj-9795	154	18	-	-	PUNCT
ecj-9795	154	19	weight	weight	NOUN
ecj-9795	154	20	heparin	heparin	NOUN
ecj-9795	154	21	:	:	PUNCT
ecj-9795	154	22	mechanisms	mechanism	NOUN
ecj-9795	154	23	of	of	ADP
ecj-9795	154	24	action	action	NOUN
ecj-9795	154	25	,	,	PUNCT
ecj-9795	154	26	pharmacokinetics	pharmacokinetic	NOUN
ecj-9795	154	27	,	,	PUNCT
ecj-9795	154	28	dosing	dosing	NOUN
ecj-9795	154	29	,	,	PUNCT
ecj-9795	154	30	monitoring	monitoring	NOUN
ecj-9795	154	31	,	,	PUNCT
ecj-9795	154	32	efficacy	efficacy	NOUN
ecj-9795	154	33	,	,	PUNCT
ecj-9795	154	34	and	and	CCONJ
ecj-9795	154	35	safety	safety	NOUN
ecj-9795	154	36	.	.	PUNCT
ecj-9795	155	1	chest	chest	PROPN
ecj-9795	155	2	2001;119:64s-94s	2001;119:64s-94s	NUM
ecj-9795	155	3	.	.	PUNCT
ecj-9795	155	4	13	13	NUM
ecj-9795	155	5	.	.	PUNCT
ecj-9795	156	1	mousavi	mousavi	PROPN
ecj-9795	156	2	s	s	PROPN
ecj-9795	156	3	,	,	PUNCT
ecj-9795	156	4	moradi	moradi	NOUN
ecj-9795	156	5	m	m	PROPN
ecj-9795	156	6	,	,	PUNCT
ecj-9795	156	7	khorshidahmad	khorshidahmad	PROPN
ecj-9795	156	8	t	t	PROPN
ecj-9795	156	9	,	,	PUNCT
ecj-9795	156	10	motamedi	motamedi	PROPN
ecj-9795	156	11	m.	m.	NOUN
ecj-9795	156	12	antiinflammatory	antiinflammatory	NOUN
ecj-9795	156	13	effects	effect	NOUN
ecj-9795	156	14	of	of	ADP
ecj-9795	156	15	heparin	heparin	NOUN
ecj-9795	156	16	and	and	CCONJ
ecj-9795	156	17	its	its	PRON
ecj-9795	156	18	derivatives	derivative	NOUN
ecj-9795	156	19	:	:	PUNCT
ecj-9795	156	20	a	a	DET
ecj-9795	156	21	systematic	systematic	ADJ
ecj-9795	156	22	review	review	NOUN
ecj-9795	156	23	.	.	PUNCT
ecj-9795	157	1	adv	adv	PROPN
ecj-9795	157	2	pharmacol	pharmacol	PROPN
ecj-9795	157	3	sci	sci	PROPN
ecj-9795	157	4	2015;2015:507151	2015;2015:507151	PROPN
ecj-9795	157	5	.	.	PUNCT
ecj-9795	158	1	14	14	NUM
ecj-9795	158	2	.	.	PUNCT
ecj-9795	159	1	lin	lin	PROPN
ecj-9795	159	2	l	l	PROPN
ecj-9795	159	3	,	,	PUNCT
ecj-9795	159	4	lu	lu	PROPN
ecj-9795	159	5	l	l	NOUN
ecj-9795	159	6	,	,	PUNCT
ecj-9795	159	7	cao	cao	PROPN
ecj-9795	159	8	w	w	PROPN
ecj-9795	159	9	,	,	PUNCT
ecj-9795	159	10	li	li	PROPN
ecj-9795	159	11	t.	t.	PROPN
ecj-9795	159	12	hypothesis	hypothesis	NOUN
ecj-9795	159	13	for	for	ADP
ecj-9795	159	14	potential	potential	ADJ
ecj-9795	159	15	pathogenesis	pathogenesis	NOUN
ecj-9795	159	16	of	of	ADP
ecj-9795	159	17	sars	sar	NOUN
ecj-9795	159	18	-	-	PUNCT
ecj-9795	159	19	cov-2	cov-2	NOUN
ecj-9795	159	20	infection	infection	NOUN
ecj-9795	159	21	-	-	PUNCT
ecj-9795	159	22	a	a	DET
ecj-9795	159	23	review	review	NOUN
ecj-9795	159	24	of	of	ADP
ecj-9795	159	25	immune	immune	ADJ
ecj-9795	159	26	changes	change	NOUN
ecj-9795	159	27	in	in	ADP
ecj-9795	159	28	patients	patient	NOUN
ecj-9795	159	29	with	with	ADP
ecj-9795	159	30	viral	viral	ADJ
ecj-9795	159	31	pneumonia	pneumonia	NOUN
ecj-9795	159	32	.	.	PUNCT
ecj-9795	160	1	emerg	emerg	PROPN
ecj-9795	160	2	microbes	microbe	NOUN
ecj-9795	160	3	infect	infect	VERB
ecj-9795	160	4	2020;9:727	2020;9:727	NUM
ecj-9795	160	5	-	-	SYM
ecj-9795	160	6	32	32	NUM
ecj-9795	160	7	.	.	PUNCT
ecj-9795	161	1	15	15	NUM
ecj-9795	161	2	.	.	PUNCT
ecj-9795	162	1	johnson	johnson	PROPN
ecj-9795	162	2	z	z	PROPN
ecj-9795	162	3	,	,	PUNCT
ecj-9795	162	4	kosco	kosco	ADJ
ecj-9795	162	5	-	-	PUNCT
ecj-9795	162	6	vilbois	vilbois	PROPN
ecj-9795	162	7	mh	mh	PROPN
ecj-9795	162	8	,	,	PUNCT
ecj-9795	162	9	herren	herren	PROPN
ecj-9795	162	10	s	s	PROPN
ecj-9795	162	11	,	,	PUNCT
ecj-9795	162	12	et	et	PROPN
ecj-9795	162	13	al	al	PROPN
ecj-9795	162	14	.	.	PROPN
ecj-9795	162	15	interference	interference	NOUN
ecj-9795	162	16	with	with	ADP
ecj-9795	162	17	heparin	heparin	ADJ
ecj-9795	162	18	binding	binding	NOUN
ecj-9795	162	19	and	and	CCONJ
ecj-9795	162	20	oligomerization	oligomerization	NOUN
ecj-9795	162	21	creates	create	VERB
ecj-9795	162	22	a	a	DET
ecj-9795	162	23	novel	novel	NOUN
ecj-9795	162	24	antiinflammatory	antiinflammatory	NOUN
ecj-9795	162	25	strategy	strategy	NOUN
ecj-9795	162	26	targeting	target	VERB
ecj-9795	162	27	the	the	DET
ecj-9795	162	28	chemokine	chemokine	ADJ
ecj-9795	162	29	system	system	NOUN
ecj-9795	162	30	.	.	PUNCT
ecj-9795	163	1	j	j	PROPN
ecj-9795	163	2	immunol	immunol	NOUN
ecj-9795	163	3	2004;173:5776	2004;173:5776	NUM
ecj-9795	163	4	-	-	SYM
ecj-9795	163	5	85	85	NUM
ecj-9795	163	6	.	.	PUNCT
ecj-9795	163	7	16	16	NUM
ecj-9795	163	8	.	.	PUNCT
ecj-9795	164	1	thachil	thachil	PROPN
ecj-9795	164	2	j.	j.	PROPN
ecj-9795	164	3	the	the	DET
ecj-9795	164	4	versatile	versatile	PROPN
ecj-9795	164	5	heparin	heparin	NOUN
ecj-9795	164	6	in	in	ADP
ecj-9795	164	7	covid-307	covid-307	PROPN
ecj-9795	164	8	19	19	NUM
ecj-9795	164	9	.	.	PUNCT
ecj-9795	165	1	j	j	PROPN
ecj-9795	165	2	thromb	thromb	PROPN
ecj-9795	165	3	haemost	haemost	VERB
ecj-9795	165	4	2020;18:1020	2020;18:1020	NUM
ecj-9795	165	5	-	-	SYM
ecj-9795	165	6	2	2	NUM
ecj-9795	165	7	.	.	NUM
ecj-9795	165	8	17	17	NUM
ecj-9795	165	9	.	.	PUNCT
ecj-9795	166	1	venclauskas	venclauskas	PROPN
ecj-9795	166	2	l	l	PROPN
ecj-9795	166	3	,	,	PUNCT
ecj-9795	166	4	llau	llau	PROPN
ecj-9795	166	5	jv	jv	PROPN
ecj-9795	166	6	,	,	PUNCT
ecj-9795	166	7	jenny	jenny	PROPN
ecj-9795	166	8	jy	jy	PROPN
ecj-9795	166	9	,	,	PUNCT
ecj-9795	166	10	kjaersgaard	kjaersgaard	PROPN
ecj-9795	166	11	-	-	PUNCT
ecj-9795	166	12	andersen	andersen	PROPN
ecj-9795	166	13	p.	p.	PROPN
ecj-9795	166	14	esa	esa	PROPN
ecj-9795	166	15	vte	vte	PROPN
ecj-9795	166	16	guidelines	guideline	NOUN
ecj-9795	166	17	on	on	ADP
ecj-9795	166	18	perioperative	perioperative	ADJ
ecj-9795	166	19	venous	venous	ADJ
ecj-9795	166	20	thromboembolism	thromboembolism	NOUN
ecj-9795	166	21	prophylaxis	prophylaxis	NOUN
ecj-9795	166	22	:	:	PUNCT
ecj-9795	166	23	day	day	NOUN
ecj-9795	166	24	surgery	surgery	NOUN
ecj-9795	166	25	and	and	CCONJ
ecj-9795	166	26	fast	fast	ADJ
ecj-9795	166	27	track	track	NOUN
ecj-9795	166	28	surgery	surgery	NOUN
ecj-9795	166	29	.	.	PUNCT
ecj-9795	167	1	eur	eur	PROPN
ecj-9795	167	2	j	j	PROPN
ecj-9795	167	3	anaesthesiol	anaesthesiol	PROPN
ecj-9795	167	4	2018;35:134	2018;35:134	PROPN
ecj-9795	167	5	-	-	SYM
ecj-9795	167	6	8	8	NUM
ecj-9795	167	7	.	.	NOUN
ecj-9795	167	8	18	18	NUM
ecj-9795	167	9	.	.	PUNCT
ecj-9795	167	10	schünemann	schünemann	PROPN
ecj-9795	167	11	hj	hj	PROPN
ecj-9795	167	12	,	,	PUNCT
ecj-9795	167	13	cushman	cushman	PROPN
ecj-9795	167	14	m	m	PROPN
ecj-9795	167	15	,	,	PUNCT
ecj-9795	167	16	burnett	burnett	PROPN
ecj-9795	167	17	ae	ae	PROPN
ecj-9795	167	18	,	,	PUNCT
ecj-9795	167	19	et	et	PROPN
ecj-9795	167	20	al	al	PROPN
ecj-9795	167	21	.	.	PROPN
ecj-9795	168	1	american	american	PROPN
ecj-9795	168	2	society	society	PROPN
ecj-9795	168	3	of	of	ADP
ecj-9795	168	4	hematology	hematology	NOUN
ecj-9795	168	5	2018	2018	NUM
ecj-9795	168	6	guidelines	guideline	NOUN
ecj-9795	168	7	for	for	ADP
ecj-9795	168	8	management	management	NOUN
ecj-9795	168	9	of	of	ADP
ecj-9795	168	10	venous	venous	ADJ
ecj-9795	168	11	thromboembolism	thromboembolism	NOUN
ecj-9795	168	12	:	:	PUNCT
ecj-9795	168	13	prophylaxis	prophylaxis	PROPN
ecj-9795	168	14	for	for	ADP
ecj-9795	168	15	hospitalized	hospitalize	VERB
ecj-9795	168	16	and	and	CCONJ
ecj-9795	168	17	nonhospitalized	nonhospitalize	VERB
ecj-9795	168	18	medical	medical	ADJ
ecj-9795	168	19	patients	patient	NOUN
ecj-9795	168	20	.	.	PUNCT
ecj-9795	169	1	blood	blood	NOUN
ecj-9795	169	2	adv	adv	PROPN
ecj-9795	169	3	2018;2:3198225	2018;2:3198225	NUM
ecj-9795	169	4	.	.	PUNCT
ecj-9795	170	1	19	19	NUM
ecj-9795	170	2	.	.	PUNCT
ecj-9795	171	1	kaatz	kaatz	PROPN
ecj-9795	171	2	s	s	PROPN
ecj-9795	171	3	,	,	PUNCT
ecj-9795	171	4	ahmad	ahmad	PROPN
ecj-9795	171	5	d	d	PROPN
ecj-9795	171	6	,	,	PUNCT
ecj-9795	171	7	spyropoulos	spyropoulos	PROPN
ecj-9795	171	8	ac	ac	PROPN
ecj-9795	171	9	,	,	PUNCT
ecj-9795	171	10	schulman	schulman	NOUN
ecj-9795	171	11	s	s	PROPN
ecj-9795	171	12	;	;	PUNCT
ecj-9795	171	13	subcommittee	subcommittee	NOUN
ecj-9795	171	14	on	on	ADP
ecj-9795	171	15	control	control	NOUN
ecj-9795	171	16	of	of	ADP
ecj-9795	171	17	anticoagulation	anticoagulation	NOUN
ecj-9795	171	18	.	.	PUNCT
ecj-9795	172	1	definition	definition	NOUN
ecj-9795	172	2	of	of	ADP
ecj-9795	172	3	clinically	clinically	ADV
ecj-9795	172	4	relevant	relevant	ADJ
ecj-9795	172	5	non	non	ADJ
ecj-9795	172	6	-	-	ADJ
ecj-9795	172	7	major	major	ADJ
ecj-9795	172	8	bleeding	bleeding	NOUN
ecj-9795	172	9	in	in	ADP
ecj-9795	172	10	studies	study	NOUN
ecj-9795	172	11	of	of	ADP
ecj-9795	172	12	anticoagulants	anticoagulant	NOUN
ecj-9795	172	13	in	in	ADP
ecj-9795	172	14	atrial	atrial	ADJ
ecj-9795	172	15	fibrillation	fibrillation	NOUN
ecj-9795	172	16	and	and	CCONJ
ecj-9795	172	17	venous	venous	ADJ
ecj-9795	172	18	thromboembolic	thromboembolic	ADJ
ecj-9795	172	19	disease	disease	NOUN
ecj-9795	172	20	in	in	ADP
ecj-9795	172	21	non	non	ADJ
ecj-9795	172	22	-	-	ADJ
ecj-9795	172	23	surgical	surgical	ADJ
ecj-9795	172	24	patients	patient	NOUN
ecj-9795	172	25	:	:	PUNCT
ecj-9795	172	26	communication	communication	NOUN
ecj-9795	172	27	from	from	ADP
ecj-9795	172	28	the	the	DET
ecj-9795	172	29	ssc	ssc	NOUN
ecj-9795	172	30	of	of	ADP
ecj-9795	172	31	the	the	DET
ecj-9795	172	32	isth	isth	NOUN
ecj-9795	172	33	.	.	PUNCT
ecj-9795	173	1	j	j	PROPN
ecj-9795	173	2	thromb	thromb	PROPN
ecj-9795	173	3	haemost	haemost	VERB
ecj-9795	173	4	.	.	PUNCT
ecj-9795	174	1	2015;13:2119	2015;13:2119	NUM
ecj-9795	174	2	-	-	SYM
ecj-9795	174	3	26	26	NUM
ecj-9795	174	4	.	.	PUNCT
ecj-9795	174	5	20	20	NUM
ecj-9795	174	6	.	.	PUNCT
ecj-9795	175	1	yang	yang	PROPN
ecj-9795	175	2	j	j	PROPN
ecj-9795	175	3	,	,	PUNCT
ecj-9795	175	4	zheng	zheng	PROPN
ecj-9795	175	5	y	y	PROPN
ecj-9795	175	6	,	,	PUNCT
ecj-9795	175	7	gou	gou	PROPN
ecj-9795	175	8	x	x	PROPN
ecj-9795	175	9	,	,	PUNCT
ecj-9795	175	10	et	et	PROPN
ecj-9795	175	11	al	al	PROPN
ecj-9795	175	12	.	.	PUNCT
ecj-9795	176	1	prevalence	prevalence	NOUN
ecj-9795	176	2	of	of	ADP
ecj-9795	176	3	comorbidities	comorbiditie	NOUN
ecj-9795	176	4	and	and	CCONJ
ecj-9795	176	5	its	its	PRON
ecj-9795	176	6	effects	effect	NOUN
ecj-9795	176	7	in	in	ADP
ecj-9795	176	8	patients	patient	NOUN
ecj-9795	176	9	infected	infect	VERB
ecj-9795	176	10	with	with	ADP
ecj-9795	176	11	sars	sar	NOUN
ecj-9795	176	12	-	-	PUNCT
ecj-9795	176	13	cov-2	cov-2	NUM
ecj-9795	176	14	:	:	PUNCT
ecj-9795	176	15	a	a	DET
ecj-9795	176	16	systematic	systematic	ADJ
ecj-9795	176	17	review	review	NOUN
ecj-9795	176	18	and	and	CCONJ
ecj-9795	176	19	meta	meta	ADJ
ecj-9795	176	20	-	-	PUNCT
ecj-9795	176	21	analysis	analysis	NOUN
ecj-9795	176	22	.	.	PUNCT
ecj-9795	177	1	int	int	NOUN
ecj-9795	177	2	j	j	PROPN
ecj-9795	177	3	infect	infect	VERB
ecj-9795	177	4	dis	dis	PROPN
ecj-9795	177	5	2020;94:91	2020;94:91	NUM
ecj-9795	177	6	-	-	SYM
ecj-9795	177	7	5	5	NUM
ecj-9795	177	8	.	.	NUM
ecj-9795	177	9	21	21	NUM
ecj-9795	177	10	.	.	PUNCT
ecj-9795	178	1	livingston	livingston	PROPN
ecj-9795	178	2	e	e	PROPN
ecj-9795	178	3	,	,	PUNCT
ecj-9795	178	4	bucher	bucher	PROPN
ecj-9795	178	5	k.	k.	PROPN
ecj-9795	178	6	coronavirus	coronavirus	PROPN
ecj-9795	178	7	disease	disease	NOUN
ecj-9795	178	8	2019	2019	NUM
ecj-9795	178	9	(	(	PUNCT
ecj-9795	178	10	covid19	covid19	NOUN
ecj-9795	178	11	)	)	PUNCT
ecj-9795	178	12	in	in	ADP
ecj-9795	178	13	italy	italy	PROPN
ecj-9795	178	14	.	.	PUNCT
ecj-9795	178	15	jama	jama	PROPN
ecj-9795	178	16	2020;323:1335	2020;323:1335	NUM
ecj-9795	178	17	.	.	PUNCT
ecj-9795	179	1	22	22	NUM
ecj-9795	179	2	.	.	PUNCT
ecj-9795	179	3	bonetti	bonetti	PROPN
ecj-9795	179	4	po	po	PROPN
ecj-9795	179	5	,	,	PUNCT
ecj-9795	179	6	lerman	lerman	PROPN
ecj-9795	179	7	lo	lo	PROPN
ecj-9795	179	8	,	,	PUNCT
ecj-9795	179	9	lerman	lerman	NOUN
ecj-9795	179	10	a.	a.	NOUN
ecj-9795	179	11	endothelial	endothelial	ADJ
ecj-9795	179	12	dysfunction	dysfunction	NOUN
ecj-9795	179	13	:	:	PUNCT
ecj-9795	179	14	a	a	DET
ecj-9795	179	15	marker	marker	NOUN
ecj-9795	179	16	of	of	ADP
ecj-9795	179	17	atherosclerotic	atherosclerotic	ADJ
ecj-9795	179	18	risk	risk	NOUN
ecj-9795	179	19	.	.	PUNCT
ecj-9795	180	1	arterioscler	arterioscler	PROPN
ecj-9795	180	2	thromb	thromb	PROPN
ecj-9795	180	3	vasc	vasc	PROPN
ecj-9795	180	4	biol	biol	PROPN
ecj-9795	180	5	2003;23:168	2003;23:168	PROPN
ecj-9795	180	6	-	-	SYM
ecj-9795	180	7	75	75	NUM
ecj-9795	180	8	.	.	PUNCT
ecj-9795	181	1	23	23	NUM
ecj-9795	181	2	.	.	PUNCT
ecj-9795	182	1	wichmann	wichmann	PROPN
ecj-9795	182	2	d	d	PROPN
ecj-9795	182	3	,	,	PUNCT
ecj-9795	182	4	sperhake	sperhake	PROPN
ecj-9795	182	5	j	j	PROPN
ecj-9795	182	6	,	,	PUNCT
ecj-9795	182	7	et	et	PROPN
ecj-9795	182	8	al	al	PROPN
ecj-9795	182	9	.	.	PROPN
ecj-9795	182	10	autopsy	autopsy	PROPN
ecj-9795	182	11	findings	finding	NOUN
ecj-9795	182	12	and	and	CCONJ
ecj-9795	182	13	venous	venous	ADJ
ecj-9795	182	14	thromboembolism	thromboembolism	NOUN
ecj-9795	182	15	in	in	ADP
ecj-9795	182	16	patients	patient	NOUN
ecj-9795	182	17	with	with	ADP
ecj-9795	182	18	covid-19	covid-19	PROPN
ecj-9795	182	19	:	:	PUNCT
ecj-9795	182	20	a	a	DET
ecj-9795	182	21	prospective	prospective	ADJ
ecj-9795	182	22	cohort	cohort	NOUN
ecj-9795	182	23	study	study	NOUN
ecj-9795	182	24	.	.	PUNCT
ecj-9795	183	1	ann	ann	PROPN
ecj-9795	183	2	intern	intern	PROPN
ecj-9795	183	3	med	me	VERB
ecj-9795	183	4	2020;173:268	2020;173:268	PROPN
ecj-9795	183	5	-	-	SYM
ecj-9795	183	6	77	77	NUM
ecj-9795	183	7	.	.	PUNCT
ecj-9795	184	1	24	24	NUM
ecj-9795	184	2	.	.	PUNCT
ecj-9795	184	3	helms	helm	NOUN
ecj-9795	184	4	,	,	PUNCT
ecj-9795	184	5	c.	c.	PROPN
ecj-9795	184	6	tacquard	tacquard	PROPN
ecj-9795	184	7	,	,	PUNCT
ecj-9795	184	8	f.	f.	PROPN
ecj-9795	184	9	severac	severac	PROPN
ecj-9795	184	10	,	,	PUNCT
ecj-9795	185	1	i.	i.	PROPN
ecj-9795	185	2	et	et	PROPN
ecj-9795	185	3	al	al	PROPN
ecj-9795	185	4	.	.	PROPN
ecj-9795	185	5	high	high	ADJ
ecj-9795	185	6	risk	risk	NOUN
ecj-9795	185	7	of	of	ADP
ecj-9795	185	8	thrombosis	thrombosis	NOUN
ecj-9795	185	9	in	in	ADP
ecj-9795	185	10	patients	patient	NOUN
ecj-9795	185	11	with	with	ADP
ecj-9795	185	12	severe	severe	ADJ
ecj-9795	185	13	sars	sar	NOUN
ecj-9795	185	14	-	-	PUNCT
ecj-9795	185	15	cov-2	cov-2	PART
ecj-9795	185	16	infection	infection	NOUN
ecj-9795	185	17	:	:	PUNCT
ecj-9795	185	18	a	a	DET
ecj-9795	185	19	multicenter	multicenter	ADJ
ecj-9795	185	20	prospective	prospective	ADJ
ecj-9795	185	21	cohort	cohort	NOUN
ecj-9795	185	22	study	study	NOUN
ecj-9795	185	23	.	.	PUNCT
ecj-9795	186	1	intensive	intensive	ADJ
ecj-9795	186	2	care	care	NOUN
ecj-9795	186	3	med	med	PROPN
ecj-9795	186	4	2020;46:1089	2020;46:1089	NUM
ecj-9795	186	5	-	-	SYM
ecj-9795	186	6	98	98	NUM
ecj-9795	186	7	.	.	PUNCT
ecj-9795	187	1	25	25	NUM
ecj-9795	187	2	.	.	PUNCT
ecj-9795	187	3	schutgens	schutgens	PROPN
ecj-9795	187	4	re	re	AUX
ecj-9795	187	5	.	.	PUNCT
ecj-9795	187	6	doac	doac	PROPN
ecj-9795	187	7	in	in	ADP
ecj-9795	187	8	covid-19	covid-19	PROPN
ecj-9795	187	9	:	:	PUNCT
ecj-9795	187	10	yes	yes	INTJ
ecj-9795	187	11	or	or	CCONJ
ecj-9795	187	12	no	no	INTJ
ecj-9795	187	13	?	?	PUNCT
ecj-9795	188	1	hemasphere	hemasphere	ADV
ecj-9795	188	2	2020;5	2020;5	NUM
ecj-9795	188	3	:	:	PUNCT
ecj-9795	188	4	e526	e526	PROPN
ecj-9795	188	5	.	.	NOUN
ecj-9795	189	1	26	26	NUM
ecj-9795	189	2	.	.	PUNCT
ecj-9795	190	1	talasaz	talasaz	PROPN
ecj-9795	190	2	ah	ah	INTJ
ecj-9795	190	3	,	,	PUNCT
ecj-9795	190	4	sadeghipour	sadeghipour	ADJ
ecj-9795	190	5	p	p	X
ecj-9795	190	6	,	,	PUNCT
ecj-9795	190	7	kakavand	kakavand	PROPN
ecj-9795	190	8	h.	h.	PROPN
ecj-9795	190	9	recent	recent	ADJ
ecj-9795	190	10	randomized	randomized	ADJ
ecj-9795	190	11	trials	trial	NOUN
ecj-9795	190	12	of	of	ADP
ecj-9795	190	13	antithrombotic	antithrombotic	ADJ
ecj-9795	190	14	therapy	therapy	NOUN
ecj-9795	190	15	for	for	ADP
ecj-9795	190	16	patients	patient	NOUN
ecj-9795	190	17	with	with	ADP
ecj-9795	190	18	covid-19	covid-19	PROPN
ecj-9795	190	19	:	:	PUNCT
ecj-9795	190	20	jacc	jacc	PROPN
ecj-9795	190	21	state	state	NOUN
ecj-9795	190	22	-	-	PUNCT
ecj-9795	190	23	of	of	ADP
ecj-9795	190	24	-	-	PUNCT
ecj-9795	190	25	the	the	DET
ecj-9795	190	26	-	-	PUNCT
ecj-9795	190	27	art	art	NOUN
ecj-9795	190	28	review	review	NOUN
ecj-9795	190	29	.	.	PUNCT
ecj-9795	191	1	j	j	PROPN
ecj-9795	191	2	am	be	AUX
ecj-9795	191	3	coll	coll	PROPN
ecj-9795	191	4	cardiol	cardiol	VERB
ecj-9795	191	5	2021;77:1903	2021;77:1903	NUM
ecj-9795	191	6	-	-	SYM
ecj-9795	191	7	21	21	NUM
ecj-9795	191	8	.	.	PUNCT
ecj-9795	192	1	article	article	NOUN
ecj-9795	192	2	[	[	X
ecj-9795	192	3	emergency	emergency	NOUN
ecj-9795	192	4	care	care	NOUN
ecj-9795	192	5	journal	journal	PROPN
ecj-9795	192	6	2021	2021	NUM
ecj-9795	192	7	;	;	PUNCT
ecj-9795	192	8	17:9795	17:9795	NUM
ecj-9795	192	9	]	]	PUNCT
ecj-9795	193	1	[	[	X
ecj-9795	193	2	page	page	NOUN
ecj-9795	193	3	31	31	NUM
ecj-9795	193	4	]	]	PUNCT
ecj-9795	193	5	non	non	ADJ
ecj-9795	193	6	-co	-co	PROPN
ecj-9795	193	7	mmerc	mmerc	PROPN
ecj-9795	193	8	ial	ial	PROPN
ecj-9795	193	9	us	us	PROPN
ecj-9795	193	10	e	e	NOUN
ecj-9795	193	11	o	o	NOUN
ecj-9795	193	12	nly	nly	ADV